



























the	 scientific	 community.	 Most	 challenging	 is	 responding	 to	 the	 evolutionary	
adaptability	 of	 influenza	 virus,	 which	 often	 hinders	 effective	 prevention	 or	
treatment.	Furthermore,	current	production	methods	are	logistically	and	technically	
inadequate	 to	 cope	 with	 pandemic	 surges,	 leaving	 a	 considerable	 number	 of	
individuals	unprotected.	
Tandem	 Core	 Virus-Like	 Particles	 (VLPs),	 expressed	 in	 Pichia	 pastoris,	 offer	 an	
exciting	proposition	to	create	a	platform	process	for	a	universal	 influenza	vaccine.	
However,	 as	 with	 all	 novel	 concepts,	 characterisation	 of	 this	 technology	 was	
required	and	process	methodologies	were	developed	accordingly.		
Initially,	 critical	 process	 parameters,	 associated	 with	 production	 of	 novel	 VLP	
constructs,	 were	 identified.	 In	 doing	 so,	 a	 need	 for	 a	 robust,	 high-throughput	
miniaturised	 fermentation	 platform	 was	 recognised.	 To	 accommodate	 such	 an	
approach,	 a	 high-throughput,	 non-contact,	 automated,	 small-scale,	 scalable	
disruption	 tool	was	developed	 to	extract	VLPs	 from	P.	pastoris.	Development	and	
optimisation	of	this	method	led	to	matching	and	even	outperforming	High	Pressure	
Homogenisation	performance.	
Having	 developed	 the	 prerequisite	 tools	 for	 miniaturised	 upstream	 process	
development,	 the	 use	 of	 microtitre	 plates	 for	 studying	 heterologous	 protein	












critical	 process	 parameters	 were	 studied	 to	 a	 greater	 extent	 using	 miniaturised	
bioreactors,	 initially	 with	 a	 simplified,	 non-epitope-exposing,	 variant	 of	 Tandem	
Core	 VLP.	 Metabolic	 responses,	 such	 as	 final	 biomass	 concentration,	 required	
significantly	 different	 optimum	 operating	 conditions	 than	 product	 expression	




This	 was	 accomplished	 by	 investigating	 the	 effects	 of	 scale-up	 and	 variation	 of	
epitope	 inserts	 that	 could	 be	 utilised	 as	 a	 universal	 influenza	 antigens.	 Following	







• Increased	 understanding	 in	 the	 potential	 and	 limitations	 of	 Tandem	 Core	
technology	 as	 an	 epitope	 scaffold	 for	 customisable	 vaccine	 development.	 This	
knowledge	will	pave	the	way,	not	only	to	a	universal	 influenza	vaccine	production	
process,	but	to	a	universal	production	process	for	vaccines	in	general.	
• Optimised	 and	 scalable	 processes	 for	 Tandem	 Core	 VLP	 production,	 allowing	 for	
scalable	and	maximum	vaccine	production	capacity.	This	is	particularly	beneficial	in	
the	event	of	a	pandemic	surge.		
• Increased	 understanding	 of	metabolic	 effects	 in	P.	 pastoris	 fermentations.	 These	
findings	could	translate	well	to	process	development	of	many	biopharmaceuticals	
• Multiple	 response	 models	 and	 correlations	 that	 can	 be	 used	 to	 predict	
performance	of	cell	disruption	using	high	pressure	homogenisers.	This	knowledge	
extends	to	extraction	of	VLPs	and	biopharmaceuticals	other	than	VLPs.		
• Development	 of	 a	 high-performance,	 high-throughput,	 non-contact,	 automated,	
small-scale,	 scalable	 disruption	 tool	 for	 microbial	 bioprocess	 development.	 The	
utility	of	this	work	means	that,	for	microbial	cultures	with	sizeable	cell	walls,	such	
as	 P.	 pastoris,	 an	 efficient	 scale-down	 tools	 is	 now	 available	 adding	 to	 the	
processing	 tools	 set.	 This	 can	 be	 used	 for	 a	 wide	 range	 of	 applications	 including	
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tHBc	 respectively.	 (C	and	D)	Expression	at	various	glycerol	 flow	rates	of	 total	
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The	 Cough	 of	 Perinthus,	 described	 in	 412	 BC	 by	 Hippocrates,	 is	 possibly	 the	 first	
name	 attributed	 to	 what	 is	 now	 known	 as	 influenza	 or	 flu	 (Martin	 and	 Martin-
Granel,	 2006;	 Monto	 and	 Sellwood,	 2013).	 Influenza	 has	 gained	 notoriety	






Most	 challenging	 is	 responding	 to	 the	evolutionary	adaptability	of	 influenza	virus,	
which	often	hinders	 effective	prevention	or	 treatment	of	 influenza	 (Brooks	et	al.,	
2013).	Furthermore,	current	production	methods	are	logistically	and	technologically	
inadequate	 to	 cope	 with	 pandemic	 surges,	 leaving	 a	 considerable	 number	 of	
individuals	unprotected	during	such	events.	
This	chapter	aims	to	review	current	vaccine	technologies	and	introduce	the	reader	








genome	 consists	 of	 8	 sections1,	 encoding	 for	 ten	 genes2	(Brooks	 et	 al.,	 2013;	
Haaheim	and	Oxford,	2013).		
The	 virus	 particle	 is	 surrounded	 by	 a	 lipid	 bilayer,	 derived	 from	 the	 host	 cell’s	
plasma	membrane	and	consisting	of	a	variety	of	transmembrane	proteins	including	
hemagglutinin	(HA),	neuraminidase	(NA),	and	matrix	protein	2	(M2).	Supporting	the	
lipid	 bilayer	 is	 a	 matrix,	 composed	 of	 matrix	 1	 proteins	 (M1),	 that	 holds	 viral	
ribonucleoproteins	 (vRNPs).	 The	 vRNPs	 are	 composed	 of	 RNA,	 wrapped	 in	
nucleoprotein	 (NP)	 and	 relatively	 small	 amounts	 of	 nuclear	 export	 protein	 (NEP)	















Figure	 1.2	 shows	 the	 lifecycle	 of	 influenza.	 After	 transmission	 of	 the	 virus	 into	 a	
host’s	 body,	 the	 virus	 attaches	 itself	 to	 the	 surface	 of	 host	 cell,	 preferably	 	 to	
epithelial	 cells	 in	 the	 respiratory	 tract	 (Brooks	 et	 al.,	 2013;	 Haaheim	 and	Oxford,	
2013)	 This	 attachment	 is	mediated	 by	 HA,	which	 binds	 to	 terminal	 sialic	 acids	 of	
glycolipids	and	glycoproteins	on	the	cell	surface.	HA	specificity	depends	 largely	on	
the	 type	 of	 linkage	 between	 sialic	 acid	 and	 the	 carbohydrates	 bound	 to	
glycoproteins	 or	 glycolipids.	 So-called	 α-2,6	 linkage	 is	 generally	 associated	 with	
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nucleus.	 (D)	 Replication	 of	 viral	 RNA.	 (E)	 Exportation	 of	 mRNA	 into	 the	 cytosol.	 (F)	
Translation	of	viral	mRNA	into	viral	proteins.	 (G)	Assembly	of	new	virus.	 (Adapted	from	
Imperial	College	London,	2000)	
Once	 the	 HA	 is	 bound	 to	 the	 cell	 surface,	 the	 cellular	 membrane	 encloses	 itself	




endosomal	membrane,	which	exposes	 the	virus	matrix	 to	 the	host	cell	 cytoplasm.	
The	M2	protein,	which	 is	 an	 ion	 channel,	 also	opens	due	 to	 the	 acidic	 conditions	














the	virus	particle.	This	 results	 in	 the	disassociation	of	vRNPs	with	M1	protein	and	
ultimately	 the	entry	of	vRNPs	 to	 the	cytoplasm	(Pinto,	Holsinger	and	Lamb,	1992;	
Samji,	2009;	Haaheim	and	Oxford,	2013).		
The	vRNPs	travel	to	the	host	cell	nucleus	after	they	are	released	into	the	cytoplasm.	
Much	 remains	 unknown	 about	 the	 mechanism	 by	 which	 this	 happens.	 What	 is	
known	 is	 that	some	regions	of	 the	NPs	 in	a	vRNP	 function	as	Nuclear	Localisation	
Signals	 (NLSs)	 that	 can	 bind	 to	 the	 cell’s	 nuclear	 import	 cascade	 (Wu,	 Sun	 and	
Pante,	2007).		
Once	 inside	 the	 cell	 nucleus,	 the	 vRNP	 complex	 uses	 its	 own	 enzymes	 to	 make	
positive	sense	cRNA	copies	of	the	negative	sense	vRNA	template.	Unlike	most	RNA	
polymerase,	 this	 particular	 viral	 polymerase	 does	 not	 require	 DNA	 as	 a	 template	
(Alberts	et	al.,	2004;	Crow	et	al.,	2004).	The	vRNP	instead	uses	its	RNA-dependent	
RNA	polymerase	(RdRp)	to	produce	positive	sense	RNA.	The	positive	sense	RNA	can	
then	 either	 be	 used	 as	 a	 template	 to	 produce	 negative	 sense	 RNA	 for	 progeny	
virions	 or	 can	 be	 altered	 to	 function	 as	messenger	 RNA	 to	 recruit	 virus	 proteins	
(Crow	et	al.,	 2004;	Haaheim	and	Oxford,	2013).	 In	 the	 latter	 case,	 for	 the	RNA	 to	
function	as	messenger	RNA,	it	needs	to	travel	from	the	nucleus	to	the	ribosomes	in	
the	cytoplasm	to	be	translated	to	protein.	Eukaryotic	mRNA	needs	to	be	modified	
before	 it	 can	 leave	 the	 nucleus	 and	 therefore	 undergoes	 two	 steps	 prior	 to	 this:	
RNA	capping	and	polyadenylation.	RNA	capping	involves	the	addition	of	a	guanine	
nucleotide	 with	 a	 methyl	 group	 at	 the	 5’	 end	 of	 the	 mRNA	 transcript.	





influenza	mimics	 the	poly-A	 tail,	however,	 it	does	not	 contain	an	RNA	cap	 (Samji,	
2009).	To	circumvent	this	obstacle,	the	RdRp	complex	utilises	a	mechanism	referred	
to	 as	 ‘cap-snatching’,	 which	 involves	 cleaving	 the	 5’	 end	 of	 cellular	 mRNA	 and	
transferring	 this	 to	 the	 viral	 cRNA	 (Plotch,	 Bouloy	 and	 Krug,	 1979).	 Once	 new	
negative	 sense	 vRNA	 strands	 have	 been	 produced	 from	 the	 cRNA	 templates	 and	
have	 formed	 vRNPs	 they	 are	 exported	 out	 of	 the	 nucleus	 via	 the	 Crm1	 pathway.	
After	 sufficient	 viral	 genetic	 material	 and	 protein	 has	 been	 generated,	 the	 virus	
surface	 proteins	 (M2,	 HA	 and	 NA)	 assemble	 on	 the	 lumen	 of	 the	 host	 cell	
























To	 further	 understand	 the	 classification	 and	 nomenclature	 of	 influenza	 virus,	
particularly	 type	A,	 one	must	 consider	 the	phenomenon	of	 genetic	 reassortment.	
This	can	occur	in	two	ways,	called	antigenic	drift	and	antigenic	shift.	
Like	most	RNA	viruses,	the	influenza	virus	has	no	genetic	proofreading	mechanism,	
causing	 as	 much	 as	 10%	 of	 a	 virus	 population	 to	 be	 mutants.	 The	 mutations	
occurring	 in	 influenza	 virus	 often	 do	 not	 compromise	 the	 structure	 of	 proteins	




that	 interact	with	 antibodies	 upon	 infection	 of	 a	 host.	 Therefore,	when	 sufficient	
changes	occur	 in	 these	 regions,	 the	 adaptive	 immune	 system	 (1.5.2)	might	 fail	 to	
neutralise	 the	 infectious	agent,	 potentially	 leading	 to	an	epidemic	outbreak.	 Such	
an	accumulation	of	mutations	in	the	genes	coding	for	the	antibody-binding	sites	is	
referred	 to	 as	 antigenic	 drift	 and	 can	 manifest	 itself	 as	 new	 field	 variants	 of	
influenza	virus	(Haaheim	and	Oxford,	2013).	
More	 fundamental	 changes	 occur	 during	 another	mode	 of	 genetic	 reassortment:	
antigenic	 shift.	 This	 can	 occur	when	 two	 different	 influenza	 species	 co-infect	 the	






Influenza	 virus	B	 and	 influenza	 virus	C	do	not	have	 related	 viruses	 existing	 in	 the	
same	 hosts.	 This	 is	 why	 antigenic	 shift	 occurs	 exclusively	 in	 influenza	 virus	 A	
serotypes.	 Therefore,	 only	 influenza	 virus	 A	 has	 designated	 subtypes,	 based	 on	
antigenic	 differences	 exhibited	 by	 HA	 and	 NA	 (Brooks	 et	 al.,	 2013).	 There	 are	
seventeen	 recorded	 subtypes	 of	 hemagglutinin	 (H1-H17)	 and	 ten	 subtypes	 of	






The	 nomenclature	 of	 a	 particular	 influenza	 virus	 serotype	 shows	 the	 following	
information	in	the	following	sequence:	type	(A,	B	or	C),	host	animal	of	isolate	(not	
for	human	host),	geographic	origin	of	isolation,	strain	number,	year	of	isolation	and	
–	 only	 in	 the	 case	 of	 influenza	 virus	 A	 -	 the	 particular	 antigenic	 variations	 of	
neuraminidase	and	hemagglutinin.	Hence,	an	influenza	virus	A	isolate	from	a	person	
in	 Brisbane	 in	 2007	 can	 look	 like:	 A/Brisbane/	 1/68(H3N2);	 an	 influenza	 virus	 B	
isolate	can	be	named:	B/Brisbane/60/2008;	and	an	influenza	virus	A	isolate	from	a	
pig	 can	 be	 labelled	 as:	A/swine/lowa/15/30(H1N1)	 (Brooks	 et	 al.,	 2013;	 Haaheim	
and	Oxford,	2013).	
1.4.4 Seasonal	influenza	
Annual	 seasonal	 epidemics	 of	 influenza	 occur	 due	 to	 the	 previously	 explained	
antigenic	drifts	 in	viral	populations,	causing	slight	amino	acid	sequence	changes	 in	
HA	and	NA	epitopes	 (Chowell,	Nishiura	and	Bettencourt,	 2007).	 This	 can	 result	 in	
the	 immune	 system	 not	 recognising	 the	 novel	 surface	 proteins	 and	 can	 cause	
previously	 acquired	 immunity	 to	 become	 ineffective	 (Nicholson,	 Wood	 and	
Zambon,	2003).	
In	 the	 northern	 hemisphere	 influenza	 virus	 typically	 circulates	 from	November	 to	
March.	 Influenza	 usually	 circulates	 between	May	 and	 September	 in	 the	 southern	
hemisphere	 (Edlund	et	al.,	 2011).	However,	 in	 tropical	 regions,	 seasonal	 influenza	
occurs	 all	 year	 around	 and	 therefore,	 some	 argue,	 the	 term	 ‘inter-pandemic’	
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influenza	 is	 technically	 more	 appropriate	 (Lowen	 et	 al.,	 2007;	 Van-Tam	 and	
Sellwood,	2013).		
1.4.5 	Pandemic	influenza	
An	 influenza	 pandemic	 is	 typically	 rare,	 in	 comparison	 to	 seasonal	 outbreaks	 of	
influenza.	 Such	 an	 event	 can	 be	 defined	 as:	 ‘When	 a	 novel	 influenza	 A	 subtype	
spreads	 worldwide’	 (Van-Tam	 and	 Sellwood,	 2013).	 It	 should	 be	 stressed	 that	
seasonal	 influenza	and	pandemic	 influenza	are	not	separate	viral	entities,	but	can	
rather	 be	 seen	 as	 different	 stages	 in	 the	 evolution	 of	 the	 virus.	 For	 instance,	 the	
A(H1N1)	 virus	 which	 emerged	 in	 1918,	 caused	 the	 Spanish	 influenza	 pandemic	
lasting	until	1920	 (Monto	and	Sellwood,	2013).	However,	 seasonal	variants	of	 the	
A(H1N1)	 virus	 kept	 circulating	 until	 1956	 (Van-Tam	 and	 Sellwood,	 2013).	 These	
viruses	were	antigenic	drifted	version	of	the	1918	virus	that	had	lost	virulence,	due	
to	wide-scale	increase	of	immunity	among	the	general	population.		




as	 reservoirs	 for	 strains	 for	 influenza	 A	 and,	 occasionally,	 through	 close	 contact,	
strains	can	jump	species	directly.	However,	it	is	more	common	that	a	third	species	












immunity	 and	 adaptive	 immunity.	 Innate	 immunity,	 also	 known	 as	 natural	
immunity,	is	largely	a	function	of	an	immediate	response	by	phagocytes.	This	class	
of	 white	 blood	 cells	 includes	 natural	 killer	 cells,	 macrophages	 and	 granulocytes;	
which	 engulf	 and	 kill	 most	 pathogens.	 The	 activation	 of	 the	 innate	 immune	
response	triggers	the	adaptive	immune	response	(Madigan	et	al.,	2009).	
Adaptive	immunity	is	arguably	more	complex	and	has	more	relevance	to	the	topic	







immunity	 is	 acquired	 over	 time	 and	 its	 response	 can	 be	 up	 to	 3	 to	 4	 days	 after	
infection	(Haaheim	and	Oxford,	2013).		
1.5.1 The	innate	immune	response		
Phagocytes	 are	 the	 major	 constituents	 of	 the	 innate	 immune	 response	 and	 can	
recognise	 pathogens	 via	membrane-bound	 Pattern-Recognition	Molecules	 (PRMs)	
also	known	as	Pattern-Recognition	Receptors	(PRRs)	(Madigan	et	al.,	2009;	Kreijtz,	
Fouchier	 and	 Rimmelzwaan,	 2011).	 Such	 a	molecule	 can	 interact	with	 a	 so-called	
Pathogen-Associated	Molecular	Pattern	(PAMP).	For	example,	Toll-Like	Receptor	4	
(TLR-4),	 a	 human	 PRM,	 interacts	 with	 lipopolysaccharide	 (LPS),	 which	 is	 an	
endotoxin	 characteristic	 to	 gram-negative	 bacteria.	 The	 specific	 PRM-PAMP	














will	 be	 destroyed	 before	 it	matures.	 The	 previously	mentioned	 APCs	 can	 present	







A	 naïve	 CD4+	 T-cell	 can	 recognise	 foreign	 antigens	 bound	 to	 MHC	 II	 receptors	
causing	the	T-cell	to	activate	to	a	T-helper	cell.	T-helper	cells	enhance	the	immune	
response	 by	 secreting	 cytokines	 that	 activate	 phagocytes,	 natural	 killer	 (NK)	 cells	
and	B-cells.			
Naïve	mature	B-cells	are	coated	in	pre-made	antibodies	that	can	bind	to	antigens.	A	
naïve	 mature	 B-cell	 initially	 functions	 as	 an	 APC	 by	 endocytosing	 and	 degrading	
these	antigens,	and	presenting	them	on	surface	MHC	II	proteins	to	a	subtype	of	T-




differentiate,	 they	 immediately	 turn	 into	plasma	cells	without	 the	assistance	of	T-
cells.	Plasma	cells	produce	antigen	specific	antibodies.	These	antibodies	can	prevent	






It	 is	 thought	 that	 there	 are	 several	 PRMs	 involved	 in	 the	 innate	 response	 to	
influenza	 virus	 infection.	 Toll-like	 receptor	 7	 (TLR-7),	 present	 in	 mainly	 dendritic	
cells,	 recognises	 single-stranded	 viral	 RNA	 (Kreijtz,	 Fouchier	 and	 Rimmelzwaan,	
2011).	Retinoic	acid	inducible	gene	I	(RIG-I)	recognises	5’-triphosphates	in	genomics	
single	stranded	RNA,	which	appear	after	infection	of	the	host	cell	(Pichlmair	et	al.,	
2006;	 Pang	 and	 Iwasaki,	 2011).	 Toll-like	 receptor	 3	 (TLR-3)	 bind	 double-stranded	
viral	RNA.	These	interactions	induce	a	cascade,	resulting	in	the	production	of	certain	
interferons	 and	 cytokines	 that	 inhibit	 protein	 production	 in	 host	 cells	 and,	
therefore,	 limit	 viral	 replication.	 They	 also	 stimulate	 dendritic	 cells	 and	 thereby	
promote	 antigen	 presentation	 to	 CD4+	 and	 CD8+	 T-cells,	 and	 ultimately	 viral	
clearance	and	immune	memory	(Kreijtz,	Fouchier	and	Rimmelzwaan,	2011).		
It	is	important	to	note	that,	although	the	immune	system	aims	to	protect	the	body	
from	 pathogens,	 paradoxically,	 it	 is	 often	 the	 cause	 of	 illness	 and	 death	 after	
exposure	 to	 these	 pathogens.	 For	 instance,	 it	 is	 thought	 the	 majority	 of	 deaths	






There	 is	 a	 difference	 between	 antigens	 and	 so-called	 immunogens	 and	 the	
distinction	 between	 these	 terms	 is	 very	 relevant	 to	 the	 project.	 Antigens	 are	
substances	 that	 interact	 with	 TCRs	 or	 antibodies.	 This	 does	 not	 mean	 that	 this	
interaction	always	induces	an	immune	response.	It	must	therefore	be	stressed	that	
an	antigen	that	triggers	an	immune	response	is	called	an	immunogen.	







Molecular	 complexity	 is	 another	 important	 indication	 of	 immunogenicity.	 Non-
repeating	polymers	such	as	proteins	and	complex	carbohydrates	are	often	effective	
immunogens,	 unlike	 less	 complex	 molecules,	 such	 as	 lipids	 and	 simple	
polysaccharides	(Madigan	et	al.,	2009).	




immune	 response	 than	 the	 individual,	 soluble	 alternatives.	 This	 is	 because	
phagocytes	are	better	at	ingesting	the	former	form.	
There	are	also	several	extrinsic	factors	that	contribute	to	immunogenicity.		The	dose	
of	 immunogen	 is	 a	 very	 important	 factor.	Generally,	 doses	 between	10µg	 and	1g	
are	effective.	Anything	outside	this	range	may	cause	tolerance	and	can	suppress	a	
specific	 immune	 response.	 Another	 extrinsic	 factor	 is	 the	 ability	 of	 the	 immune	
system	to	recognise	an	antigen	as	foreign.	Also,	the	route	of	administration	has	an	
effect	 on	 immunogenicity.	 For	 example,	 orally	 administered	 immunogens	 can	








channel	 blockers,	 both	 only	 active	 against	 influenza	 A	 viruses:	 Amantadine	
(Lysovir®,	 Symadine®)	 and	 Rimantadine	 (Flumadine®).	 Side	 effects	 of	M2	 channel	




Neuraminidase	 inhibitors	 prevent	 the	 release	 of	 progeny	 virions	 from	a	 host	 cell.	
(Haaheim	 and	Oxford,	 2013).	 There	 are	 four	 NA	 inhibiting	 compounds:	 zanamivir	
(Relenza®),	 oseltamivir	 (Tamiflu®),	 peramivir	 (Rapiacta®,	 Peramiflu®)	 and	
laninamivir	(Inavir®)	(Van-Tam	and	Lim,	2013).		The	effectiveness	of	these	antivirals	
can	 vary	 widely	 and	 is	 dependent	 on	 the	 strain	 of	 influenza	 itself.	 In	 the	 2009	
pandemic,	 antivirals	 such	 as	 zanamivir	 and	 oseltamivir	 were	 utilised	 in	 the	 early	
stages	of	the	pandemic,	but	to	little	effect	(Kawai	et	al.,	2009).		
1.6.2 Vaccines	
Vaccination	 is	 still	 considered	 the	 gold	 standard	 in	 protecting	 against	 influenza.	
There	are	various	ways	to	prime	the	immune	system	for	future	influenza	infections.	
All	methods	of	 influenza	vaccination	involve	varying	presentations	of	antigens	and	
are	 listed	 below.	 For	 influenza,	 these	 antigens	 are	 almost	 exclusively	HA,	NA	 and	
M2	or	derivatives	of	these	surface	proteins.	
Seasonal	 influenza	vaccines	are	 commonly	a	 trivalent	dose,	 containing	derivatives	
from	 three	 different	 strains	 of	 influenza	 A	 and	 B	 viruses	 to	 account	 for	 annual	
antigenic	drift	(Wolff	and	Reichl,	2008;	WHO,	2009).	However,	the	vaccine	industry	









to	 replicate	 and	 cause	 an	 immune	 response	 however,	 usually,	 without	 causing	
disease.	In	the	case	that	disease	is	caused	by	an	attenuated-type	vaccine,	symptoms	
are	 weaker	 and	 are	 generally	 referred	 to	 as	 adverse	 reactions	 (CDC,	 2011).	
Attenuated	viruses	generate	the	strongest	and	longest	acting	immune	response	out	
of	 all	 vaccine	 classes.	 However,	 they	 are	 unsuitable	 for	 immunocompromised	
individuals	 and	 carry	 the	 theoretical	 risk	 of	 pathogenic	 reversion.	 Also,	 it	 is	 very	






This	 class	 of	 vaccine	 involves	 the	 expansion	 of	 the	 pathogen	 in	 question	 in	 a	
particular	host.	In	the	case	of	influenza	virus	vaccine	production	this	is	achieved	in	
the	allantoic	 fluid	of	 fertilised	chicken	eggs.	After	harvesting	this	 fluid,	 the	virus	 is	







by	 removing	more	 internal	 viral	 proteins,	 the	 resulting	 vaccine	 is	 referred	 to	 as	 a	
subunit	 vaccine	 (College	 of	 Physicians	 of	 Philadelphia,	 2014;	 Talbot	 et	 al.,	 2015).	
Overall,	 inactivated	 virus	 vaccines	 generally	 yield	 relatively	 short-lived	 immune	
responses	(Madigan	et	al.,	2009).	
1.6.2.3 Virus-like	particle	vaccines	
Virus-like	 particles	 (VLPs)	 are	 structures	 consisting	 of	 multiple	 proteins	 that	 are	
arranged	 to	 collectively	 mimic	 authentic	 native	 viruses.	 Although	 a	 VLP	 typically	
contains	nucleotides	originating	 from	 its	host	expression	 system	 (i.e.	a	genetically	


















further	 assistance	 to	 achieve	 the	 right	 levels	 of	 immuno-stimulation.	 Thus,	
adjuvants	 are	 often	 added	 to	 the	 formulated	 vaccine	 product.	 Adjuvants	 are	
substances	 that	 cause	 a	 non-specific	 immune	 enhancement,	making	 the	 immune	
system	 more	 receptive	 to	 the	 accompanying	 vaccine	 (National	 Research	 Council	




World	 Health	 Organisation	 (WHO),	 candidate	 high-growth	 seed	 strains	 are	
distributed	to	various	collaborating	centres,	depending	of	the	region	(Gerdil,	2003).	
Manufacturers	 can	use	 these	 recommendations	 to	prepare	a	 range	of	vaccines.	A	
selection	of	methods	of	vaccine	production	is	described	below.		
1.7.1 Fertilised	chicken	egg-derived	vaccine	production	
The	 most	 widely	 used	 method	 for	 vaccine	 production	 involves	 injecting	 live	




of	 vaccine	 (Layton	 and	 Lenfestey,	 2005b).	 After	 an	 incubation	 period	 of	 up	 to	 72	
hours,	 the	 virus	 or	 virus	 derivative	 is	 harvested	 (Tree	et	 al.,	 2001;	 Roland,	 2014).		
Eggs	 are	 generally	 used	 to	 produce	 live	 attenuated	 vaccines	 or	 inactivated	 virus	
vaccines	(Palache,	Brands	and	van	Scharrenburg,	1997;	Wolff	and	Reichl,	2008).		
1.7.1.1 Bioprocessing		
The	 following	 describes	 one	 possible	method	 to	 purify	 egg-derived	 vaccines.	 The	
allantoic	 fluid	 of	 the	 embryo	 is	 harvested	 and	 is	 subsequently	 clarified	 by	
centrifugation.	Using	tangential	 flow	ultrafiltration,	the	volume	of	the	supernatant	
is	 reduced.	 The	 retained	 virus	 is	 then	 resuspended	 overnight	 in	 Ca-Mg-saline	
solution.	 This	 suspension	 is	 subsequently	 loaded	 onto	 a	 sucrose	 gradient	 and	
centrifuged,	 which	 allows	 the	 virus	 to	 be	 pooled	 and	 collected	 (Liu	 et	 al.,	 1995).	
There	are,	however,	a	number	of	ways	to	purify	a	vaccine.	For	 instance,	on	 larger	
scales,	 the	 latter	 step	might	 not	 always	 be	 feasible	 and	 can	 be	 substituted	 by	 a	














The	 supply	 of	 such	 an	 amount	 of	 eggs	 can	 take	 up	 to	 six	 months	 and	 poses	 a	
significant	limit	to	the	scalability	of	vaccine	production	(Gerdil,	2003).	Furthermore,	


























(Nayak,	 Lehmann	 and	 Reichl,	 2005).	 A	 significant	 disadvantage	 is	 that	 this	
production	method	 can	be	highly	unsuitable	 for	 avian	 related	 influenza	A	 vaccine	
production.	For	instance,	the	avian	related	H5N1	influenza	A	strain	of	1997	showed	
a	 mortality	 rate	 of	 70%-100%	 in	 chickens	 (Cox	 and	 Hashimoto,	 2011).	 Chicken	
embryos	 used	 for	 the	 production	 of	 a	 vaccine	 against	 this	 virus	 were	 therefore	
killed	before	significant	amounts	of	vaccine	could	be	produced.		
Much	 of	 the	 industry	 has	 established	 capacity	 in	 egg-based	 vaccine	 production.	






vaccine.	For	 instance,	 in	 the	2004-2005	 influenza	season	 in	 the	United	States,	 the	
highest	 recorded	wholesale	price	of	 influenza	 vaccines	was	USD	8.50	 (Layton	and	
Lenfestey,	2005a).		
1.7.2 Vaccine	production	in	mammalian	cells	
As	 with	 fertilised	 eggs,	 mammalian	 cells	 are	 generally	 used	 to	 produce	 live	
attenuated	 vaccines,	 inactivated	 virus	 vaccines	 or	 split	 virion	 vaccines	 (Palache,	
Brands	and	van	Scharrenburg,	1997;	Wolff	and	Reichl,	2008).	There	are,	however,	











during	 growth	 and	 the	 number	 of	 live	 viruses	 can	 be	 measured	 by	 solid	 plaque	
assays	 (Mahy,	 1985;	 Tree	 et	 al.,	 2001).	 Once	 the	 required	 amount	 of	 virus	
production	has	been	determined	and	cultures	have	been	appropriately	diluted,	the	
cultures	are	further	expanded	by	inoculating,	for	example,	roller	bottles	or	spinner	
flasks	 containing	micro-carriers.	 For	 larger	 scale	production,	micro-carriers	 can	be	
used	(Genzel	et	al.,	2004;	Genzel,	Fischer	and	Reichl,	2006;	Chen	et	al.,	2010).		
The	downstream	processing	of	mammalian	 cell-derived	 vaccines	 is	 very	 similar	 to	
that	of	fertilised	egg-derived	vaccines	(Figure	1.4).	
1.7.2.2 Advantages	and	disadvantages	
Vaccine	 production	 in	 mammalian	 cells	 offers	 numerous	 advantages	 to	 vaccine	
production	in	fertilised	eggs.	Mammalian	cell-derived	vaccines	have	been	shown	to	




1999;	 Percheson	 et	 al.,	 1999).	 Furthermore,	 mammalian	 cell-derived	 vaccine	
production	is	scalable	and	can	employ	the	use	of	well-characterised	and	stable	cell	




poses	 significant	 risks	 with	 respect	 to	 biological	 containment.	 Also,	 the	 risk	 of	
contamination	by	pathological	agents	 is	 increased	when	the	use	of	animal	derived	
products,	such	as	serum,	is	required	(Nims,	2006;	Chen	et	al.,	2008).	Furthermore,	
the	 productivity	 of	 the	 process	 depends	 heavily	 on	 the	 cell	 line	 employed.	 In	
addition,	a	reassortant	virus,	which	contains	genes	from	two	parental	viruses,	often	
needs	 be	 employed	 to	 achieve	 high	 productivity	 (Tree	 et	 al.,	 2001;	 Cox	 and	
Hashimoto,	2011;	Ellis,	Rappuoli	and	Ahmed,	2013).		
1.7.3 Vaccine	production	in	Escherichia	coli		
E.	 coli	 is	 a	 popular	 expression	 system	 for	 a	 variety	 of	 recombinant	 proteins.	





The	 M2	 ectodomain	 is	 highly	 conserved	 and	 cross-reactive,	 making	 it	 a	 good	
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expanded	 through	 large-scale	 fermentation,	 which	 is	 a	 well-established	 process		
(Hewitt	et	al.,	2000;	Huleatt	et	al.,	2008).		
At	 the	 end	 of	 the	 fermentation	 process,	 the	 cells	 are	 harvested	 through	
centrifugation.	 The	 sediment	 is	 resuspended	 and	 lysed	 in	 buffer	 containing	
lysozyme	 and	 a	 protease	 inhibitor	 cocktail.	 This	 mixture	 will	 facilitate	 lysis	 while	
minimising	 proteolytic	 cleavage	 of	 the	 product.	 Following	 lysis,	 the	 suspension	 is	
centrifuged	to	separate	cell	debris	and	other	insoluble	materials.	The	supernatant	is	
subsequently	 passed	 through	 a	 depth	 filter	 to	 protect	 chromatographic	 columns	
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further	 downstream.	 The	 first	 chromatographic	 step	 is	 a	 gradient	 ion	 exchange	
separation	 that	 captures	 the	 product.	 To	 remove	 endotoxin,	 Size	 Exclusion	
Chromatography	 is	 used.	 The	 final	 stages	 of	 downstream	 processing	 include	




Figure	1.5	Schematic	overview	of	 the	production	process	 for	 the	manufacturing	of	M2e	
fusion	 proteins.	 (A)	 Fermentation.	 (B)	 Harvest	 centrifugation.	 (C)	 Cell	 lysis.	 (D)	









However,	 recombinant	 type	 vaccine	 production	 in	 E.	 coli	 can	 also	 result	 in	
unpredictable	 clinical	 efficacy	 and	 safety.	 It	 has	 been	 reported	 that	 after	 the	
vaccination	of	pigs	with	a	fusion	protein	of	M2e	and	influenza	nucleoprotein	(M2e-
NP),	 the	 vaccine	 aggravated	 influenza	 symptoms	 rather	 than	 preventing	 them	
A B C D E F G H I
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(Heinen	 et	 al.,	 2002).	 Furthermore,	 E.	 coli	 produces	 endotoxin,	 which	 can	 cause	
inflammatory	reactions	 if	not	removed	from	a	vaccine.	Finally,	E.	coli	can	be	quite	





On	 October	 22	 2013	 Protein	 Sciences	 Corporation’s	 “FluBlok”	 seasonal	 influenza	




The	 vaccine	 consists	 of	 trivalent	 recombinant	 hemagglutinin	 (rHA)	 proteins	
produced	in	Spodoptera	frugiperda.	This	is	one	of	the	most	popular	insect	host	used	
in	 industry	 for	 the	 production	 of	 recombinant	 proteins	 (Summers,	 Smith	 and	
Station.,	 1987).	 The	 rHA	 is	 expressed	 in	 the	 insect	 cells	 through	 infection	 with	
baculovirus,	a	popular	 insect	expression	 system	 (Verma,	Boleti	 and	George,	1998;	
Cox	and	Hashimoto,	2011).	First	a	HA	gene	is	cloned	using	RT-PCR	resulting	in	RNA	
being	transcribed	to	cDNA.	The	DNA	is	subsequently	introduced	into	a	baculovirus	




frugiperda	 Sf9	 cells	 together	 with	 linearised	 genomic	 Autographa	 californica	
nucleopolyhedrovirus	(AcMNPV)	DNA	to	enable	homologous	recombination.		
After	 fermentation,	 the	 infected	 cells	 are	 harvested	 and	 separated	 from	 the	
medium	using	disk	stack	centrifugation.	After	the	pellet	is	collected,	it	is	exposed	to	
a	non-ionic	detergent	 in	order	 to	dissolve	 the	 insect	membranes.	A	depth	 filter	 is	
subsequently	used	to	remove	cell	debris.	This	is	followed	by	three	chromatographic	
processes.	The	first	is	a	cation	exchange	process	(CEX),	which	captures	the	vaccine	
product	 and	 other	 protein	 contaminants.	 The	 second	 process	 is	 Hydrophobic	
Interaction	 Chromatography	 (HIC),	 which	 retains	 rHA	 and	 discards	 protein	




	Figure	1.6	Schematic	overview	of	 the	production	process	 for	 the	manufacturing	of	 rHA	
(adapted	 from	Blaha	et	al.,	 2012).	 (A)	 Fermentation.	 (B)	Harvest	 centrifugation.	 (C)	Cell	
lysis.	 (D)	 Clarification	 centrifugation.	 (E)	 Depth	 filtration.	 (F)	 Cation	 exchange	
chromatography.	 (G)	 Hydrogen	 interaction	 chromatography.	 (H)	 Size	 Exclusion	
Chromatography.	(I)	Diafiltration.		
1.7.4.2 Advantages	and	disadvantages	
The	 risk	 of	 contamination	 by	 advantageous	 agents	 in	 insect	 cell	 cultures	 is	
significantly	 lower	 than	 in	 mammalian	 cell	 cultures	 because	 insect	 cells	 do	 not	
require	any	animal-derived	products,	such	as	serum,	for	growth	(Nims,	2006;	Chen	










Louis	 encephalitis	 virus	 (Verma,	 Boleti	 and	George,	 1998).	 An	 advantage	 that	 the	
arthropod	 expression	 system	has	 over	 prokaryotic	 expression	 systems,	 such	 as	E.	
coli,	 is	 that	 insect	 cells	 are	 able	 to	 perform	 most	 eukaryotic	 post-translational	
alterations,	generally	 resulting	 in	higher	clinical	efficacy.	The	polyhedrin	promoter	
used	 in	 insect-cell	 cultures	 is	 considerably	 stronger	 than	 most	 eukaryotic	
promoters.	 Therefore,	 this	 type	 of	 expression	 system	 produces	 higher	 levels	 of	
protein	than	mammalian	cell	cultures	(Luckow	and	Summers,	1989).	
For	the	purposes	of	human	vaccine	production,	insect	cells	have	more	appropriate	
post-translational	 mechanisms	 than	 E.	 coli.	 However,	 insect	 cells	 process	 mature	







This	 thesis	 will	 focus	 on	 the	 development	 of	 a	 production	 process	 for	 a	 novel	
universal	 influenza	 A	 vaccine.	 Universal	 implies	 a	 vaccine	 that	 is	 reactive	 with	
multiple	 types	 of	 influenza	 A,	 accounting	 for	 annual	 antigenic	 drift	 and	
unpredictable	antigenic	shift.			
A	 strategy	 to	 increase	 cross-protection	 against	 variants	 of	 influenza	 virus	 is	 to	
develop	a	vaccine	consisting	of	highly	evolutionary	conserved	epitopes	of	influenza	
virus.	Examples	 of	 such	 epitopes	 are	 the	 aforementioned	M2e	 peptide,	 influenza	
nucleoprotein	(NP)	and	the	stem	of	hemagglutinin	(Fiers	et	al.,	2009;	Abate,	2013;	
Kim	 et	 al.,	 2013;	 IQur,	 2014).	 However,	 the	 absence	 of	 evolutionary	 pressure	 on	
these,	 usually	 structural,	 epitopes	 is	 likely	 due	 to	 a	 lack	 of	 recognition	 by	 the	
immune	system.	Thus,	it	is	often	found	that	such	epitopes	alone	elicit	no	significant	
immune	 response.	 However,	 the	 immunogenicity	 of	 these	 poorly	 immunogenic	
antigens	 can	 be	 increased	 through	 presentation	 on	 the	 surface	 of	 a	 Virus-Like	
Particle.	
Compared	 to	 individual	 viral	 peptides	 or	 proteins,	 such	 as	 M2e,	 VLPs	 present	
epitopes	 in	 such	 a	way	 as	 to	 achieve	 higher	 conformational	 similarity	 to	 a	 native	
virus.		
Hepatitis	B	Core	protein	(HBc),	a	monomer	that	self-assembles	into	VLPs,	has	been	
a	 popular	 carrier	 of	 a	 variety	 of	 heterologous	 epitopes	 derived	 from	 many	





for	 the	development	of	 a	 universal	 flu	 vaccine	 as	 this	would	 enable	higher	 cross-
protection	 than	employing	 single	epitopes	or	monovalent	 vaccines.	However,	 it	 is	




attaching	 a	 different	 heterologous	 epitope	 to	 the	major	 insertion	 region	 (MIR)	 of	
each	 monomer,	 results	 in	 the	 expression	 and	 subsequent	 assembly	 of	 VLPs	
presenting	 an	 equal	 amount	 of	 each	 epitope.	 The	 linking	 of	 these	 two	 HBc	
monomers,	 via	 use	 of	 a	 flexible	 linker,	 will	 be	 referred	 to	 as	 Tandem	 Core	
technology	(iQur,	2014).		






Figure	 1.7	 Tandem	 Core	 Technology	 overview:	 (A)	 DNA	 sequence	 of	 construct.	 AOX	
promotor	followed	by	two	HBc	units	connected	by	a	flexible	linker	sequence.	Within	each	
HBc	 sequence	 is	 a	 Major	 Immunodominant	 Region	 (MIR)	 sequence,	 allowing	 for	 the	





adjuvants.	 Finally,	 Tandem	 Core	 VLPs	 can	 act	 as	more	 agile	 antigen	 presentation	
scaffolds	than	conventional	VLPs,	allowing	for	the	combination	of	multiple	epitopes	
associated	 with	 a	 wide	 variety	 of	 diseases.	 This	 property	 makes	 Tandem	 Core	
technology	a	good	candidate	central	component	for	a	universal	vaccine	production	






Tandem	 Core	 VLPs	 have	 another	 important	 advantage	 over	 conventional,	 egg-
derived	vaccines.	VLPs,	in	general,	can	be	produced	in	suspension	cultures,	offering	
the	benefit	of	scalability.	
VLPs	 have	 previously	 been	 successfully	 produced	 in	 suspension	 cultures	 using	 P.	
pastoris	 (Freivalds	 et	 al.,	 2011;	 Jiang	 et	 al.,	 2011).	 Indeed,	 in	 this	 series	 of	
experiments,	a	variety	of	Tandem	Core	VLPs	will	be	expressed	by	P.	pastoris.		
P.	pastoris	 is	a	single-celled	yeast	and,	since	yeasts	are	eukaryotic,	 it	 is	more	likely	
that	 proteins	 typically	 expressed	 in	 a	 eukaryotic	 environment	 are	 appropriately	
translated	and	assembled	in	P.	pastoris	than	in	non-eukaryotic	expression	systems	
such	 as	 E.	 coli.	 However,	 the	 most	 important	 reason	 for	 choosing	 to	 express	
Tandem	 Core	 VLPs	 in	 P.	 pastoris	 rather	 than	 in	 E.	 coli,	 is	 the	 absence	 of	
lipopolysaccharides	(LPS)	in	the	purified	product	(iQur,	2014).	
What	distinguishes	P.	pastoris	 from	many	other	yeast	species,	 like	Saccharomyces	
cerevisiae,	 is	 its	preference	for	respiratory	growth,	 i.e.	 its	use	of	molecular	oxygen	




general	 challenge	associated	with	P.	pastoris	 is	 low	yields	of	 recombinant	protein	
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when	 compared	 to	 other	 expression	 systems,	 such	 as	 E.	 coli;	 insect	 cells;	 and	
Chinese	Hamster	Ovary	(CHO)	cells	(Weinacker	et	al.,	2013;	Maccani	et	al.,	2014).		
P.	 pastoris	 can	 use	 methanol	 as	 a	 sole	 source	 of	 carbon	 and	 because	 of	 this	
characteristic,	 a	 specific	 set	 of	 genes	 can	 be	 induced	 to	 produce	 the	 following	
metabolic	 enzymes:	 alcohol	 oxidase	 (AOX)	 and	 dihydrosynthase	 (DHAS).	 The	
regulatory	 genes	 involved	 in	 the	 transcription,	 aox1,	 aox2	 and	 das	 respectively,	
constitute	 a	 major	 advantage	 of	 the	 P.pastoris	 expression	 system	 as	 they	 are	





via	 homologous	 recombination	 at	 sites	 where	 there	 is	 significant	 homology	
between	sequences	(>0.5	kb)	 (Cregg,	2007).	For	P.	pastoris	 transformations,	these	
sites	 are	 typically	 two	 aligned	 AOX1	 promoter	 (pAOX1)	 sequences	 (Cregg	 et	 al.,	
1985).	
1.9.1 Bioprocessing	–	fermentation	
As	 shown	 in	 Figure	 1.8,	 a	 typical	 bioreactor-based	 fermentation	 of	 P.	 pastoris	




The	 objective	 of	 the	 first	 stage,	 the	 batch	 phase,	 is	 to	maximise	 culture	 biomass	
through	the	consumption	of	glycerol.	As	the	culture	grows,	more	oxygen	is	required	
to	 support	 growth	 and	 cell	 maintenance.	 It	 is	 therefore	 important	 that	 the	
Dissolved	 Oxygen	 (DO)	 content	 is	 controlled	 and	 maintained	 above	 20%.	 This	 is	
typically	achieved	through	a	cascade	of	increased	culture	agitation	followed	by	gas	
blending	 of	 pure	 oxygen	 in	 the	 sparged	 gas.	 The	 batch	 culture	 is	 grown	until	 the	
glycerol	 in	 the	 medium	 has	 been	 completely	 consumed.	 This	 stage	 is	 usually	





Once	 glycerol	 has	 been	 completely	 consumed	 during	 the	 batch	 phase,	 a	 carbon-
limiting	 glycerol	 feed	 is	 introduced	 for	 at	 least	 4	 hours.	 This	 stage	 serves	 two	
purposes:	 firstly,	 it	 allows	 for	 control	 in	 achieving	 a	 target	 biomass;	 secondly,	 it	
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gradually	 creates	 a	 carbon-limiting	 environment	 to	 facilitate	 adaptation	 to	
methanol	during	the	induction	phase	of	fermentation.	
During	 this	 final	 stage,	heterologous	protein	 is	produced	by	 the	cells.	The	start	of	




phase	 can	 range	 between	 24	 and	 100	 hours	 in	 duration	 (Invitrogen	 Corporation,	
2002;	Mirro,	 2011).	 Tandem	 Core	 technology,	 expressed	 in	 P.	 pastoris,	 offers	 an	
exciting	proposition	 for	 creating	a	 future	universal	 influenza	vaccine.	However,	 as	
with	 all	 novel	 concepts,	 development	 and	 characterisation	 of	 applying	 this	
technology	 will	 be	 required	 and	 process	 methodologies	 should	 be	 developed	
accordingly.		
1.10 Thesis	aims		
A	wide	variety	of	methods	exist	 for	producing	 influenza	vaccines.	However,	 these	
platforms	cannot	fulfil	public	demand	in	the	event	of	a	pandemic	due	to	limitations	




This	 research,	 which	 represents	 a	 component	 of	 research	 performed	 by	 an	 FP74	
consortium	 project,	 will	 focus	 on	 using	 Tandem	 Core	 technology	 to	 develop	 a	
universal	influenza	vaccine.	Using	this	technology,	recombinant	Virus-Like	Particles	
can	be	expressed	in	bioreactor-based	suspension	cultures	of	P.	pastoris,	providing	a	
highly	 scalable	 production	 platform.	 	 To	 realise	 the	 potential	 of	 Tandem	 Core	
technology	as	a	central	component	in	a	universal	vaccine	production	platform,	the	




This	 chapter	 will	 aim	 to	 identify	 critical	 process	 parameters	 associated	 with	
upstream	and	downstream	processing	of	novel	Tandem	Core	VLP	 constructs.	 This	
will	 involve	 investigating	 the	 effects	 of	 changing	 constructs,	 yeast	 phenotype,	
fermentation	modes	and	methods	of	primary	recovery.		











will	 discuss	 how	 cell	 disruption	 processes	 are	 characterised,	 optimised	 and	
miniaturised.		
Microscale	upstream	process	platform	development	(Chapter	5)	
Having	 developed	 the	 prerequisite	 tools	 to	 implement	 in	 miniaturised	 upstream	
process	 development,	 the	 use	 of	 miniaturised	 fermentation	 platforms	 can	 be	
investigated	to	address	several	key	observations	made	in	chapter	3,	and	to	identify	
appropriate	 scale-down	 platforms	 and	 expression	 techniques	 for	 monitoring	
product	 expression.	 This	 chapter	 will	 therefore	 aim	 to	 develop	 a	 miniaturised	
fermentation	platform	intended	for	rapid	upstream	process	characterisation.		
Characterisation	of	Tandem	Core	Virus-Like	Particle	production	(Chapter	6)	
This	 chapter	 aims	 to	use	miniature	bioreactors,	DoE-based	methodology,	 and	 the	
aforementioned	 scale-down	 cell	 disruption	 tools,	 to	 study	 Virus-Like	 Particle	
production	 in	 a	 bioprocessing	 context	 through	 variance	 of	 previous	 identified	
critical	process	parameters	and	windows	of	operation,	to	maximise	VLP	expression.		






VLP.	 This	 chapter	 aims	 to	 translate	 these	 findings	 to	 industrially	 relevant	 vaccine	















All	 P.	 pastoris	 transformants	 described	 in	 this	 work	 were	 provided	 by	 iQur	 Ltd.	
(London,	UK).	
Two	 phenotypes	 of	 P.	 pastoris	 were	 used	 throughout	 this	 work:	Mut+	 (X33)	 and	
MutS	(KM71h).	
P.	pastoris	Mut+	was	used	to	express	GFP-fused	VLPs	(GFP,e).	P.	pastoris	MutS	was	
used	 to	 express	 the	 following	VLP	 constructs:	 k1,k1;	 LAH3,k1;	HA2.3,	 (M2e)3;	 and	
LAH3,	(M2e)3.	











10µL	 frozen	 seed	 stock	 was	 cultured	 in	 50mL	 Greiner	 (Greiner	 Bio-One,	
Kremsmünster,	Austria),	 skirted	 centrifuge	 tubes	 in	 9990µL	BMGY	media	 [13.8g/L	
yeast	 nitrogen	 base	 with	 ammonium	 sulphate	 and	 without	 amino	 acids,	 12.6g/L	




inoculate	 a	 2L	 baffled	 polymer	 reusable	 Nalgene™	 Erlenmeyer	 shake	 flask	
containing	250mL	BMGY.	Post-inoculation,	OD600	values	at	this	stage	were	typically	
around	0.2.	The	culture	was	harvested	after	22-24	hours,	 typically	 reaching	OD600	
values	 between	 60-80,	 indicating	 stationary	 phase.	 The	 harvested	 culture	 was	
diluted	 to	an	OD600	of	36	using	BMGY	and	subsequently	diluted	 to	25	using	100%	
sterile	 glycerol	 to	 achieve	 a	 final	 glycerol	 stock	 concentration	 at	 30%	 (v/v).	 The	






A	Master	 Cell	 Bank	 (MCB)	 vial	 was	 defrosted	 at	 room	 temperature	 for	 about	 10	
minutes.	 2mL	 of	 each	 tube	 was	 transferred	 to	 a	 reusable	 Nalgene™	 Erlenmeyer	
shake	 flask	 containing	 250mL	 BMGY	 and	 grown	 as	 described	 in	 section	 2.2.1.1.	
OD600	measurements	were	taken	frequently	to	characterise	the	MCB	and	develop	a	
growth	profile	(see	Figure	10.1).	To	assess	MCB	quality,	this	procedure	was	carried	





agar	 plate-based	 culture	 inspection	was	 performed.	 50µL	 of	 frozen	 cell	 bank	was	
grown	on	YPD	agar	plates	 [20g/L	bacteriological	peptone,	10g/L	yeast	extract	and	
20g/L	agar]	 for	one	week	at	28°C.	Cultures	were	assumed	to	be	of	a	monoculture	







of	methods	were	 used	 rather	 than	 a	 single	 protocol.	 The	 commonalities	 of	 these	
procedures	are	described	in	this	section.	
Basal	Salts	Medium	(BSM)	[26.7mL/L	85%phosphoric	acid,	0.93g/L	calcium	sulphate,	
18.2g/L	 potassium	 sulphate,	 14.9g/L	 magnesium	 sulphate	 heptahydrate,	 4.13g/L	
potassium	 hydroxide,	 40g/L	 glycerol,	 20mL/L	 28%	 ammonium	 hydroxide]	 was	
prepared	without	glycerol	to	serve	as	a	variable	induction	medium.	The	volume	of	
glycerol	 was	 substituted	 by	 reverse	 osmosis	 water.	 4.35mL	 of	 PTM1	 trace	 salts	
[6.0g/L	 cupric	 sulphate	 pentahydrate,	 80mg/L	 sodium	 iodide,	 3.0g/L	 manganese	






was	 performed	 by	 creating	 aliquots	 of	 equal	 volumes	 of	 seed	 culture	 into	 15mL	
Greiner	 tubes	 (Greiner	 Bio-One,	 Kremsmünster,	 Austria)	 and	 centrifuging	 the	









Some	 microwell	 fermentations	 involved	 induction	 using	 Pectin	 Digest	 Medium	
(PDM).	
PDM5	was	 prepared	 by	 autoclaving	 a	 suspension	 of	 2.7mL	 85%	 phosphoric	 acid,	
8mL	50%	ammonium	hydroxide	and	3.67g	pectin	 from	apple.	The	suspension	was	
cooled	 to	 25°C	 and	 the	 pH	 was	 adjusted	 to	 5.5	 using	 NaOH	 or	 2M	 HCl.	 30mg	
pectolyase	Y-23	 from	Aspergillus	 japonicas	 (MP	Biomedicals,	 Eschwege,	Germany)	
was	added	 to	 the	 suspension.	 The	enzymatic	 reaction	was	 left	 for	33	hours.	BSM	
components	 and	 PTM1	 trace	 salts	 were	 subsequently	 added	 in	 the	 appropriate	
amounts.	 The	 pH	 of	 the	 solution	 was	 adjusted	 to	 5.0	 as	 described	 earlier.	 The	
suspension	 was	 divided	 into	 two	 50mL	 aliquots	 in	 50mL	 centrifuge	 tubes.	 To	









inoculated	 with	 1.8mL	 working	 cell	 bank	 (2.2.1.2).	 This	 was	 incubated	 for	 16-20	
hours	at	30°C	and	250	rpm	in	a	Kuhner®	(Glossop,	UK)	incubator.	When	exponential	
phase	 characteristics	 were	 required,	 the	 culture	 was	 grown	 to	 OD600	 values	




A	 250mL	 ambr®	modular	 bioreactor	 system	 (Sartorius,	 Epsom,	 UK)	 was	 used	 for	
studying	P.	pastoris	MutS	fermentations.	Each	bioreactor	unit	(see	Figure	2.2)	had	5	
reservoirs	 of	 which	 reservoir	 A	 contained	 20mL	 50%	 (v/v)	 glycerol	 solution	
supplemented	with	PTM1	trace	salts;	reservoir	B	25mL	10%	ammonium	hydroxide	
solution;	reservoir	C	contained	5mL	sterile	PPG	2000	antifoaming	agent;	5mL	8.5%	
phosphoric	 acid	 was	 added	 to	 reservoir	 D;	 and	 reservoir	 E	 contained	 25mL	
methanol	 with	 PTM1	 trace	 salts.	 The	 bioreactors	 were	 heated	 to	 30°C	 prior	 to	
calibrating	Dissolved	Oxygen	Tension	(DOT)	and	pH.	After	at	 least	3	hours,	2mL	of	
sample	 was	 drawn	 from	 each	 of	 the	 bioreactors	 to	 perform	 offline	 pH	
measurements,	which	were	required	to	complete	pH	calibration.	Bioreactors	were	
deemed	 ready	 for	 inoculation	 at	 DOT=100±5%,	 pH	 4.75-5.0	 and	 T=30±0.1°C.	
Bioreactors	 had	 a	 working	 volume	 of	 100mL	 of	 which	 7mL	 was	 provided	 by	 an	
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appropriately	 diluted	 and	 resuspended6	inoculum	 culture	 to	 achieve	 a	 starting	
bioreactor	 culture	optical	 density	of	 1.0	OD600.	 Throughout	 the	 fermentation	DOT	
was	maintained	at	30%	by	(1)	agitating	the	culture	between	1323	and	3175	rpm,	(2)	
maintaining	an	airflow	 rate	of	0.5vvm	and,	 (3)	when	 required,	additively	blending	
pure	oxygen	with	the	sparged	gas.			
A	20%	drop	in	Carbon	Evolution	Rate	(CER)	and	spike	in	DOT,	indicating	depletion	of	
carbon	 source,	 triggered	 a	 fed-batch	 glycerol	 feed.	 This	 was	 generally	 observed	
between	 18-20	 hours	 after	 bioreactor	 inoculation.	 This	 glycerol	 fed-batch	 phase	
was	 maintained	 for	 a	 fixed	 4	 hours	 at	 a	 constant	 flow	 rate	 between	 11.9-24.4	
millilitres	per	litre	initial	working	volume	per	hour	(mL/Li/h).	20	minutes	prior	to	the	
induction	phase	the	temperature	setpoint	was	varied	between	18.8-31.3°C.		
For	 the	 first	 two	 hours	 of	 the	 induction	 phase	 the	methanol	 flow	 rate	 was	 kept	
constant	 at	 1mL/Li/h.	 After	 this	 the	 feed	 rate	 was	 increased	 by	 10%	 increments	
every	30	minutes	until	the	target	feed	rate	was	reached.	Note	that	the	time	of	each	
final	 increment	 was	 shortened	 accordingly	 to	 achieve	 the	 precise	 final	 value	 of	










were	 several	 differences.	 Instead	 of	 using	methanol,	 mixed	 induction	media	 was	
used	 comprised	 of	 a	 60:40	 ratio	 of	 50%	 (v/v)	 glycerol	 and	 pure	 methanol	
respectively,	plus	12	mL	PTM1	salts	per	 litre	of	 induction	media.	Bioreactors	had	a	
working	volume	of	83.3mL	of	which	6.16mL	was	provided	by	an	 inoculum	culture	
(10-30	OD600)	 to	achieve	a	 starting	bioreactor	 culture	optical	density	of	1.0	OD600.	
Throughout	 the	 fermentation	 DOT	 was	 maintained	 at	 30%	 by	 (1)	 agitating	 the	
culture	 between	 1130	 and	 2826	 rpm,	 (2)	maintaining	 an	 airflow	 rate	 of	 0.51vvm	
and,	(3)	when	required,	blending	pure	oxygen	with	the	sparged	gas,	maintaining	a	
constant	gas	flow	rate.		
The	 induction	phase	was	 followed	 immediately	 after	 the	batch	phase.	 Feeding	of	







Computer	 interface.	 (E)	 250mL	 bioreactor	 with	 baffled	 walls.	 (F-J)	 Reservoirs	 A-E.	 (K)	
Removable	 stopper	 for	 inoculation	 procedures.	 (L)	 DO	 sensor.	 (M)	 Impeller	 with	 two	





A	 7L	 BioFlo®	 New	 Brunswick	 (Eppendorf,	 Stevenage,	 UK)	 was	 used	 for	 initial	
fermentation	 scoping	 studies	 using	 the	 MutS	 pure	 methanol	 induction	 protocol	
(Invitrogen	Corporation,	2002).		
The	initial	working	volume	was	set	at	4L.	The	DOT	setpoint	was	set	at	30%	and	was	
controlled	 in	 a	 sequence	 cascade	 by	 agitating	 the	 impeller	 between	 500	 to	 1200	
rpm	 followed	by	 oxygen	 gas	 blending	 in	 ratio	mode	 at	 a	 constant	 volumetric	 gas	
flow	rate	of	1.5L/min.	Fermentations	were	run	in	batch	mode	for	18-20	hours	until	
a	DOT	 spike	was	observed.	 This	was	 followed	by	a	4	 to	6-hour	 glycerol	 fed-batch	

















pH	 range	 was	 maintained	 between	 4.75-5.0	 and	 pre-induction	 temperature	 at	
30±0.1°C.	 A	 20%	 drop	 in	 CER	 and	 spike	 in	 DOT,	 indicating	 depletion	 of	 carbon	
source,	 triggered	 a	 fed-batch	 glycerol	 feed.	 This	was	 generally	 observed	between	
18-20	 hours	 after	 bioreactor	 inoculation.	 This	 glycerol	 fed-batch	 phase	 was	
maintained	for	a	fixed	4	hours	at	a	constant	glycerol	feed	flow	rate	of	18.15	mL/Li/h.	
20	minutes	prior	to	the	induction	phase	the	temperature	setpoint	was	adjusted	to	
25°C.	 The	 end	 of	 the	 glycerol	 fed-batch	 phase	 triggered	 the	 methanol	 induction	







were	 several	 differences.	 Instead	 of	 using	methanol,	 mixed	 induction	media	 was	







OD600)	 to	 achieve	 a	 starting	 bioreactor	 culture	 optical	 density	 of	 1.0	 OD600.	
Throughout	 the	 fermentation	 DOT	 was	 maintained	 at	 30%	 by	 (1)	 agitating	 the	
culture	between	400	and	1000	rpm,	(2)	maintaining	an	airflow	rate	of	0.51vvm	and,	
(3)	 when	 required,	 blending	 pure	 oxygen	 with	 the	 sparged	 gas,	 maintaining	 a	
constant	gas	flow	rate.		
The	 induction	phase	was	 followed	 immediately	 after	 the	batch	phase.	 Feeding	of	




A	 7L	 BioFlo®	 New	 Brunswick	 (Eppendorf,	 Stevenage,	 UK)	 was	 used	 for	 initial	
fermentation	scoping	studies	using	the	Mut+	pure	methanol	induction	protocol.		
The	initial	working	volume	was	set	at	4L.	The	DOT	setpoint	was	set	at	30%	and	was	
controlled	 in	 a	 sequence	 cascade	 by	 agitating	 the	 impeller	 between	 500	 to	 1200	




flow	 rate	 of	 18.15	 mL/Li/h.	 The	 induction	 temperature	 was	 subsequently	 varied	
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between	 20-30°C.	 The	 culture	 was	 induced	 with	 methanol,	 supplemented	 with	
12mL/L	PTM1	trace	salts.	The	 initial	 flow	rate	was	maintained	a	3.6	mL/h	per	 litre	
initial	working	volume	(mL/Li/h)	for	2-4	hours	depending	on	the	stability	of	the	DOT	
reading.	 The	 feed	 rate	was	 subsequently	 increased	 to	 7.3	mL/	 Li/h	 for	 another	 2	


















This	 procedure	 applies	 to	 the	 harvesting	 of	 material	 derived	 from	 7	 and	 30L	
bioreactors.	 	Fermentation	broth	was	harvested	at	3000	g,	20	min	and	4°C	using	a	




morpholino)propane	 sulfonic	 acid	 (MOPS)	 ,	 [1mM	 4-(2-aminoethyl)	 benzene	
sulfonyl	 fluoride]	 (AEBSF)	 hydrochloride,	 5U/mL	 benzonase	 (E8263-25KU),	 5mM	
Dithiothreitol	 (DTT)	 in	 reverse	 osmosis	 water	 (R>18.2	 MΩ/cm)	 titrated	 with	 1M	
sodium	hydroxide	to	achieve	a	of	pH	7.5	(@10°C)]	or	TRIS	lysis	buffer	[20mM	Tris	X	,	
(1mM	 4-(2-aminoethyl)	 benzene	 sulfonyl	 fluoride	 (AEBSF)	 hydrochloride,	 5U/mL	
benzonase	 (E8263-25KU),	 5mM	 Dithiothreitol	 (DTT)	 in	 reverse	 osmosis	 water	
(R>18.2	MΩ/cm)	titrated	with	1M	sodium	hydroxide	to	achieve	a	of	pH	8.5	(@10°C)]	
to	achieve	wet	cell	weight	(WCW)	concentrations	of	30	g/L	unless	stated	otherwise.	
40mL	 aliquots	 were	 prepared	 and	 subsequently	 disrupted	 using	 an	 APV	 Gaulin	
Lab40	High	Pressure	Homogeniser	as	stated	between	300-1200	bar,	for	1-5	passes.	
Homogenisation	was	performed	at	T<10°C	with	the	aid	of	a	glycol	cooling	loop.	
















disruption.	 Experiments	were	 conducted	with	 1mL	 cell	 suspensions	 in	MOPS	 lysis	
buffer,	0.1%	Triton	X-100,	in	12	x	12mm	milliTUBE	vials	(Covaris,	Brighton,	UK),	each	










MOPS	 Enzymatic	 Lysis	 buffer	 [4%	 (v/v)	 lyticase	 stock	 solution	 (2000U/mL	 lyticase	








were	 subsequently	 centrifuged	 at	 2000	 rpm	 for	 10	 minutes	 using	 a	 benchtop	
Eppendorf	 Centrifuge	 (5415R)	 to	 separate	 cells	 from	 the	 liquor.	 The	 supernatant	
was	discarded	and	the	pellets	were	resuspended	in	100µL	lysis	buffer	(20mM	Tris,	
pH	8.0,	1mM	EDTA,	5mM	DTT,	0.75%	Sodium	Deoxycholate).	The	suspensions	were	
incubated	 at	 room	 temperature	 for	 20	 minutes	 to	 react	 with	 lysis	 buffer	 as	 per	
findings	of	previous	unpublished	works	(data	not	shown).		
2.4.8 Cell	disruption	with	YeastBuster™	
Cell	 pellets	 were	 resuspended	 at	 room	 temperature	 in	 5mL/gWCW	 YeastBuster™	
reagent	 (Merck	 Millipore,	 Watford,	 UK)	 and	 50µL/gWCW	 100X	 THP	 solution.	






Bead	 lysis	 served	 as	 a	 small-scale	 cell	 disruption	 tool	 for	 iQur	 Ltd	 and	 was	
performed	by	IQur	as	outlined	below.	
Pellets	 were	 resuspended	 in	 1.5ml	 MOPS	 lysis	 buffer	 and	 mechanically	 lysed	
through	 bead	 lysis	 (1g	 mixed	 bead	 (2	 part	 0.1mm	 beads	 (0.4g),	 2	 parts	 0.5mm	
beads(0.4g)	 and	 1	 part	 1.5-2mm	 beads	 (0.2g)	 ratio	 2:2:1))	 for	 30	 seconds	 on	 a	
vortex	mixer	followed	by	30	seconds	of	cooling	time	on	ice.	This	cycle	was	repeated	
10	time	per	sample.	
Lysate	was	 separated	 from	beads	 through	manual	 extraction	with	 a	 pipette.	 This	
lysate	 was	 sonicated	 using	 a	 SoniPrep	 150	 device,	 operated	 at	 10000	 amplitude	
microns	for	two	10	second	cycles.		








for	 sample	volumes	over	2mL.	The	 supernatant	of	each	 sample	was	with	a	Millex	
0.22µm	33mm	PVDF	syringe	filter	(Merck	Millipore,	Watford,	UK).	A	Millex	0.45µm	





Exclusion	 Chromatography	 (SEC).	 The	 200nm	 upper	 limit	 was	 assumed	 as	 the	
preceding	 step	 to	 this	 unit	 operation	 was	 consistently	 a	 200nm	 depth-filtration	
step.	The	20nm	lower	limit	was	defined	as	the	assumed	smallest	size	for	a	HBc	VLP.		
Purification	was	 achieved	 by	 passing	 2mL	 of	 clarified	 lysate	 through	 a	 Sepharose	
CL4B	 column	 (XK16/20)	 fitted	on	 an	ÄKTA	pure	pump	 system	 (GE	Healthcare	 Life	
Sciences;	Hatfield,	UK).	The	flow	rate	of	the	mobile	phase	(20mM	Tris	pH	8.4,	5mM	

















When	 using	 small-scale	 bioreactors	 (V<250mL),	 wet	 cell	 weight	 (WCW)	 was	
determined	 as	 follows.	 In	 a	 pre-weighed	 1.5mL	 Protein	 LoBind	 tube	 (Eppendorf,	
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Stevenage,	 UK),	 a	 1.0mL	 sample	was	 centrifuged	 at	 3200	 g,	 10°C	 for	 10	minutes	
using	 a	 benchtop	 Eppendorf	 Centrifuge	 (5415R).	 The	 supernatant	 was	 either	
















Triplicate	 two-fold	 dilution	 series	 of	 25µL	 samples	 were	 prepared	 alongside	 a	




wells.	 The	plate	was	wrapped	 in	 foil	 and	 incubated	 for	 30	minutes	 at	 37°C.	 Plate	



























NuPage™	 4x	 LDS	 sample	 buffer	 and	 4µL	 NuPage™	 10x	 reducing	 agent.	 All	 tubes	
were	centrifuged	for	30	seconds	to	ensure	that	all	 liquid	resided	at	the	bottom	of	
the	 tubes.	 The	 tubes	were	 vortexed	 and	 heated	 using	 a	 C1000	 TouchÔ	 Thermal	
Cycler	(Bio-Rad,	Watford,	UK)	at	95°C	for	10	minutes	to	denature	protein	content.		






Carlsbad,	 USA)	 allowing	 for	 protein	 transfer	 to	 two	 respective	 nitrocellulose	
membranes	 (Invitrogen,	 Carlsbad,	 USA).	 Transfer	 buffer	 was	 prepared	 by	 mixing	







Samples	 were	 diluted	 in	 MOPS	 lysis	 buffer	 (2.4.3)	 to	 achieve	 total	 protein	
concentrations	of	1mg/mL	at	a	total	volume	of	50µL	in	0.2mL	Protein	LoBind™	PCR	
tubes	(Eppendorf,	Stevenage,	UK)	
Reference	 standard	 (Recombinant	 Hepatitis	 B	 Core	 Antigen,	 Abcam	 AB49013,	
1.0mg/mL)	 was	 diluted	 in	 MOPS	 0.1%	 TX100	 buffer	 to	 achieve	 100µL	 stock	
solutions.	 These	 stock	 solutions	 were	 serial	 diluted	 two-fold	 to	 final	 volumes	 of	












Note	 that,	 unless	 stated	 otherwise,	 all	 samples	 were	 analysed	 with	 triplicate	
measurements	to	determine	average	values	and	standard	deviations.		
2.5.11 Immunostaining	
Membranes	 were	 blocked	 in	 5%	 skimmed	 milk	 power	 PBS-T	 (0.05%	 Tween20)	
solution	 for	 1	 hour	 at	 room	 temperature	 or	 overnight	 at	 4-7°C.	 Hepatitis	 B	 virus	
core	 antigen-specific,	 mouse	 monoclonal	 antibody	 (Abcam;	 AB8639;	 Cambridge,	
UK)	 was	 applied	 in	 a	 1:1000	 solution	 in	 2.5%	 Skimmed	 Milk	 Power	 PBS-T	 and	
incubated	 for	 45	 minutes	 at	 room	 temperature	 and	 washed	 three	 times	 for	 5	
minutes	 each	 wash	 with	 PBS-T.	 Secondary	 antibody	 (Abcam;	 A4416-1ML;	
Cambridge,	UK)	was	applied	in	a	1:2000	dilution	in	PBS-T	followed	by	a	30-minute	
incubation	at	room	temperature.	Membranes	were	finally	washed	three	times	for	5	
minutes	 with	 PBS-T	 and	 once	 for	 5	 minutes	 with	 PBS	 to	 rinse	 away	 residual	
detergent.	10mL	of	Bio-Rad’s	Clarity	Western	ECL	substrate	was	used	to	develop	the	
membranes.	 Detection	 was	 performed	 using	 automated	 exposure	 setting	 on	 an	











Methanol	 concentrations	 in	 clarified	 supernatant	 samples	 were	 determined	 by	
HPLC	using	a	Dionex	UltiMate3000	HPLC	pump	and	fitted	with	an	Aminex	HPX-87H	
column.	 Columns	 were	 run	 at	 0.6	mL/min	for	 30	minutes	 using	 0.1%	 (v/v)	
trifluoroacetic	 acid	 (TFA)	as	 mobile	 phase,	 a	 column	 temperature	 of	 60	°C,	 an	
injection	volume	of	10	μL	and	monitored	with	an	ERC	Refractomax	520	 refractive	




Clarified	 supernatant	 samples	 were	 analysed	 using	 a	 Reagent-FreeÔ	 Ion	
Chromatography	System	(ICS)	 (Thermo	Fisher	Scientific,	Paisley,	UK)	fitted	with	an	
AminoPac	PA10	(2	×	250	mm)	anion	exchange	column,	with	AminoPac	PA10	guard	
column	 (2	×	50	mm),	 an	 eluent	 generator	 with	 a	 KOH	 500	 cartridge,	 and	 an	
electrochemical	 detector	 (gold	 electrode).	 An	 injection	 volume	of	 10	μL	was	used	
and	 a	 7.5	mM	 KOH	 solution	 was	 used	 as	 the	 mobile	 phase	 with	 a	 flow	 rate	 of	













Unclarified	 lysate	 samples	 were	 diluted	 to	 [X]=5-10gwcw/L	 using	 PBS	 and	 stained	
using	a	1:1000	volumetric	addition	BODIPYÒ	in	DMSO.	After	an	incubation	period	of	
15	minutes,	 5µL	 aliquots	of	 stained	 suspension	were	used	 to	prepare	microscopy	













Central	 Composite	Designs	 (CCDs)	with	on-face	 axial	 points	 (a=1)	 and	 two	 center	











The	 aims	 of	 bioprocess	 development	 are	 to	 create	 processes	 that	 produce	 the	
highest	 possible	 yield	 of	 product,	 at	 the	 highest	 purity,	 at	maximum	 throughput,	
with	the	greatest	level	of	reproducibility	at	a	variety	of	scales,	and,	preferably	at	the	
lowest	possible	cost.		
As	discussed	 in	 the	chapter	1,	when	aiming	 to	 fulfil	 the	above	criteria,	 there	exist	
multiple	 process	 options	 to	 produce	 a	 single	 biopharmaceutical	 compound.	
Although	 the	 scope	 of	 this	 research	 has	 been	 limited	 to	 using,	 specifically,	 P.	
pastoris	 as	 an	 expression	 system	 to	 produce	 Tandem	 Core	 Virus-Like	 Particles	
(VLPs),	a	multitude	of	process	options	still	need	to	be	addressed.		
Firstly,	 one	 must	 consider	 the	 architecture	 of	 the	 plasmid	 to	 be	 tested.	 As	 the	
Tandem	Core	VLP	is	still	novel,	testing	for	appropriate	assembly	and	expression	of	
the	VLP	will	be	required.	In	this	case,	rather	than	choosing	an	immunogenic	fusion	
protein	 associated	 with	 influenza,	 reporter	 proteins,	 such	 as	 Green	 Fluorescent	










Thirdly,	 there	 are	 several	 upstream	 process	 options	 available.	 The	 first	 aspect	 to	
consider	 is	 which	 platform	 is	 most	 suitable.	 In	 upstream	microbial	 bioprocessing	
this	 typically	 involves	 a	 variety	 of	 available	 modes	 of	 fermentation:	 either	
continuous	mode,	batch	mode,	fed-batch	mode,	or	a	combination	of	these	modes	
of	 fermentation.	 A	 subsequent	 aspect	 to	 consider	 is	 how	 the	 chosen	 platform	 is	
operated.	 Operating	 variables	 typically	 include	 operating	 temperature,	 agitation	
rate,	 aeration	 or	 sparge	 rate,	 operating	 pH,	 Dissolved	 Oxygen	 Tension	 (DOT),	
induction	 initiation	 time	 and	 harvest	 time.	 Media	 composition	 also	 needs	
consideration	 and	 can	 be	 controlled	 through	 media	 formulation,	 culture	 feeding	
and	culture	dilution.	For	fed-batch	systems,	feed	flow	rates	need	to	be	considered,	
whereas	with	 continuous	 systems,	 culture	 dilution	 rates	 need	 consideration.	 This	
group	of	options	will	be	referred	to	as	upstream	process-associated	factors.		
Fourthly,	 there	 is	a	multitude	of	options	available	 for	primary	 recovery.	Primarily,	
and	 indeed	 in	 the	 case	 of	 this	 research,	 the	 product	 of	 interest	 needs	 to	 be	
liberated	 from	 the	 cells.	 This	 can	 be	 achieved	 with	 various	 disruption	 methods:	
autolysis,	chemical	 lysis,	enzymatic	 lysis,	bead-facilitated	lysis,	sonication,	adaptive	
focused	 acoustics	 and	 homogenisation.	 Each	 of	 these	 methods	 has	 trade-offs	 in	
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terms	 of	 throughput,	 scalability	 and	 effectiveness.	 Notably,	 sonication	 and	
enzymatic	 lysis	are	not	used	at	pilot	 scale	because	no	 large-scale	apparatus	exists	
for	the	former	and	operational	costs	are	too	high	for	the	latter.	
Subsequently,	a	 suitable	method	must	be	chosen	 to	separate	cell	debris	 from	the	
soluble	product	of	interest.	This	can	be	achieved	through	a	variety	of	combinations	
of	various	modes	of	centrifugation	and	filtration.	Again,	these	modes	of	operation	
have	 various	 operating	 parameters	 associated	 with	 them	 that	 can	 considerably	
affect	 yield,	 purity,	 throughput,	 scalability,	 reproducibility	 and	 cost.	 This	 group	 of	
process	factors	will	be	referred	to	as	primary	recovery-associated	factors.		
Finally,	 the	 recovered	 product	 can	 be	 purified	 in	 numerous	 ways.	 For	 the	
purification	 of	 heterologous	 protein,	 this	 typically	 involves	 removal	 of	 unwanted	
protein	 species	 and	 nucleotides.	 This	 can	 be	 achieved	 through	 numerous	
precipitation	 methods,	 gradient	 centrifugation,	 and	 many	 chromatographic	
methods,	 including	 varieties	 of	 size-exclusion	 chromatography,	 hydrophobic	
interaction	 chromatography	 and	 ion-exchange	 chromatography.	 This	 group	 of	
process	factors	will	be	referred	to	as	downstream	process-associated	factors.	
Due	 to	 the	 sheer	magnitude	of	 options	 available,	 process-design	 limitations	were	
imposed.	Construct-associated	factors	were	limited	to	the	investigation	of	upstream	
process	 effects	 by	 several	 fusion	 protein	 inserts.	 This	 is	 because	 cell-engineering	
specifically	falls	outside	the	scope	of	this	research.	For	the	same	reason,	host	cell-
associated	 factors	were	 limited	 to	 investigating	 relevant	 differences	 in	 the	 use	 of	
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MutS-type	 (slow	 methanol	 metabolising)	 and	 Mut+-type	 (fast	 methanol	
metabolising)	P.	pastoris,	 specifically	and	 respectively	 the	KM71h	and	X33	strains.	
Upstream	process-associated	 factors	were	 limited	 to	 the	use	of	 a	 combination	of	
batch	 mode	 and	 fed-batch	 mode	 fermentations,	 as	 described	 by	 Invitrogen	
(Invitrogen	 Corporation,	 2002).	 The	 chosen	 primary	 recovery-associated	 factors,	
excluding	 extraction	 methods,	 were	 restricted	 to	 bench-top	 centrifugation	 and	
depth	filtration	methods.	Downstream	process-associated	factors	were	constrained	
to	salt	precipitation	methodology	and	to	Size	Exclusion	Chromatography.	These	two	






observations	 through	 addressing	 relatively	 simple	 initial	 hypotheses.	 These	
observations	 can	 be	 used	 to	 (1)	 formulate	 more	 in-depth	 hypotheses	 and	 (2)	
establish	a	base	case	experimental	platform	which,	in	turn,	can	be	used	to	address	
these	matured	hypotheses.		
The	order	of	 the	hypotheses	and	the	associated	research	reported	 in	 this	chapter	
will	 generally	 follow	 the	 same	 sequence	 as	 unit	 operations	 in	 a	 bioprocess:	






Previous	works	have	 shown	 that	Tandem	Core	Hepatitis	B	Virus-Like	Particles	 can	
be	produced	in	both	bacteria	and	plants	(Peyret	et	al.,	2015);	while	other	VLPs,	such	
as	those	based	on	Human	Papilloma	Virus	(HPV),	have	been	produced	in	P.	pastoris		
using	 bioreactors	 (Jiang	 et	 al.,	 2011).	 Initial	 work	 was	 undertaken	 to	 establish	
fermentation	protocols	for	the	correct	expression	and	formation	of	Tandem	Core	in	
P.	pastoris,	and	to	assess	formation	using	a	GFP	reporter	for	analysis.	This	reporter	





Core	VLPs	with	 a	 single	GFP	 insert	 on	one	of	 the	Major	 Insertion	Regions	 (MIRs).	









All	 stages	of	 fermentation	were	operated	as	described	 in	section	2.3.6.1,	with	the	
following	exceptions:	as	shown	 in	Figure	3.1A,	due	to	an	extended	period	of	poor	
temperature	 control,	 a	 higher	 than	 desired	 temperature	 (43°C)	 resulted	 in	
unfavourable	 conditions	 for	 biomass	 accumulation	 and,	 therefore,	 most	 likely	
prolonged	the	batch	phase	of	the	fermentation,	although	no	product	was	 induced	
at	 this	stage.	Additionally,	 the	glycerol	 fed	batch	phase	 involved	the	use	of	a	50%	
w/w	feed	as	opposed	to	a	50%	volumetric	 feed,	resulting	 in	a	slightly	more	dilute	






OD600	measurements	were	 taken	as	described	 in	section	2.5.1	and	can	be	seen	 in	
Figure	 3.1B.	 In	 addition	 to	 biomass	 monitoring,	 using	 optical	 density,	 multiple	







lysis,	 the	 pellets	 were	 vortexed	 and	 50µL	 samples	 were	 taken,	 representing	 the	
total	 protein	 expression	 fraction.	 This	 was	 followed	 by	 centrifugation	 so	 a	 that	


















380g/L	 WCW	 at	 the	 point	 of	 harvest.	 The	 Western	 blot	 results	 also	 show	 that	
induction	 was	 successful.	 The	 full-length	 monomer	 is	 expected	 at	 a	 molecular	
weight	of	around	64kDa	and,	while	this	represents	the	main	band,	it	is	clear	to	see	
that	 some	 truncations	 of	 the	monomer	 are	 visible,	 possibly	 indicating	 proteolytic	
activity.	Furthermore,	the	higher	bands	may	also	indicate	dimer	formations,	though	
this	 is	 difficult	 to	 establish	 with	 the	 existing	 resolution.	 However,	 unfortunately,	
most	 of	 the	 product	 was	 not	 recoverable	 in	 soluble	 form	 at	 any	 time	 of	 the	








expressing	 tHBc-GFP,e	 was	 possible.	 However,	 the	 majority	 of	 expressed	
heterologous	protein	detected	was	insoluble	and	therefore	it	was	unclear	whether	
VLP	assembly	had	occurred.		Furthermore,	if	VLP	assembly	had	occurred,	VLPs	were	
not	 able	 to	 be	 detected	 due	 to	 potential	 association	 with	 insoluble	 cell	 debris,	
possibly	as	a	result	of	the	method	of	extraction	employed.		
Various	sources	indicate	that	changing	operating	temperature	and	implementing	a	
sorbitol-methanol	mixed	 feeding	 strategies	 can	have	beneficial	 effects	on	process	
yields	and	product	quality	 (Li	et	al.,	 2001;	Xie	et	al.,	 2005;	Celik,	Calik	 and	Oliver,	
2009;	 Zhong	et	 al.,	 2014).	 Figure	 3.2	 showed	 variations	 between	band	 intensities	
and	 profiles	 over	 time,	 particularly	 when	 comparing	 early	 induction	 time	 points	















To	 test	 the	 first	 hypothesis,	 a	 fermentation	was	 operated	 as	 described	 in	 section	
3.2.1,	 however,	 induced	 at	 a	 lower	 temperature	 of	 20°C.	 Fermentation	 data	 is	
shown	in	Figure	10.4	in	the	appendix.	
Looking	 at	 Figure	 3.3,	 and	 comparing	 induction	with	 pure	methanol	 at	 20°C	with	
pure	 methanol	 induction	 at	 30°C	 (as	 described	 in	 section	 3.2.1),	 it	 appears	 that	




GFP,e	 monomer	 (band	 2,	 ~64kDa)	 has	 become	 insoluble	 at	 a	 low	 temperature	
induction	 process,	 while	 higher	 induction	 temperatures	 seem	 to	 result	 in	 higher	







Figure	3.3	 Specific	 tHBc-GFP,e	expression	 (RFU/OD600)	 of	harvested	material	 from	 three	
fermentations,	each	with	different	modes	of	induction.	‘Methanol’	refers	to	an	induction	
process	with	 only	methanol	 in	 the	 feed;	 ‘Mixed’	 refers	 to	 an	 induction	 process	with	 a	
mixture	 of	 sorbitol	 and	 methanol	 in	 the	 feed.	 Extractions	 were	 performed	 with	




of	 induction.	 Extractions	 were	 performed	 with	 homogenisation	 or	 with	 sonication	 (*).	
Protein	 presence	 in	 clarified	 culture	 media	 was	 also	 studied	 (**).	 (A)	 Reversible	
membrane	stain	of	reduced	SDS-PAGE	gel	showing	soluble	and	insoluble	host	cell	protein	
expression	profiles.	(B)	Western	blot	showing	soluble	and	insoluble	expression	profiles	of	





The	 second	 hypothesis	 was	 addressed	 by	 running	 a	 fermentation	 as	 described	
earlier	in	this	section,	however,	inducing	with	a	1:1	carbon	mole	ratio	of	sorbitol	to	
methanol	 mixture,	 at	 an	 induction	 temperature	 of	 20°C.	 Fermentation	 data	 is	
shown	in	Figure	10.5	in	the	appendix.	
Comparing	 this	 fermentation	with	 the	 previously	 discussed	 process	where	 a	 20°C	
pure	methanol	induction	strategy	was	used,	looking	at	Figure	3.3	and	Figure	3.4,	it	
appears	 the	 addition	 of	 sorbitol	 as	 a	 co-substrate	 does	 not	 obviously	 benefit	 the	
expression	of	 soluble	 tHBc-GFP,e.	 In	 fact,	 expression	of	heterologous	protein,	 per	
cell,	 is	 decreased	 through	 the	 addition	 of	 a	 co-substrate,	 possibly	 due	 to	
competition	 between	 the	 activation	 of	 the	 AOX1	 gene	 and	 cell	 growth	 and	
maintenance.	 This	 could	 have	 resulted	 in	 lower	 specific	 heterologous	 expression.	
Nonetheless,	of	what	little	protein	expression	is	monitored,	a	higher	proportion	of	
expressed	 protein	 appears	 to	 be	 soluble.	 Thus,	 while	 mixed	 feed	 strategies	 can	
indeed	have	an	impact	on	expression	of	heterologous	protein,	the	titres	generated	
did	not	result	in	a	beneficial	improvement.		
The	 third	 hypothesis	 was	 investigated	 by	 analysing	 protein	 expression	 of	 a	 low-
temperature	 fermentation	 over	 time.	 As	 seen	 in	 Figure	 3.5	 and	 Figure	 3.6,	
representing	 specific	 protein	 expression	 over	 time	 in	 the	 previously	 discussed	
fermentation	 with	 a	 20°C	 pure	 methanol	 induction,	 time	 does	 appear	 to	 be	 a	
significant	 factor	 for	 overall	 expression	 of	 tHBc-GFP,e.	 However,	 note	 that	 the	
amount	of	soluble	heterologous	protein,	measured	in	RFUs,	is	consistent	over	time:	
8.27±1.61%	 relative	 to	 the	 total	 amount	 of	 heterologous	 protein	 expressed.	 This	
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data	 would	 suggest	 that	 time	 is	 not	 strictly	 a	 significant	 contributing	 factor	 to	
product	 solubility.	Yet,	 looking	at	 the	corresponding	Western	blot	 (Figure	3.6B),	 it	
seems	that	as	induction	time	progresses,	insoluble	degradation	products	(bands	2,3	
and	4)	accumulate.	This	conflicting	data	between	RFUs	from	GFP	and	Western	blot	








Figure	3.5	Time	 course	analysis	of	protein	expression	of	 20°C	pure	methanol	 induction.	
GFP-positive	 protein	 expression	 is	 displayed	 as	 Relative	 Fluorescence	 Units	 (RFUs)	 per	
unit	of	biomass	(OD600).	Total	protein	is	expressed	in	mass	per	unit	of	biomass.	

































insoluble	 host	 cell	 protein	 expression	 profiles.	 (B)	 Western	 blot	 showing	 soluble	 and	
insoluble	expression	profiles	of	tHBc-GFP,e.		
The	 fourth	 hypothesis	 was	 addressed	 by	 comparing	 protein	 extraction	 with	




In	 addition	 to	 assessing	 the	 above	 hypotheses,	 the	 following	 observations	 were	
made:	 The	banding	profiles	 on	 the	Western	blot	 on	 Figure	 3.4B	 seem	 to	 indicate	
that	 truncation	 of	 heterologous	 protein	 contributes	 to	 insolubility.	 Six	 species,	 or	
breakdown	products,	 of	 expressed	 heterologous	 tHBc-GFP,e	 protein	 fractions	 can	
be	identified,	numbered	as	1	to	6.	As	seen	on	Figure	3.4,	only	species	1,	2	and	6	are	
found	to	be	soluble.	This	suggests	either	certain	truncations	are	inherently	insoluble	







Due	 to	 inconsistencies	 in	 generating	 the	analysed	materials,	 it	 should	be	 stressed	
that	the	findings	in	this	section	are	strictly	indicative,	rather	than	conclusive.		These	
irregularities	 include:	 temporary	 loss	 of	 control	 of	 operating	 parameters	 such	 as	
DOT,	pH	and	 temperature;	different	 induction	 feed	 rates	and	different	harvesting	
times.	Harvesting	times,	ranging	from	70	to	92	hours	post-inoculation,	were	based	
on	 consistent	 target	 OD600	 values	 of	 500	 rather	 than	 consistent	 harvesting	 time,	
which,	after	testing	the	third	hypothesis	of	this	section,	seems	to	have	proven	to	be	
an	incomplete	approach	as	time	was	shown	to	affect	heterologous	expression.	Also	





on	 the	Major	 Insertion	 Region.	 These	 units	were	 expressed	 in	 a	P.	 pastoris	Mut+	
phenotype.	 Results	 show	 that,	 despite	 investigating	multiple	 process	 parameters,	
most	of	 the	expressed	material	 remained	 insoluble	 and	was	often	degraded.	 This	
indicated	 that	VLP	 formation	had	been	problematic.	 In	 addition,	 results	 indicated	
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hindrance	 and/or	 hydrophobic	 interactions.	 Secondly,	 the	 rate	 of	 heterologous	
protein	expression,	manipulated	through	varying	modes	of	induction,	was	shown	to	
have	an	effect	on	tHBc-GFP,e	expression	and	solubility.		
Work	 by	 Zlotnik	 et	 al	 indicates	 that	 VLP	 self-assembly	 requires	 regulation,	 as	
uncontrolled	 assembly	 of	 free	 units	 of	 recombinant	 protein	 can	 result	 in	 ‘kinetic	
traps’	 and	 thus	 incomplete	 formation	 of	 capsids	 (Zlotnick	 and	 Mukhopadhyay,	
2011).	 Specifically,	 at	 high	 induction	 rates,	 there	will	 be	multiple	monomers	 that	












Following	 these	observations,	 the	next	experiments	 tested	whether	Tandem	Core	
protein	 assembly	 is	 hindered	 by	 the	 size	 of	 the	 insert	 placed	 in	 the	MIR.	 It	 was	
noted	that	GFP	appeared	to	cleave	off	 the	Tandem	Core	monomer,	 therefore	this	
was	 replaced	 with	 a	 lysine	 residue	 in	 each	 MIR.	 Secondly,	 if	 VLP	 self-assembly	
requires	 regulation	and	can	be	controlled	 through	 lower	protein	expression	 rates,	







Prior	 to	 induction,	 the	 fermentation	 processes	 were	 similar	 between	 MutS	 and	
Mut+.	 However,	 the	 induction	 phase	 yielded	 very	 different	 fermentation	
performance,	mostly	relating	to	methanol	consumption.	As	expected,	due	to	lower	
AOX	 expression,	 the	 MutS	 fermentation	 required	 a	 longer	 adaptation	 period	 to	
methanol	and	was	not	capable	of	utilising	this	substrate	at	the	same	rates	as	Mut+	















material.	 (A)	Homogenisation	at	1200	bar,	3	passes	 (section	2.4.3);	 (B)	centrifugation	at	
15000	 g,	 30	 min,	 4°C;	 (C)	 heat	 treatment	 in	 a	 water	 bath	 at	 55°C,	 30	 minutes;	 (D)	
centrifugation	 at	 15000	 g,	 30	 min,	 22°C;	 (E)	 ammonium	 hydroxide	 precipitation;	 (F)	













isolate	 Tandem	 Core	 protein	 with	 no,	 or	 negligible	 amounts	 of,	 truncated	 core-
positive	 species.	 The	 full-length	 monomer	 is	 expected	 at	 molecular	 weight	 of	




be	 present	 due	 to	 incomplete	 chemical	 reduction	 in	 preparation	 of	 the	 assay.		
Figure	3.9	shows	how	these	same	unit	operations	facilitate	the	removal	of	host	cell	
protein	and	nucleic	acids	(Figure	3.9).	Finally,	Figure	3.10	proves	that	the	expressed	
tHBc-k1,k1	 monomers	 are	 assembling	 into	 Virus-Like	 Particles.	 As	 shown	 by	 the	
profiles	associated	with	clarification	in	Figure	3.8B,	it	would	appear	that	most	of	the	
expressed	 tHBc	 is	 soluble.	 A	 slight	majority	 of	 this	 soluble	material	 is	 heat-stable	
and,	 in	 turn,	 all	 of	 this	 material	 precipitated	 after	 the	 addition	 of	 ammonium	
sulphate.	 This	 last	 step	 eliminated	 a	 significant	 portion	 of	 host	 cell	 protein	 and	
























However,	not	addressed	were:	 (1)	 the	effect	of	 time	on	 the	expression	of	 soluble	
tHBc-k1,k1	and;	(2)	how	robust	this	process	is	from	a	bioprocessing	perspective.		
To	 address	 this,	 firstly,	 a	 replicate	 fermentation	 run	 was	 attempted,	 the	 original	
fermentation	 being	 depicted	 previously	 in	 Figure	 10.6.	 The	 data	 for	 this	 replicate	
run	 is	 shown	 in	 Figure	 3.11.	 Samples	 were	 taken	 throughout	 the	 fermentation,	
which	were	then	processed	as	described	in	Figure	3.7	until	unit	operation	‘G’,	prior	
to	 Size	 Exclusion	 Chromatography,	 together	 with	 samples	 taken	 throughout	 the	
original	 fermentation.	 Expression	 of	 tHBc-k1,k1	 in	 both	 the	 original	 and	 replicate	






k1,k1:	 (A)	 Offline	 data	 including	 OD600,	 sampling	 events,	 carbon	 source	 feed	 rates,	





Unfortunately,	 the	 fermentations	 could	 not	 be	 operated	 identically	 due	 to	









Figure	 3.12	 Qualitative	 protein	 data	 of	 time	 course	 analysis.	 Time	 represents	 the	 time	



























































































































applied	 consistently.	 In	 particular,	 it	 was	 often	 difficult	 to	 isolate	 a	 pellet	 with	
centrifugation	 following	precipitation	 (Figure	3.13).	Therefore,	 future	 investigation	
should	be	carried	out	on	more	robust	platforms	with	tighter	control.	
	








single	GFP	 insert	 in	 one	of	 the	MIRs.	No	 evidence	was	 found	 to	 suggest	 that	 the	
expressed	material	was	assembling	 into	VLPs.	This	 could	possibly	be	explained	by	
the	 large	 number	 of	 product	 truncations	 detected	 in	 analyses.	 These	 truncations	
could	have	hindered	the	assembly	of	VLPs.		





conditions	 for	 the	 expression	 and	 assembly	 of	 soluble	 VLPs.	 This	 hypothesis	 was	
tested	 using	 a	P.	 pastoris	MutS	 strain	 expressing	 Tandem	 Core	 protein	with	 two,	
single	 lysine	 inserts.	 Results	 showed	 that,	 using	 this	 strategy,	 soluble	 and	 heat-
stable	VLPs	were	indeed	produced	in	the	appropriate	size	range.		
It	must	be	stressed	that	certain	results	in	this	chapter,	particularly	those	relating	to	





robust,	 reproducible	 and,	 preferably,	 high-throughput	 fashion.	 This	 could	 be	
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achieved	 through	 the	 use	 of	 miniaturised	 fermentation	 platforms,	 more	
streamlined	 extraction	 processes,	 and	 combined	 with	 experimental	 design	
methodology.		
The	 time	 and	 cost	 benefits	 of	 these	miniaturised	 fermentation	 platforms	 can	 be	
gained	only	by	employing	 complementary	 techniques,	 facilitating	high-throughput	
at	 small	 sample	 volumes.	 As	 indicated	 earlier	 in	 this	 chapter,	 the	 method	 of	
extraction	has	a	significant	effect	on	the	yield	of	soluble	heterologous	material	and,	
since	the	investigated	miniaturised	extraction	platforms	investigated	in	this	chapter	
yielded	 poor	 soluble	 yields,	 this	 is	 something	 that	 needs	 to	 be	 addressed	 in	 the	
subsequent	chapter.		
This	chapter	has	established	the	formation	of	a	VLP	using	the	k1,k1	construct	and	a	
MutS	 phenotype	 strain.	 The	 following	 chapters	 will	 seek	 to	 conduct	 process	
development	on	these	Tandem	Core	VLPs	using	a	high-throughput	methodology	for	
upstream	processing	and	primary	recovery.	As	sample	analysis	has	proven	to	be	a	














fermentation	 platforms	 can	 only	 be	 gained	 by	 employing	 complementary	
techniques	facilitating	high-throughput	at	small	sample	volumes.	
This	 chapter	will	 therefore	describe	 research	 aimed	at	 structurally	 addressing	 the	
effects	of	primary	 recovery	methods,	with	an	emphasis	on	 cell	 disruption,	on	 the	
yield	of	soluble	Tandem	Core	material.	In	doing	so,	the	chapter	will	discuss	how	cell	
disruption	processes	could	be	characterised,	optimised	and	miniaturised	such	that	
they	 could	 be	 employed	 in	 a	 platform	 approach	 when	 coupled	 with	 miniature	
fermentation,	 or	 situations	 of	 limited	 sample	 volumes.	 Note	 that	 all	 biomass	 (P.	







Cell	disruption	 is	essential	 for	almost	all	 intra-cellular	products.	Most	studies	have	
defined	 total	 cell	 disruption	 (R)	 as	 a	 performance	 criterion	 of	 cell	 disruption	
processes,	 often	 measured	 as	 total	 soluble	 protein	 content.	 However,	 counter-
intuitively,	 maximising	 cell	 disruption	 is	 not	 always	 the	 main	 objective	 of	 cell	
disruption,	as	product	can	associate	with	cell	debris,	such	that	is	becomes	difficult	
to	remove	using	centrifugation.	This	chapter	will	define	cell	disruption	performance	
with	 five	different	performance	criteria:	 (1)	Total	 cell	disruption,	measured	as	 the	
concentration	 of	 total	 soluble	 protein,	 R	 (mg/mL),	 (2)	 specific	 cell	 disruption,	
defined	 as	 the	 amount	 of	 protein	 released	 per	 unit	 of	 suspended	 biomass,	 Rs	
(mg/gWCW)8,	 (3)	 total	 product	 recovery	 expressed	 as	 the	 concentration	 of	 soluble	
Tandem	Core	Hepatitis	B	core	protein	[tHBc]	(µg/mL),	(4)	specific	product	recovery,	
tHBcs	 (µg/gWCW)9	and	 (5)	 product	 purity,	 expressed	 as	 a	 ratio	 of	 total	 recover	
product	 relative	 to	 the	 amount	 of	 total	 release	 soluble	 protein,	 P	 (%)10.	 By	
understanding	 the	 response	 models	 of	 multiple	 performance	 criteria,	 the	 range	
applications	 of	 cell	 disruption	 platforms	 can	 be	 broadened	 as	 well	 as	 create	 a	
performance-based	scaling	methodology.		
																																																						
8	!" = !/ % 		
with	[X]	being	the	concentration	of	biomass	(g/L)	
9	&'()* = &'() /[%]	












Through	high-velocity	 impact,	 cavitation,	 fluid	 shear	 and	decompression,	 the	 cells	
are	disrupted	causing	 their	contents	 to	be	 released.	This	process	can	be	repeated	







./ 0123012340 = 5678 Equation	4-1 
Where,	Rmax	is	the	maximum	amount	of	releasable	protein	(mg/mL),	R	the	observed	
amount	of	released	protein	(mg/mL),	N	the	discrete	number	of	passes	through	the	
valve,	 k	 a	 temperature	 dependent	 rate	 constant	 and	 is	 specific	 to	 the	 organism	
being	disrupted;	p	 the	operating	pressure	(bar)	and	a	 is	a	measure	of	a	microbe’s	
resistance	to	disruption.	
In	 addition,	 efficiency	 of	 homogenisation	 is	 known	 to	 decrease	 at	 high	 biomass	
suspension	 concentrations	 (Kleinig	 et	 al.,	 1995).	 Therefore,	 for	 a	 given	 organism	
harvested	 at	 fixed	 conditions	 the	 following	 relation	 can	 be	 observed	 for	 cell	
disruption:	
0 = 9(6, 7, [<])	 Equation	4-2 
Where	[X]	is	the	concentration	of	biomass	(gWCW/L)	in	suspension.	
4.2.2 Miniaturised	cell	disruption	platforms	
However,	 High	 Pressure	 Homogenisation	 is	 only	 suitable	 for	 processing	 large	
volumes	 with	 the	 smallest	 representative	 size	 being	 40mL	 using	 an	 APV	 Gaulin	
Lab40	homogeniser	 (Jenning,	 Lippacher	and	Gohla,	2002).	 	 Scale-down	bioprocess	
sequences	often	start	with	the	use	of	microtiter	plates	or	miniaturised	bioreactors	







The	 aim	 of	 this	 chapter	 is	 to	 develop	 a	 miniaturised	 cell	 disruption	 platform	
intended	for	rapid	upstream	process	characterisation.	The	specific	objectives	are	to:	
• Investigate	the	effects	of	 lysis	buffer	components.	This	will	be	necessary	as	
these	 factors	 could	 contribute	 to	 overall	 cell	 disruption,	 product	 release,	
product	stability	and,	once	optimised,	will	be	invariable	between	large-scale	
and	small-scale	(mechanical)	disruption	platforms.		
• Characterise	 high-pressure	 homogenisation	 by	 investigating	 a	 number	 of	
responses.	 This	will	 be	necessary	 to	establish	process	performance	 targets	
for	small-scale	methods.		
• Investigate	the	performance	and	implementation	of	several	small-scale	cell	
disruption	 technologies.	 This	 will	 allow	 for	 the	 selection	 of	 the	 most	
appropriate	platform.		
• Screen	 for	 significant	 process	 factors	 for	 the	 chosen	 small-scale	 cell	
disruption	 platform.	 This	 process	 will	 eliminate	 the	 need	 to	 investigate	
potentially	insignificant	process	factors	during	optimisation	studies,	allowing	
for	a	more	economical	experimental	approach.		
• Characterise	 and	 optimise	 small-scale	 cell	 disruption	 process	 parameters.	
This	 will	 maximise	 process	 the	 output	 of	 key	 quality	 attributes	 and,	 in	 so	
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All	 detergents	 investigated	 in	 this	 chapter	 are	 non-ionic,	 implying	 that	 the	
hydrophilic	region	of	the	molecule	is	uncharged.	Typically	considered	a	mild	class	of	
detergents,	 these	 affect	 lipid	 interactions	 without	 significantly	 affecting	 protein-
protein	 interactions.	 This	 class	 of	 detergents	 is	 predominantly	 used	 to	 isolate	








performed	 on	 the	 concentration	 of	 salt,	 the	 concentration	 of	 the	 chosen	 type	 of	
detergent	and	the	concentration	of	biomass	 in	suspension	(also	referred	to	as	the	
concentration	of	solids).		
Figure	 4.2	 shows	 the	 experimental	 procedures	 involved	 in	 studying	 the	 effects	 of	
various	 buffer	 conditions	 on	 a	 variety	 of	 key	 quality	 attributes.	 The	 studied	
attributes	 were	 (1)	 total	 cell	 disruption,	measured	 as	 total	 protein	 concentration	
(section	 2.5.5)	 after	 unit	 operation	 ‘E’;	 (2)	 total	 Tandem	 Core	 material	 recovery,	
estimated	 using	 western	 blotting	 and	 densitometry	 (sections	 2.5.9	 and	 2.5.11),	
measured	 after	 units	 ‘E’	 and	 ‘G’;	 (3)	 particle-size	 distribution	 of	 clarified	 lysate,	
measured	after	unit	operation	‘E’.	Note	that	product	analysis	on	western	blotting	is	











taken	 after	 this	 incubation.	 (D)	 Centrifugation	 of	 crude	 lysate	 at	 15000g,	 4°C	 for	 30	
minutes.	 (E)	 0.45µm	 &	 0.22µm	 dead-end	 filtration	 of	 supernatant.	 (F)	 Incubation	 of	
supernatant	 at	 4°C,	 investigated	 variable	 is	 the	 incubation	 time,	 samples	 are	 taken	




incubated	 sample.	 Samples	 were	 taken	 after	 incubations	 to	 study	 the	 effect	 of	
aggregation	on	product	recovery.		
4.3.2 Investigating	the	effect	of	detergent	type	and	quantity	
This	 set	 of	 experiments	 focussed	 on	 the	 effect	 on	 the	 solubility	 of	 Tandem	 Core	
protein	 in	 clarified	 lysate	 (step	 F	 in	 Figure	 4.2)	 resulting	 from	 the	 addition	 of	
different	types	of	detergents	in	lysate	immediately	after	homogenisation	(step	C	in	
Figure	 4.2	 at	 1200	 bar	 for	 3	 passes).	 Note	 that	 this	 addition	 step	 was	 after	
homogenisation,	 rather	 than	 before,	 as	 adding	 detergents	 during	 the	
homogenisation	 process	 could	 result	 in	 the	 formation	 of	 liquid-gas	 interfaces,	
typically	 detrimental	 to	 product	 quality.	 Detergent	 types	 used	 were	 Triton	 X100	
(TX100),	polysorbate	80	 (PS80)	and	Tween	20	at	 final	 lysate	concentrations	of	1%	
and	 0.1%.	 To	 capture	 the	 full	 effect	 of	 detergent-mediated	 solubilisation,	 an	
incubation	period	of	1	hour	was	performed	prior	to	sample	analysis.	Total	product	
and	protein	 released	 in	 crude	 lysate	was	 assessed	 through	Western	blotting	with	
densitometry	analysis	(sections	2.5.9	and	2.5.11)	and	total	protein	analysis	(section		
2.5.5)	 on	 material	 after	 incubation	 in	 step	 C	 in	 Figure	 4.2.	 Using	 similar	








two	 separate	 two-point	 calibration	 curves.	 The	 first	 membrane	 contained	 buffer	
conditions	 at	 volumetric	 concentrations	 of	 1%,	 whereas	 the	 second	 membrane	
depicts	 data	 from	 buffer	 concentrations	 of	 0.1%.	 One	 must	 consider	 that	 this	
method	 of	 analysis	 is	 hard	 to	 reproduce	 quantitatively,	 and	 so	 it	 is	 not	
recommended	 that	 the	 two	 concentration-groups	 be	 compared	 directly.	 In	
addition,	 the	 difference	 in	 total	 soluble	 protein	 content	 after	 incubation	 was	
roughly	 the	 same	 in	 all	 buffer	 conditions,	 with	 marginally	 higher	 soluble	 protein	
content	when	using	higher	concentrations	of	TX100.	Therefore,	assuming	that	total	
soluble	protein	content	would	positively	correlate	to	solubility	of	tHBc,	and	bearing	





after	 44	 hours	 and	 72	 hours	 of	 incubation	 at	 4°C.	 Peak	 area	 was	 determined	 through	
densitometry	analysis	on	Western	blots.	Peak	area	was	converted	to	HBc	concentration	
using	 a	 two-point	 calibration	 curve.	No	 replicate	 data	was	 generated.	 (B)	 Total	 protein	
content	 in	 crude	 lysate	 and	 in	 clarified	 lysate	 after	 1	 hour,	 44	 hours	 and	 72	 hours	 of	

































































































The	 previous	 section	 described	 how	 several	 detergents	 contributed	 to	 buffer	
stability,	product	recovery	and	total	cell	disruption.		
However,	 one	 unaddressed	 variable,	 contributing	 to	 the	 aforementioned	 key	
quality	 attributes,	 is	 the	 concentration	 of	 salt.	 Sources	 report	 that	 salt	
concentration	can	have	a	significant	effect	on	the	recovery	of	VLPs	in	storage	(Shi	et	
al.,	2005).		
To	 study	 this	 effect	 in	 combination	with	 the	previous	 studies,	 an	experiment	was	
conducted	 as	 follows:	 after	 determining	 the	 most	 suitable	 detergent,	 a	 4-factor,	
two-level,	 full	 factorial	 experimental	 screening	 design	 with	 3	 midpoints	 was	
executed.	The	factors	chosen	and	their	corresponding	values	are	listed	in	Table	4-1.	
Table	 4-1	 Experimental	 overview	 for	 a	 4-factor,	 two-level,	 full	 factorial	 experimental	
screening	design	with	3	midpoints	to	characterise	homogenisation	conditions.			
STD	 [NaCl]	(mM)	 [TX100]	(%vol.)	 WCW	(g/L)	 t	(h)	
1	 500	 0.1	 150	 1	
2	 0	 0.1	 30	 72	
3	 500	 1.5	 150	 72	
4	 500	 1.5	 30	 72	
5	 0	 1.5	 30	 1	
6	 250	 0.8	 90	 45	
7	 500	 1.5	 150	 1	
8	 0	 15	 150	 1	
9	 500	 1.5	 30	 1	
10	 0	 1.5	 30	 72	
11	 0	 0.1	 150	 1	
12	 500	 0.1	 30	 1	
13	 250	 0.8	 90	 45	
14	 0	 0.1	 30	 1	
15	 0	 1.5	 150	 72	
16	 0	 0.1	 150	 72	
17	 250	 0.8	 90	 45	
18	 500	 0.1	 30	 72	
19	 500	 0.1	 150	 72	
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Several	 responses	were	chosen	to	generate	screening	 results.	Firstly,	 total	 soluble	
protein	 released	 (R	 (mg/mL))	 was	 chosen	 to	 represent	 an	 overall	 level	 of	 cell	
disruption.	 As	 the	 solid	 loading	 percentage	 was	 varied,	 second	 variable	 was	
introduced	to	indicate	a	level	of	cell	disruption	per	unit	of	biomass:	specific	protein	
release	(Rs	(mg/gWCW)).	This	measure	is	relevant	when	wanting	to	make	efficient	
use	 of	 biomass	 input.	 Thirdly,	 overall	 product	 recovery	 was	 measured	 ([HBc]	





of	 squares	 (Type	 III)	 of	 each	 factor-associated	 first-degree	 polynomial	 term	 as	 a	
percentage	of	the	total	of	the	sum	of	squares	of	all	terms	in	the	screening	models.	
Note	 that	 quadratic	 terms	were	 not	 included	 in	 the	 analysis	 of	 variance	 as	 these	
terms	 are	 aliased	 to	 all	 studied	 factors.	 Table	 4-2	 shows	 the	 level	 of	 overall	
response	 variance	 created	 by	 each	 factor	 in	 this	 screening	 experiment	 when	 all	
possible	first-degree	polynomial	 interactions	are	considered.	The	 left	side	of	Table	
4-3	 shows	 the	 goodness	 of	 fit	 of	 these	models,	 using	 r2.	 The	 robustness	 of	 these	
models	 is	 then	 assessed	 using	 r2	 adjusted.	 The	 same	 table	 subsequently	 shows	









of	 released	 soluble	 protein,	 hence	 the	 positive	 gradient	 seem	 in	 the	 formula	 in	
Table	 4-3.	 From	 Table	 II	 it	 can	 also	 be	 said	 that	 the	 contribution	 of	 the	
concentration	of	detergent	is	also	relevant.		This	can	be	explained	by	the	significant	
factor	 interaction	 existing	 between	 biomass	 concentration	 and	 detergent	





disruption	 (Rs)	 differed	 significantly	 from	 the	 response	 R.	 Like	 with	 R,	 major	
response	 variance	 contributions	 are	 due	 to	 variation	 of	 [X]	 and	 [TX].	 However,	 a	
combined	28.54%	of	response	variance	was	caused	by	variance	of	[NaCl]	and	t.	But	
because	 no	 significant	 model	 terms	 were	 associated	 with	 these	 factors,	 despite	
considerably	contributing	to	model	variance,	a	notable	reduction	in	goodness	of	fit	
is	 seen	 in	 simplified	models	 (Table	 4-3).	Moreover,	 the	most	 significant	 factor	 in	
both	 responses	 for	R	 and	RS,	 the	concentration	of	biomass	 ([X]),	has	 the	opposite	
effect.	Maximising	R	requires	maximising	[X],	as	indicated	by	the	positive	gradient	in	





the	 scenario	 with	 relatively	 less	 biomass,	 more	 kinetic	 energy	 directed	 to	 cell	
disruption	is	available	per	unit	of	biomass.	




effect	 of	 product	 “salting	 out”	 at	 higher	 concentrations	 of	 salt	 and	 relatively	
hydrophobic	molecules.		
Variance	 in	HBcs	 levels	are	mainly	caused	by	variance	 in	 [TX],	 followed	by	 [X]	 and	
[NaCl].	 Table	 4-3	 shows	 that	 the	 both	 the	 complex	 and	 simplified	models	 have	 a	
very	high	goodness	of	fit	and	are	both	very	robust.	As	seen	with	[HBc],	the	negative	
model	 terms	 for	 [TX]	 and	 [NaCl]	 could	be	explained	by	salting	out	effects.	Finally,	
like	specific	cell	disruption,	[X]	has	a	negative	effect	on	specific	product	release.		
Table	4-2	Relative	factor	contributions	in	a	four-factor,	two-level,	half-fractional	factorial	
screening	 designs.	 Six	 different	 screenings	 were	 performed:	 Total	 cell	 disruption	 (R);	
specific	 cell	 disruption	 (RS);	 total	 product	 released	 ([HBc]);	 specific	 product	 released	
(HBcs);	and	recovered	product	purity	relative	to	total	protein	concentration	(P).	
Factor	 [X]	(g/L)	 [NaCl]	(mM)	 [TX]	(%)	 t	(h)	
Range	 (30,150)	 (0.1,1.5)	 (0.1,10)	 (1,72)	
%	contribution	
R	(mg/mL)	 84.78%	 2.98%	 8.35%	 3.89%	
Rs	(µg/gWCW)	 41.99%	 11.97%	 29.47%	 16.57%	
[HBc]	(µg/mL)	 68.56%	 13.93%	 14.27%	 3.24%	
HBcs	(µg/gWCW)	 36.52%	 19.82%	 38.26%	 5.39%	
P	(‰)	 27.20%	 11.17%	 55.00%	 6.63%	
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Table	 4-3	Models	 and	 goodness	 of	 fit.	 Screened	 responses	 for	 total	 cell	 disruption	 (R);	
specific	 cell	 disruption	 (RS);	 total	 product	 released	 ([HBc]);	 specific	 product	 released	
(HBcs);	and	recovered	product	purity	relative	to	total	protein	concentration	(P).	Goodness	
of	 fit	 is	given	on	the	 left-hand	side	of	 the	table	 (‘All	 terms’)	using	r2	and	adjusted	r2	 for	
models	 in	 which	 all	 possible	 first-degree	 polynomial	 terms	 have	 been	 considered.	









	 R2	 R2	adj.	 Formulae	 R2	 R2	adj.	
R	(mg/mL)	 0.992	 0.951	
! = 17.9 + 8.20F( < ) +2.03F( H< )		 0.933	 0.925	
Rs	(µg/gWCW)	 0.980	 0.878	 !* = 240 − 73.4F < +48.7F( H< ) − 39.3F([<] ∙ [H<])		 0.657	 0.589	
[HBc]	(µg/mL)	 0.966	 0.799	
'() = 37.5 + 17.0F < −7.30F( 62M. ) − 5.06F( H< ) −4.77F([<] ∙ [H<])		 0.905	 0.878	
HBcs	(ng/gWCW)	 0.999	 0.994	
['()]* = 493 − 165F([H<]) +163([<] ∙ [H<]) − 146F([62M.]) −137F([<]) + 97.8F([<] ∙[62M.]) − 65.0F([H<] ∙ O)		 0.951	 0.926	
P	(‰)	 0.985	 0.909	
- = 2.28 − 0.888F H< −0.754F <] ∙ [H< −0.478F 62M. 		 0.836	 0.803	F < = P 4QRSR 		 F H< = TP 4R.UR.V 		 F 62M. = P 4WXRWXR 		 F O = P 4YS.XYX.X 		
Detergent	concentration	was	 found	to	have	the	greatest	effect	on	product	purity,	
(Table	 4-2).	 As	 seen	 with	 [HBc]	 and	 HBcs	 in	 Table	 4-3,	 salt	 and	 detergent	
concentration	both	have	a	negative	effect	on	product	purity,	suggesting	that	certain	
host	 cell	 proteins	 have	 a	 significantly	 higher	 solubility	 than	 the	 expressed	
heterologous	protein	found	in	the	soluble	fraction.	




The	 performance	 of	 various	 detergents	 was	 investigated.	 It	 was	 found	 that	
polysorbate	 80	 and	 Triton-X100	 performed	 similarly.	 For	 future	 work,	 the	 choice	
was	made	to	continue	working	with	Triton-X100	as	this	detergent	had	been	used	in	
most	experiments	thus	far.		
Finally,	 within	 the	 ranges	 investigated,	 salt	 concentration	 and	 detergent	
concentration	had	mostly	negative	effects	on	the	five	studied	performance	criteria.	
It	should	be	noted	that	this	is	a	two-level	screening	experiment	and	the	existence	of	




buffer	 properties,	 the	 next	 objective	was	 addressed:	 characterising	 high-pressure	
homogenisation.		
This	 series	 of	 experiments	 investigated	 the	 number	 of	 passes	 (N),	 the	 operating	
pressure	 (p)	 and	 the	 amount	of	 biomass	 in	 suspension	 ([X]).	 Table	 4-4	 shows	 the	








STD	 [X]	(gWCW/L)	 p	(bar)	 N		
1	 50	 300	 1	
2	 50	 300	 5	
3	 50	 1200	 1	
4	 50	 1200	 5	
5	 100	 300	 1	
6	 100	 300	 5	
7	 100	 1200	 1	
8	 100	 1200	 5	
9	 50	 750	 3	
10	 100	 750	 3	
11	 75	 300	 3	
12	 75	 1200	 3	
13	 75	 750	 1	
14	 75	 750	 5	
15	 75	 750	 3	





the	number	of	passes	 (N)	 on	 cell	 disruption	 (R)	expressed	as	 the	 total	 amount	of	
soluble	 total	 protein	 (mg/mL).	 The	 response	 model	 can	 be	 described	 with	 the	




As	 indicated	 by	 the	 term	 1.97·10-4	 p[X]	 the	 factor	 interaction	 of	 biomass	
concentration	and	pressure	has	a	positive	effect	on	the	level	of	cell	disruption.	The	
term	 is	 highly	 significant	 (p=0.00253),	 which	 is	 in	 contrast	 with	 the	 assumption	
made	by	others	(Follows	et	al.,	1971),	that	the	effect	of	biomass	concentration	on	
cell	 disruption	 is	 minor.	 This	 difference	 is	 most	 likely	 because	 Follows	 et	 al.	
investigated	 cell	 disruption	 at	 a	 significantly	 higher	 cell	 suspension	 concentration	
range	 (450-750g/L	 vs	 50-100g/L)	 where	 the	 effect	 of	 biomass	 had	 diminished.	
Follows	et	al.	used	a	different	species	of	yeast,	Saccharomyces	cerevisiae,	and	the	
concentrations	 of	 biomass	 used	 are	 considerably	 higher	 than	 would	 be	 used	 for	







number	 of	 passes,	 however	 it	must	 be	 noted	 that	 these	 are	 quadratic	 estimates	
that	are	only	valid	within	the	investigated	range.	The	response	surface	methodology	
in	 this	 series	 of	 experiments	 only	 considers	 linear	 or	 quadratic	 functions,	 not	 for	
instance,	 asymptotic	 functions	which	 are	 very	 common	 in	 biological	 systems	 and	






the	 context	 of	 cell	 disruption.	 As	 mentioned	 previously,	 this	 paper	 aims	 to	
investigate	 five	 different	 performance	 criteria	 as	 response	 surfaces.	 Instead	 of	
displaying	 four	 additional	 response	 models,	 Figure	 4.5	 summarises	 the	 factor	
settings	 for	 various	 performance	 optima	 derived	 from	 corresponding	 surface	
models.		
	
Figure	 4.5	 High	 Pressure	 Homogenisation	 performance	 optima	 summary.	 Factor	 values	
and	 optima	 for	 various	 responses:	 R	 (r2=0.98),	 RS	(r2=0.97),	 [TC-HBc]	 (r2=0.92),	 TC-HBcS	
(r2=0.90)	and	P	(r2=0.77).	
Looking	 at	 Figure	 4.5,	 one	 can	 conclude	 that	 different	 operating	 conditions	 are	
required	to	achieve	different	maximum	performance	levels.	For	instance,	maximum	
pressure	 (1200	 bar)	 is	 required	 to	 achieve	maximum	 cell	 disruption	 (R).	 However	
sub-maximal	pressure	(1000	bar)	is	preferable	for	maximum	purity	(P).	Note	that	in	











































In	 summary,	 this	 section	 has	 described	 the	 characterisation	 and	 optimisation	 of	
high-pressure	Homogenisation	 on	 the	 basis	 of	 five	 different	 performance	 criteria.	









digesting	 cell	 wall	 components.	 Several	 sources	 report	 that	 the	 enzyme,	 lyticase,	
hydrolyses	beta-glucans	in	fungal	cell	walls,	resulting	in	the	transformation	of	cells	
into	so-called	protoplasts	(Burden,	no	date;	Salazar	and	Asenjo,	2007;	Miyajima	et	






To	 assess	 the	 effect	 of	 incubation	 time	 with	 lyticase	 on	 harvested	 material,	 30	
gWCW/L	cells	(from	3.2.1)	was	incubated	in	20mM	Tris-based	lyticase	buffer	(2.4.6).	
Protein	concentrations	in	crude	lysate	were	measured	every	ten	minutes	using	the	
Nanodrop	 method	 described	 in	 section	 2.5.5.	 After	 90	 minutes,	 an	 addition	 of	
Triton-X100	 was	 added	 to	 achieve	 a	 concentration	 of	 0.1%	 (vol.),	 in	 order	 to	
maximise	 disruption	 and	 assess	 this	 augmentation	 effect	 of	 detergent	 on	 cell	
disruption.		
It	 was	 estimated	 that	maximum	 disruption	 through	 enzymatic	 lysis	 had	 occurred	
after	around	20	minutes	but	with	a	higher	degree	of	certainty	after	60	minutes	(see	
Figure	4.6).	After	90	minutes	of	incubation,	subsequent	addition	of	TX100	resulted	




concentration	of	30gWCW/L.	Standard	deviations	per	data	point	 represent	 triplicate	 total	
protein	measurements	 of	 crude	 lysate.	 The	 lower	 highlighted	 grey	 area	 represents	 the	
fluctuation	 of	 maximum	 enzymatic	 cell	 disruption	 and	 was	 defined	 as	 the	 overall	
standard	deviation	of	 all	measurements	 taken	between	20-90	minutes.	 The	upper	 grey	
area	represents	the	level	of	cell	disruption	after	90	minutes	of	incubation	and	an	addition	
of	Triton-X100	to	achieve	a	concentration	of	0.1%	(vol.).		





















The	 efficacy	 of	 lyticase	 as	 a	 disruption	 agent	 was	 further	 assessed	 by	 incubating	
harvested	material	(from	3.3.1)	at	various	cell	densities	in	20mM	Tris-based	lyticase	










the	 concentration	 of	 biomass	 increases,	 the	 specific	 level	 of	 cell	 disruption,	
indicated	 by	 gradient,	 decreases.	 This	 indicates	 a	 substrate	 dependant	 process,	
typical	of	enzymatic	reactions.	Note	that	a	similar	trend	is	seen	when	no	lyticase	is	
applied.	 The	 absolute	 increase	 of	 observed	 cell	 disruption	 resulting	 from	 an	





















Adaptive	 Focused	 Acoustics	 (AFA)	 has	 been	 shown	 to	 be	 a	 suitable	 miniaturised	
platform	for	 the	disruption	of	 the	yeast,	Saccharomyces	cerevisiae	 (Wenger	et	al.,	
2008).	An	AFA	device	generates	acoustic	shock	waves	in	the	kilohertz	(KHz)	region.	
These	 sonic	waves	 cause	 controlled	 cavitation	 at	 a	 focal	 point	within	 the	 sample	




Figure	 4.8	 Covaris	 components	 and	 parameters.	 (A1)	 Tank	 containing	 cooled	 degassed	
deionised	water,	 (A2)	acoustic	 transducer,	 (A3)	vial	containing	suspended	cells	and	 (A4)	
acoustic	 focal	 zone.	 (B)	 Covaris	 parameters:	 Duty	 Factor,	DF	 (%),	 refers	 to	 the	 relative	
time	between	 sonic	 bursts,	 hence	Z[ = O\ O] ∙ \^^%.	 Intensity,	 I	 (mV),	 denotes	 the	


















0 = 9(Z[, `, a7b, O, [<])	 Equation	4-3	
Duty	Factor,	DF	(%),	refers	to	the	relative	time	between	sonic	bursts,	hence	
Z[ = O\ O] ∙ \^^		 Equation	4-4	
Intensity,	 I	 (mV),	 denotes	 the	amplitude	of	 the	 sonic	wave.	Cycles	per	burst,	cpb,	
refers	 to	 the	 amount	 of	 cycles	 per	 acoustic	 wave.	 Time,	 t	 (s),	 refers	 to	 the	 total	
acoustic	 exposure	 time.	 [X]	 (g/L)	 refers	 to	 the	 wet	 cell	 biomass	 concentration	 in	
suspension.		
Although	 there	 are	 studies	 showing	 promising	 results	 for	 extracting	 intracellular	
product	 from	 S.	 cerevisiae,	 no	 such	 extensive	 studies	 exist	 for	 AFA-mediated	 cell	
disruption	of	P.	pastoris.		
AFA-mediated	 cell	 disruption	 of	 P.	 pastoris	 was	 investigated	 by	 incubating	
harvested	material	(from	3.3.1)	at	various	cell	densities	in	20mM	Tris-based	lyticase	
buffer	 (2.4.6).	 These	 samples	 were	 subsequently	 transferred	 to	 6mL	 Chromacol	
tubes	and	exposed	to	AFA	treatment	for	0	or	120	seconds	using	maximum	settings	
for	Duty	Factor,	Cycles	Per	Burst	 and	 Intensity	on	Power	Tracking	mode.	 Samples	
were	stored	overnight	storage	at	4°C	prior	 to	clarification.	Total	cell	disruption,	R,	





Figure	 4.9	 Total	 cell	 disruption	 through	 various	 methods.	 Cell	 disruption	 averages	 and	
standard	 deviations	 (not	 visible)	 are	 derived	 from	 triplicate	 measurements	 of	 total	
soluble	protein	in	clarified	lysate.		
Figure	4.9	shows	that	AFA	treatment	resulted	in	higher	levels	of	cell	disruption	than	




























Figure	4.10	Qualitative	dot	blot	analysis	of	 crude	and	clarified	 lysates	 following	 lyticase	
treatment,	 AFA	 treatment	 and	 lyticase	 treatment	 followed	 by	 AFA	 treatment	 at	 a	
biomass	 concentration	 of	 100gWCW/L	 and	 (*)	 50gWCW/L.	 Measurements	 were	






The	previous	 sections	described	how	Adaptive	 Focused	Acoustics	was	 selected	 as	
the	best	candidate	for	a	small-scale	cell	disruption	platform.		














Table	 4-5	 shows	 the	 results	 of	 the	 first	 screening	 experiment	 which	 was	 a	 five-
factor,	half	fractorial	design	was	used	to	generate	two	factor	screenings.		
Table	4-5	Relative	factor	contributions	 in	a	 five	factor,	 two-level,	half	 fractional	 factorial	
screening	designs.	Two	different	screenings	were	performed:	One	for	R	and	one	for	Rs.	
Factor	 DF	(%)	 cpb	 I	(mv)	 t	(s)	 [X]	(g/L)	
Range	 (0.1,20)	 (50,1000)	 (0.1,10)	 (60,300)	 (10,100)	
%	contribution	
Total	disruption	(R)	 23.5%	 8.6%	 9.9%	 8.7%	 49.1%	
Specific	disruption	
(RS)	
1.6%	 0.1%	 0.3%	 0.3%	 97.7%	
Biomass	([X])	was	found	to	be	the	most	significant	factor	for	both	specific	(Rs)	and	
total	 cell	 disruption	 (R).	 However,	 the	 magnitude	 of	 the	 range	 of	 [X]	 may	 have	
diminished	 the	 significance	 of	 other	 factors	 and	 may	 therefore	 not	 be	
representative.		
Time,	on	the	other	hand,	initially	seems	to	be	insignificant	relative	to	other	factors	
which	was	 in	 contradiction	 to	 other	 sources	 (Wenger	 et	 al.,	 2008).	 This	 could	 be	





this	 four-factor	 full	 fractional	 screening,	 biomass	 was	 fixed	 at	 [X]=55g/L	 so	
responses	R	and	RS	were	equal.	Additionally,	the	cycles	per	burst	were	found	to	be	
insignificant.	 Therefore,	 in	 further	 experiments	 this	 was	 fixed	 at	 1000	 cpb.	 The	
exposure	 times	were	 lowered,	 as	 it	was	hypothesised	 that	 longer	 exposure	 times	
were	 excessive	 to	 achieving	 disruption	 and	would	 therefore	 not	 show	 significant	
contribution	to	response	variance.	The	results	of	this	screening	are	shown	in	Table	
4-6.	 Following	 two	 screening	experiments	 it	was	 found	 that	biomass,	 duty	 factor,	
intensity	 and	 acoustic	 exposure	 time	were	 significant	 factors.	 Increasing	 acoustic	
exposure	time	did	not	have	a	significant	effect	beyond	60s	so	this	factor	was	fixed	




Factor	 DF	(%)	 cpb	 I	(mv)	 t	(s)	
Range	 (0.1,20)	 (50,1000)	 (0.1,10)	 (10,60)	
%	contribution	 Total	cell	disruption	(R=RS)	 40.1%	 0.4%	 38.4%	 21.1%	
4.6.2 Adaptive	Focused	Acoustics	Optimisation			
Figure	4.12	shows	 the	effects	of	different	 types	of	vials,	milliTUBE	and	Chromacol	
vials	 (shown	 in	 Figure	 4.11),	 on	 cell	 disruption	 performance.	 The	 milliTUBE	 vials	





For	 total	 cell	 disruption	 and	 specific	 cell	 disruption	 (see	 Figure	 4.12A)	 maximum	
performance	values	of	the	Chromacol	configuration	were	found	to	be	slightly	lower	
than	 that	 for	milliTUBE	vials.	However,	 the	values	 for	maximum	product	 recovery	
and	specific	recovery	(Figure	4.12B)	are	significantly	 lower	 in	the	Chromacol	tubes	















Figure	 4.13,	 showing	 Response	 Surface	 Models	 of	 total	 cell	 disruption	 (R)	 using	
milliTUBE	 and	 Chromacol	 vials,	 explains	 these	 differences	 in	 overall	 performance.	
Although	 AFA-mediated	 disruption	 using	 the	 Chromacol	 vials	 does	 influence	
disruption	within	a	certain	range,	as	proven	by	significant	contribution	to	variance	
by	 the	 studies	 factors,	 its	effect	on	overall	disruption	 is	most	 likely	diminished	by	
other	 mechanisms,	 such	 as	 cell	 autolysis	 during	 fermentation,	 osmotic	 shock,	
mechanical	stress	or	heat	lysis	during	buffer	resuspension.	This	is	demonstrated	in	









working	 volume	and	 additional	mechanical	 stress	 through	 the	 addition	of	 an	AFA	
fiber	 in	 the	milliTUBE	 vials.	 Because	 the	 total	 vessel	 volume	 of	 Chromacol	 vial	 is	
significantly	larger	than	that	of	a	milliTUBE	vial,	acoustic	energy	is	dispersed	over	a	
larger	 volume	 resulting	 in	 lower	 levels	 of	 disruption.	 Additionally,	 the	 Chromacol	





the	 lysis	 medium.	 As	 higher	 working	 volumes	 reduce	 mixing	 in	 the	 sample,	 the	
added	integrated	AFA	fiber	facilitates	the	generation	of	high	numbers	of	uniformly	
distributed	 cavitation	 bubbles.	 The	 simultaneous	 collapse	 of	 these	 high-energy	




Salazar	 &	 Asenjo	 2007).	 Lacking	 cell	 walls,	 these	 protoplasts	 are	 much	 more	




Results	 in	 Figure	 4.11	 show	 that	 this	 enzymatic	 pre-treatment	 step	 resulted	 in	
significantly	higher	overall	performance	 in	AFA-mediated	cell	disruption	compared	
to	the	other	small-scale	methods	lacking	this	enzymatic	treatment	step.		
Anand	 et	 al.	 (2007)	 described	 how	 pre-treatment	 of	 Escherichia	 coli	 cells	 with	
guanidium	 hydrochloride,	 affected	 the	 first	 order	 disruption	 rate	 constant,	 k,	 for	
homogenisation.	 Li	 et	 al.	 (2012)	 subsequently	 described	 this	 rate	 constant	 in	 the	
context	 of	 adaptive	 focused	 acoustic	 in	 the	 following	 equation	 at	 fixed	 biomass	
concentration:	
!" #$%#&#$%# = ()		 Equation	4-5	
Where	Rm	is	the	total	maximum	available	amount	of	protein	available	for	release.	R0	
is	the	level	of	protein	release	prior	AFA-mediated	cell	disruption	and	was	found	to	
be	 4.17mg/mL	 for	 untreated	 cells	 and	 16.90mg/mL	 for	 enzymatically	 pre-treated	








milliTUBE	 configuration,	 we	 found	 that	 the	 disruption	 rate	 constant	 for	 AFA	
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mediated	cell	disruption	preceded	by	 lyticase	 treatment	 (kLY,AFA=	6.82×10-3	 s-1)	was	
2.65	times	higher	than	the	disruption	rate	constant	of	AFA-mediated	cell	disruption	
(kAFA=2.57×10-3	 s-1).	 This	 strongly	 suggests	 that	enzymatic	pre-treatment	augments	
performance	of	AFA-mediated	cell	disruption	by	weakening	cells.		
Because	 of	 this	 pre-treatment,	 maximum	 levels	 of	 AFA-mediated	 cell	 disruption	
almost	matched	maximum	 levels	 achievable	with	 homogenisation.	Moreover,	 the	
performance	of	the	augmented	method	for	maximum	specific	product	recovery	was	
superior	 to	 that	 of	 homogenisation.	 Likewise,	 both	 platforms	 using	 milliTUBE	
achieved	higher	product	purity	levels	than	High	Pressure	Homogenisation.		
4.7 Causes	and	effects	of	micronised	debris		
The	 previous	 section	 demonstrated	 the	 differences	 in	 various	 response	 between	
High	Pressure	Homogenisation	and	various	modes	of	adaptive	focused	acoustics.		
This	 section	aims	 to	explain	 the	mechanisms	 involved	behind	 the	performance	of	
the	discussed	cell	disruption	methods.			
Figure	 4.14A	 shows	 Particle	 Size	 Distribution	 (PSD)	 curves	 of	 various	 unclarified	
lysates	 from	 disrupted	 samples.	 The	 amount	 of	 micro	 debris	 (less	 than	 1µm)	
generated	 through	 High	 Pressure	 Homogenisation	 is	 much	 higher	 than	 that	
generated	through	AFA-mediated	disruption.	These	high	levels	of	micro	debris	are	
associated	 with	 high	 levels	 of	 cell	 disruption,	 however	 also	 impede	 recovery	 of	
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product.	 This	 is	demonstrated	 in	 Figure	4.14B	where	homogenisation	 is	 shown	 to	
lead	to	lower	product	purities	than	AFA	despite	higher	levels	of	cell	disruption.		
	
Figure	 4.14:	 Effect	 of	micronised	 debris	 on	 purity.	 (A)	 PSD	 analysis	 derived	 from	 static	
light	 scattering	 analysis	 (2.5.12),	 of	 untreated	 cells	 in	 suspension	 ([X]=50g/L)	 and	
respective	crude	lysates	disrupted	by	homogenisation	(p=1200	bar,	N=5	passes,	T=8±2°C),	
AFA	 (I=10mV,	 DF=20%,	 cpb=1000,	 t=60s,	 T=9±1°C)	 and	 AFA	 preceded	 by	 lyticase	
incubation	 (t=1hr,	 T=25°C).	 (B)	 Modelled	 quantitative	 analysis	 of	 clarified	 lysates	
disrupted	by	AFA,	AFA	preceded	by	 lyticase	 incubation	and	homogenisation.	Two	 levels	
of	 cell	 disruption	 (R)	 and	 product	 purity	 (P)	 are	 given:	 the	 maximum	 values	 of	 the	
respective	 Response	 Surface	 Models	 (Rmax,	 Pmax)	 and,	 superimposed,	 the	 levels	 of	


































































The	 generation	 of	 micro	 debris	 during	 homogenisation	 can	 lead	 to	 subsequent	
formation	 of	 aggregates	 as	 seen	 Figure	 4.15A	 and	 Figure	 4.15B.	 The	 fluorescent	





light	microscopy	 image	of	homogenised	 sample	 (p=1200	bar,	N=5	passes,	T=8±2°C)	 and	
(A2)	corresponding	fluorescent	 image;	arrows	indicate	 intact	cell.	 (B1,	B2)	AFA	(I=10mV,	
DF=20%,	cpb=1000,	t=60s,	T=9±1°C);	arrows	indicate	disrupted	cell.	(C1,	C2)	Lyticase	pre-




In	 contrast,	 AFA	mediated	 cell	 disruption	 does	 not	 seem	 to	 generate	micronised	
debris.	As	 shown	 in	Figure	4.15B,	a	 cell	disrupted	by	AFA,	 visible	with	bright	 light	
microscopy	 yet	 undetectable	 using	BODIPY	 staining,	 has	 released	 its	 lipid-positive	
content	 out	 of	 the	 cell	 wall	 through	 a	 single	 cavity,	 without	 generating	 large	
amounts	 of	 micronised	 debris.	 Figure	 4.15C	 shows	 what	 appears	 to	 be	 an	
enzymatically	 treated	cell	 that	has	 lost	 its	 characteristic	 shape,	most	 likely	due	 to	
cell	 wall	 disintegration	 by	 lyticase.	 Figure	 4.15D	 shows	 a	 similar	 effect	 on	
enzymatically	treated	cell	subsequently	disrupted	using	AFA.		
4.8 Process	scaling	and	cell	disruption	mimicry	
This	 chapter	 has	 made	 many	 comparisons	 between	 the	 relatively	 large-scale	
industry	 standard	 of	 cell	 disruption,	 High	 Pressure	 Homogenisation,	 and	 various	
modes	of	small-scale,	non-contact	Adaptive	Focused	Acoustics	methods.			
For	 some	 performance	 criteria,	 it	 was	 found	 that	 it	 is	 possible	 for	 AFA	 to	
outperform	High	Pressure	Homogenisation.		
However,	 when	 scaling	 down	 a	 process,	 the	 goal	 is	 often	 not	 to	 outperform	 the	
large-scale	 surrogate,	 but	 to	 mimic	 its	 performance	 as	 closely	 as	 possible.	 To	
achieve	this,	one	must	define	these	performance	criteria.	
This	 section	 considered	 a	 scenario	where	 the	 objective	was	 to	maximise	 product	








Overlaying	 the	 purity	 and	 product	 recovery	 response	 functions	 for	 enzymatically	









It	 should	 be	 noted	 that	 the	 above	 scenario	 serves	 as	 an	 example	 of	 how	 the	
proposed	 scale-down	methods	 can	 be	 implemented	 to	mimic	 any	 large-scale	 cell	
disruption	 process.	 By	 assigning	 multiple	 performance	 criteria,	 more	 defined	
conditions	can	be	achieved	to	mimic	performance	at	small-scale.	Likewise,	the	same	
methodology	can	be	applied	to	scale-up	a	micro-scale	cell	disruption	process.	This	




This	 chapter	 presents	 the	 development	 of	 a	 high-performance,	 high-throughput,	
non-contact,	 automated,	 small-scale,	 scalable	 disruption	 tool	 for	 microbial	
bioprocess	development.	This	was	achieved	through	several	steps.	
Firstly,	 the	 effects	 of	 lysis	 buffer	 components	 were	 investigated	 to	 establish	
standardised	buffer	conditions	amongst	different	cell	disruption	platforms.	This	was	
followed	 by	 a	 full	 characterisation	 of	 high-pressure	 homogenisation	 to	 establish	
scale-down	 performance	 targets.	 After	 this,	 various	 small-scale	 disruption	 cell	
disruption	 techniques	were	 compared.	 It	was	 found	 that	 enzymatic	 lysis	with	 the	
enzyme	 lyticase	and	Adaptive	Focused	Acoustics	 (AFA)	provided	the	most	suitable	
characteristics	 for	 further	 investigation.	 Following	 this,	 screening	 and	 subsequent	
optimisation	 experiments	 were	 conducted	 on	 AFA.	 These	 investigations	 were	
carried	 out	 through	 statistical	 screening	 methods,	 the	 development	 of	 twenty	
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Response	 Surface	 Models,	 various	 modes	 of	 microscopy	 and	 particle	 size	
distribution	analysis.		
Significant	process	parameters	 for	AFA	were	 found	 to	be	 acoustic	 exposure	 time,	
biomass	 suspension	 concentration,	 duty	 factor	 and	 intensity.	 After	 performing	
optimisation	experiments	for	these	significant	factors,	it	was	found	that	the	design	
of	 the	 vessel	 in	 which	 samples	 were	 sonicated	 had	 a	 great	 impact	 on	 all	 cell	
disruption	performance	criteria.	Specifically,	it	was	found	that	the	use	of	milliTUBE	
vials	 greatly	 enhanced	 performance	 compared	 to	 using	 Chromacol	 vials.	
Performance	was	subsequently	augmented	using	a	lyticase	pre-treatment	step.	This	
augmentation	 led	 to	 matching	 and	 even	 outperforming	 homogenisation	
performance,	 depending	 on	 the	 performance	 criterion	 investigated.	 The	 resulting	

















Having	 developed	 the	 necessary	 tools	 to	 implement	 in	 miniaturised	 upstream	











• Assess	 growth	 kinetics	 in	 microtitre	 plates	 to	 determine	 their	 capacity	 of	
sustaining	biomass	for	P.	pastoris	cultures.	




The	 most	 basic	 form	 of	 a	 miniaturised	 fermentation	 characterisation	 platform	 is	





investigate	 induction	 phase-associated	 factors,	 the	 capacity	 of	 these	 deep	 well	
plates	 to	 sustain	 biomass,	 and	 mimic	 batch-mode	 fermentation,	 had	 to	 be	
investigated.		
This	section	will	hence	aim	to	describe	the	capacity	of	microtitre	plates	to	sustain	










[,]) = [,]&/0)		 Equation	5-2	
Hence:	
ln[4]5 = ln[4]6 + µ8	
∴ µ = ln[4]5 − ln[4]68 	
Therefore,	to	study	this	response,	[X]0	and	t,	needed	to	be	varied.		
In	addition,	the	working	volume,	Vw,	was	also	varied.	The	working	volume	directly	
affects	 the	 Oxygen	 Transfer	 Rate.	 This	 in	 turn	 has	 a	 significant	 effect	 on	 cellular	
metabolism.	This	effect	is	explained	in	more	detail	in	10.4.		
In	this	way,	the	working	volume,	VW,	could	affect	(1)	the	consumption	of	substrate,	
(2)	 the	expression	of	product	and	 (3)	 the	production	of	biomass.	 It	was	 therefore	




This	 was	 investigated	 through	 a	 three-factor,	 two-level,	 full-fractional	 factorial	
screening	designs.	Microtitre	plate	batch-mode	fermentations	were	carried	out	as	
described	in	section	2.3.1.	
A	 screening	model,	 consisting	 of	 8	 experimental	 points	 and	 3	 centre	 points,	 was	
generated	 with	 a	 minimum	 resolution	 of	 5	 to	 estimate	 all	 possible	 first-degree	
polynomial	 interactions.	 The	design	 space	and	 corresponding	 response	 values	 are	
shown	in	Table	10-2.	
The	relative	contribution	of	an	individual	factor	was	defined	as	the	total	of	the	sum	
of	 squares	 (Type	 III)	 of	 each	 factor-associated	 first-degree	 polynomial	 term	 as	 a	
percentage	of	the	total	of	the	sum	of	squares	of	all	terms	in	the	screening	models.	
Note	 that	 quadratic	 terms	were	 not	 included	 in	 the	 analysis	 of	 variance	 as	 these	
terms	are	aliased	to	all	studied	factors.	
Table	5-1	shows	the	level	of	overall	response	variance	created	by	each	factor	in	this	
screening	 experiment	 when	 all	 possible	 first-degree	 polynomial	 interactions	 are	
considered.	 The	 left	 side	 of	 Table5-2	 shows	 the	 goodness	 of	 fit	 of	 these	models,	
using	 r2.	 The	 robustness	 of	 these	models	 is	 then	 assessed	 using	 r2	 adjusted.	 The	
same	 table	 subsequently	 shows	 formulae	 for	 each	 response	model	 showing	 only	
significant	 model	 terms	 (p<0.05).	 Similarly,	 r2	 and	 r2	 adjusted	 of	 these	 simplified	
models	are	shown	on	the	right-hand	side	of	this	table.		
As	 seen	 in	 Table	 5-1	 each	 studied	 factor	 has	 different	 levels	 of	 relative	 variance	
contribution	 depending	 on	 the	 response	 investigated.	 Table	 5-2	 shows	 that	 r2	
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Factor	 [X]0	(OD600)	 Vw	(mL)	 t	(h)	
Range	 (20,100)	 (0.5,	2.5)	 (2,30)	
%	contribution	 µ	(h-1)	 3.51%	 44.4%	 52.1%	
	
Table	5-2:	Model	and	goodness	of	fit	for	specific	growth	rate	(µ).	Goodness	of	fit	is	given	
on	 the	 left-hand	side	of	 the	 table	 (‘All	 terms’)	using	 r2	and	adjusted	 r2	 for	 the	model	 in	
which	all	possible	first-degree	polynomial	terms	have	been	considered.	Following	this,	is	






	 R2	 R2	adj.	 Formula	 R2	 R2	adj.	
µ	(h-1)	 0.948	 0.826	
µ = 4.91 ∙ 10%A − 3.78 ∙ 10%AE ) −3.37 ∙ 10%AE FG + 3.35 ∙ 10%AE FG ∙) 		 0.904	 0.863	
E ,& = 46 − 6040 	 E ) = 8 − 1614 	 E FG = FG − 1.5	
Table	5-2	shows	that	the	specific	growth	rate,	µ,	decreases	as	the	incubation	time	




	Overall,	 model	 simplification	 for	 this	 response	 resulted	 in	 an	 increase	 in	 model	
robustness,	 represented	 by	 an	 increase	 in	 adjusted	 r2.	 Interestingly,	 the	 initial	
																																																						





concentration	 of	 biomass	 was	 not	 found	 to	 have	 a	 significant	 effect	 on	 specific	
growth	rate	within	the	chosen	range.	However,	this	could	be	due	to	oxygen-limiting	
and	substrate-limiting	effects.	
The	specific	growth	 rate	was	of	 interest	as	one	of	 the	aims	of	 this	 section	was	 to	
determine	 the	 capacity	 of	 this	 fermentation	 platform	 to	 sustain	 biomass.	 For	 a	
fermentation	platform	to	be	deemed	suitable	for	maintaining	or	growing	biomass	at	
any	 particular	 time,	 one	 could	 define	 that	 the	 specific	 growth	 rate	 needs	 to	 be	
equal	 to	 or	 higher	 than	 0	 (µ≥0).	 Therefore,	 the	 factor	 exclusion	 of	 [X]0	 in	 the	













Figure	5.1	Correlation	between	VW	 and	 t	when	µ=0	 in	BMGY	media	within	 the	 range	of	
working	volume	investigated.		
This	 asymptotic	 correlation,	 within	 the	 ranges	 investigated,	 shows	 the	maximum	
incubation	time	at	various	working	volumes.	For	coordinates	outside	the	grey	area	
in	 Figure	 5.1,	 the	 specific	 growth	 rate	 is	 negative,	 indicating	 cell	 death	 due	 to	
substrate	depletion.	As	postulated	earlier,	 increasing	 the	working	volume	 reduces	
the	concentration	of	dissolved	oxygen	in	the	media.	When	oxygen	becomes	limited,	
substrate	 consumption	 rates	 decrease.	 This	 results	 in	 extended	 batch-mode	

























With	 the	aim	of	 creating	a	microtitre	platform,	 characterising	VLP	assembly	 in	 an	






in	 culture	death	due	 to	 toxicity.	As	mentioned	 in	 chapter	 1,	 in	 typical	 bioreactor-
based	fermentations	of	P.	pastoris,	this	issue	is	usually	mitigated	through	the	use	of	
continuous	 feeding	 of	 methanol,	 often	 combined	 with	 sophisticated	 feedback	
control	 systems.	 However,	 in	 microtitre	 based	 platforms,	 no	 such	 control	
mechanisms	 are	 available.	 Therefore,	 a	 major	 conceptual	 challenge	 in	 the	
implementation	 of	 microtitre	 plate-based	 fermentations	 in	 upstream	 process	
development	 for	P.	pastoris,	 is	 translating	continuous	 feeding	 into	bolus	additions	
of	methanol.		










concentration	 of	 0.313	%	 vol.	 is	 required	 to	 avoid	 culture	 starvation.	 The	 growth	
rate	 decreases	 between	 5.00	 and	 10.0%	 vol.	 methanol.	 Negative	 specific	 growth	
rates	were	observed	at	the	latter	concentration,	indicating	toxicity.		
Note	 that	 the	 error	 in	 some	measurements	 its	 quite	 high,	 obscuring	 trends.	 This	
error	 could	 have	 possibly	 been	 introduced	 by	 differences	 in	 media	 evaporation	




In	 addition,	 methanol	 toxicity	 seems	 to	 occur	 at	 lower	 ranges	 than	 the	 Mut+	
phenotype,	between	1.25	and	2.50%	vol.	methanol.		
However,	both	profiles,	assuming	a	One-Factor-at-a-Time	(OFAT)	approach,	do	not	
take	 variance	 of	 time	 and	 initial	 biomass	 into	 account.	 The	 additions	 of	 these	




5.3.	 Understanding	 the	 differences	 in	 the	 manifestation	 of	 methanol	 toxicity	
between	 the	 two	studied	phenotypes	allowed	 for	 suitable	 range	determination	 in	
subsequent	 microtitre	 plate-based	 screening	 experiments	 for	 induction	 phase-
associated	factors.	
5.4.1 Initial	induction	screening	results	
The	 previous	 sections	 have	 investigated	 (1)	 the	 capacity	 of	 microtitre	 plates	 to	
sustain	biomass	and	mimic	bioreactor	batch-mode	performance	and	(2)	the	effects	
of	methanol	concentrations	on	the	growth	of	both	phenotypes	of	P.	pastoris.		




In	 addition	 to	 the	 specific	 growth	 rate,	 studied	 in	 section	 5.2.1,	 this	 section	 will	






The	design	 space	and	corresponding	 response	values	are	 shown	 in	Table	10-3	 for	
the	 Mut+	 phenotype	 and	 in	 Table	 10-4	 for	 the	 MutS	 phenotype.	 Based	 on	 the	
methanol	toxicity	profiles	shown	in	Figure	5.2,	the	methanol	concentrations	chosen	
for	the	Mut+	phenotype	were	higher	than	for	the	MutS	phenotype.		
The	 relative	 contribution	 of	 an	 individual	 factor	 was	 determined	 as	 described	 in	
5.2.1.	Table	5-3	and	Table	5-4	show	the	 level	of	overall	response	variance	created	
by	 each	 factor	 in	 screening	 experiments	 for	 Mut+	 and	 MutS	 phenotypes	
respectively.	 The	 left	 side	of	Table	5-5	and	Table	5-6-	Mut+	and	MutS	phenotypes	
respectively-	show	the	goodness	of	fit	of	these	models,	using	r2.	The	robustness	of	
these	 models	 was	 subsequently	 assessed	 using	 r2	 adjusted.	 The	 same	 tables	
subsequently	 show	 formulae	 for	 each	 response	 model	 showing	 only	 significant	





screening	 designs	 investigating	 induction	 of	 P.	 pastoris	 Mut+	 with	 pure	 methanol	 in	
microtitre	plates:	Specific	growth	rate	(µ)	total	heterologous	protein	expression	([tHBc]),	
specific	 heterologous	 protein	 expression	 (tHBcS),	 initial	 biomass	 concentration	 ([X]0),	
initial	methanol	concentration	([MeOH])	and	induction	time	(t).	*:	Curvature	detected	in	
screening	response	model.	
Factor	 [X]0	(OD600)	 [MeOH]	(%	vol.))	 t	(h)	
Range	 (18,	90)	 (0.5,	5.0)	 (2,30)	
%	contribution	
µ	(h-1)*	 32.3%	 0.748%	 67.0%	
[tHBc]*	
(µg/mL	 21.9%	 5.30%	 72.8%	
tHBcs	
(µg/mL/OD600)	 58.6%	 5.91%	 35.5%	
	
Table	 5-4:	 Similar	 to	 Table	 5-3,	 this	 table	 shows	 the	 relative	 factor	 contributions	 of	 a	
screening	 design	 investigating	 induction	 of	 P.	 pastoris	 MutS	 with	 pure	 methanol	 in	
microtitre	plates.	
Factor	 [X]0	(OD600)	 [MeOH]	(%	vol.)	 t	(h)	
Range	 (18,	90)	 (0.3,	1.0)	 (2,30)	
%	contribution	
µ	(h-1)*	 47.4%	 0.282%	 52.3%	
[tHBc]*	
(µg/mL)	 48.0%	 3.91%	 48.0%	
tHBcs	
(µg/mL/OD600)	 46.3%	 7.38%	 46.3%	
	
Table	5-5:	Models	and	goodness	of	fit	for	screening	responses	investigating	induction	of	
P.	 pastoris	Mut+	with	 pure	methanol	 in	microtitre	 plates:	 Specific	 growth	 rate	 (µ)	 total	
heterologous	 protein	 expression	 ([tHBc]),	 specific	 heterologous	 protein	 expression	
(tHBcS),	initial	biomass	concentration	([X]0),	initial	methanol	concentration	([MeOH])	and	
induction	time	(t).	Goodness	of	fit	is	given	on	the	left-hand	side	of	the	table	(‘All	terms’)	
using	 r2	 and	 adjusted	 r2	 for	models	 in	which	 all	 possible	 first-degree	 polynomial	 terms	







	 R2	 R2	adj.	 Formulae	 R2	 R2	adj.	
µ	(h-1)	 0.885	 0.618	 µ = −0.147 + 0.170	E ) −0.0970E ,& ∙ ) + 0.0939 ,& 		 0.877	 0.825	
[tHBc]	(µg/mL)	 0.734	 0.113	 )NOP = 53.9 + 23.7E ) 	 0.514	 0.460	
tHBcS	
(µg/mL/OD600)	











	 R2	 R2	adj.	 Formulae	 R2	 R2	adj.	
µ	(h-1)	 0.935	 0.782	 µ = −0.119 + 0.131E ) −0.121E ,& ∙ ) + 0.119E ,& 		 0.931	 0.902	
[tHBc]	(µg/mL)	 0.921	 0.736	 [)NOP] = 2.07 + 2.84E ) +2.84E ,& ∙ ) + 2.84E ,& 		 0.871	 0.816	
[tHBc]	
(µg/mL/OD600)	
0.924	 0.749	 NOPQ = 0.0415 + 0.0570E ) +0.0570E ,& ∙ ) + 0.0570E ,& 		 0.829	 0.756	E ,& = 46 − 5436 	 E ) = 8 − 1614 	
In	the	case	of	both	phenotypes,	the	concentration	of	methanol	seems	to	have	little	
effect	 on	 any	 of	 the	 responses.	 However,	 this	 seems	 to	 be	 conflicting	 the	 data	
shown	 in	 Figure	5.2,	where	 the	 concentration	of	methanol	 shows	 to	have	a	 clear	
effect	 on	 the	 growth	 rate.	 There	 are	 several	 possible	 explanations	 for	 this.	 By	
looking	at	the	measured	concentrations	of	hepatitis	B	core-positive	material	Table	
10-4	 one	 could	 conclude	 that	 the	 lack	 of	 observed	 expression	 suggests	 that	 the	
design	 space	 was	 not	 appropriately	 chosen	 for	 MutS	 phenotype.	 For	 both	
phenotypes,	many	 responses	models	 indicated	 curvature.	 Also	 noteworthy	 is	 the	
fact	 that,	 contrary	 to	 the	 MutS	 cultures,	 expression	 of	 tHBc	 was	 consistently	
observed	in	each	run	for	the	Mut+	phenotype	(Table	10-3)	However,	the	screening	
methodology	 described	 here	 excludes,	 by	 definition,	 the	 implementation	 of	
quadratic	 terms	 in	 response	 models	 since	 it	 is	 not	 possible	 to	 attribute	 this	
curvature	to	a	single	factor.	The	omission	of	the	hypothetically	significant	quadratic	
model	terms	could	explain	the	observed	poor	goodness	of	fit	for	µ	and	[tHBc].	It	is	





same	 could	 be	 hypothesised	 for	 time,	 t,	 and	 initial	 biomass	 concentration,	 ([X0]).	
Regarding	 the	 hypothesis	 of	 the	 existence	 of	 an	 optimum	 for	 initial	 biomass	
concentration,	 one	 could	 imagine	 that	 the	 quadratic	 relationship	 of	 the	 ratio	 of	
biomass	 concentration	 to	 methanol	 concentration	 is	 highly	 significant:	 relatively	
high	ratios	would	result	 in	relatively	rapid	substrate	depletion	followed	by	culture	
stagnation,	while	relatively	low	ratios	could	result	in	the	culture	to	be	overwhelmed	
by	 methanol	 resulting	 in	 cell	 death.	 An	 optimum	 for	 harvesting	 time	 could	 be	
explained	 by	 the	 fact	 that	 P.	 pastoris,	 like	 many	 microorganisms,	 is	 known	 to	
require	a	minimum	period	of	adaptation	to	metabolically	adjust	to	the	introduction	
of	a	different	carbon	source	(Invitrogen	Corporation,	2002),	this	affecting	all	of	the	




for	 the	 design	 space	 for	 the	 MutS	 phenotype	 induction	 screening.	 Therefore,	 a	








incubation	 time	 could	 yield	 higher	 expression	 for	 the	MutS	 phenotype	 induced	 in	
microtitre	plates.		
• If	 the	 above	 strategy	 indeed	 would	 improve	 the	 levels	 of	 heterologous	
protein	 expression,	 then	 it	 should	 also	 be	 ensured	 that	 no	 carbon	 source	
depletion	 occurs	 after	 the	 adaptation	 period	 to	 methanol.	 Therefore,	 a	
slightly	 higher	 and	 a	 wider	 range	 of	 methanol	 concentration	 –





• The	 previous	 section	 (5.4.1)	 showed	 good	 expression	 of	 heterologous	
protein	 for	 the	Mut+	phenotype.	 In	addition,	all	 the	observed	growth	rates	
were	negative.	This,	just	like	with	the	MutS	phenotype	this	could	be	due	to	
the	requirement	of	relatively	long	adaptation	times	to	methanol.	Also,	it	was	
shown	 that	 time	 had	 a	 positive	 effect	 on	 specific	 growth	 rate,	 volumetric	






volumetrically	 more	 product	 than	 higher	 cell	 density	 cultures.	 This	 is	
probably	 because	 higher	 cell	 density	 cultures	 require	 higher	 amounts	 of	
substrate	(MeOH)	for	cell	maintenance.	Hence,	lowering	the	initial	biomass	

















Table	 5-7:	 Relative	 factor	 contributions	 in	second	 three-factor,	 two-level,	 full-fractional	
factorial	screening	designs	investigating	induction	of	P.	pastoris	Mut+	with	pure	methanol	
in	 microtitre	 plates:	 Specific	 growth	 rate	 (µ)	 total	 heterologous	 protein	 expression	
([tHBc]),	 specific	 heterologous	 protein	 expression	 (tHBcS),	 initial	 biomass	 concentration	
([X]0),	initial	methanol	concentration	([MeOH])	and	induction	time	(t).	
Factor	 [X]0	(OD600)	 [MeOH]	(%	vol.))	 t	(h)	
Range	 (9,	45)	 (2.5,	7.5)	 (16,46)	
%	contribution	
µ	(h-1)	 24.74%	 48.78%	 26.48%	
[tHBc]	
(µg/mL	 41.23%	 26.61%	 32.16%	
tHBcs	
(µg/mL/OD600)	 35.25%	 31.89%	 32.86%	
	
Table	 5-8:	 Similar	 to	 Table	 5-7,	 this	 table	 shows	 the	 relative	 factor	 contributions	 of	 a	
screening	 design	 investigating	 induction	 of	 P.	 pastoris	 MutS	 with	 pure	 methanol	 in	
microtitre	plates.	*:	Curvature	detected	in	screening	response	model.		
Factor	 [X]0	(OD600)	 [MeOH]	(%	vol.)	 t	(h)	
Range	 (90,	135)	 (0.5,	2.5)	 (16,46)	
%	contribution	
µ	(h-1)	 51.87%	 22.54%	 25.60%	
[tHBc]	
(µg/mL)*	 63.41%	 30.94%	 5.65%	
tHBcs	
(µg/mL/OD600)	 71.75%	 4.84%	 23.41%	
	
Table	 5-9:	 Models	 and	 goodness	 of	 fit	 for	 second	 screening	 designs	 investigating	
induction	 of	 P.	 pastoris	 Mut+	 in	 microtitre	 plates:	 Specific	 growth	 rate	 (µ)	 total	
heterologous	 protein	 expression	 ([tHBc]),	 specific	 heterologous	 protein	 expression	
(tHBcS),	initial	biomass	concentration	([X]0),	initial	methanol	concentration	([MeOH])	and	
induction	time	(t).	Goodness	of	fit	is	given	on	the	left-hand	side	of	the	table	(‘All	terms’)	







	 R2	 R2	adj.	 Formulae	 R2	 R2	adj.	
µ	(h-1)	 0.993	 0.978	
µ = 0.0185 − 0.0134E R/SN +0.0126E R/SN ∙ ) +0.0118E R/SN ∙ ,& −0.0107E R/SN ∙ ,& ∙ ) −0.00684E ,& ∙ ) 		 0.993	 0.986	
[tHBc]	(µg/mL)	 0.956	 0.852	 )NOP = 0.430 + 0.306E ,& ∙ ) 		 0.251	 0.168	
[tHBc]	
(µg/mL/OD600)	
0.961	 0.869	 NOPQ = 0.0431 − 0.0541E ,& 		 0.163	 0.067	
E ,& = 46 − 2718 	 E R/SN = TUVW − 52.5 	 E ) = 8 − 3115 	
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	 R2	 R2	adj.	 Formulae	 R2	 R2	adj.	
µ	(h-1)	 0.989	 0.963	
µ = 5.92 ∙ 10%X − 3.76 ∙10%YE ,& + 2.65 ∙ 10%YE ,& ∙) + 	2.53 ∙ 10%YE R/SN − 1.63 ∙10%YE R/SN ∙ ) − 8.81 ∙ 10%XE ) 		 0.982	 0.963	




NOPQ = 0.0761 − 0.0235E ,& +0.0128E R/SN ∙ ,& 		
	
0.823	 0.779	
E ,& = 46 − 112.522.5 	 E R/SN = TUVW − 1.5	 E ) = 8 − 3115 	
Based	 on	 the	 data	 generated	 for	 the	 second	 screening	 for	 the	Mut+	 phenotype,	
several	 deductions	 can	 be	made	 as	 a	 result	 of	 changing	 screening	 ranges	 for	 the	
investigated	process	parameters.	
Comparing	 the	data	sets	generated	 for	 the	 first	and	second	screening	 (Table	10-3	
and	10-5	respectively),	a	significant	contrast	becomes	apparent.	The	chosen	ranges	
in	 the	 first	 screening	 resulted	 in	 predominantly	 high	 expression,	 yet	 negative	
growth	 rates	 for	all	observations.	The	second	screening	 shows	 the	exact	opposite	
result.	 The	 observed	 expression	 is	 so	 low	 that	 it	 is	 indistinguishable	 from	 noise,	
reflected	by	the	lack	of	significant	model	terms	shown	in	Table	5-9	while	for	all	but	










to	 variation	 in	 methanol	 concentration	 indicates	 that,	 at	 higher	 methanol	
concentrations,	 growth	 -rather	 than	 heterologous	 protein	 expression-	 is	
preferential	 for	 the	Mut+	 phenotype.	 As	 suggested	 by	 other	 research	 (Chiruvolu,	
Cregg	 and	 Meagher,	 1997;	 Krainer	 et	 al.,	 2012),	 this	 could	 be	 explained	 by	 the	
elevated	 requirement	 of	 alcohol	 oxidase	 at	 increased	 levels	 of	 methanol.	 This	
creates	a	scenario	in	which	more	resources	are	allocated	to	the	synthesis	of	alcohol	
oxidase	rather	than	the	heterologous	protein	of	 interest.	 It	 is	 therefore	crucial	 for	
the	 remainder	 of	 this	 research	 to	 bear	 in	 mind	 that	 increased	 induction,	
counterintuitively,	 does	 not	 necessarily	 result	 in	 higher	 levels	 of	 heterologous	
production.		
In	 addition	 to	 the	 nutrient	 competition-effect,	 described	 above,	 another	 possible	
explanation	 for	 the	 observation	 that	 low	 levels	 of	 recombinant	 protein	 are	
associated	 with	 high	 growth	 and	 vice	 versa,	 is	 the	 consumption	 of	 heterologous	
protein	 as	 a	 carbon	 source.	 Therefore,	 at	 limiting	 levels	 of	 carbon	 source	 (i.e.	
methanol),	P.	pastoris	would	consume	any	heterologous	protein	already	expressed,	
whereas	 at	 high	 levels	 of	 methanol,	 the	 required	 overexpression	 of	 AOX	 and	
increased	growth	 rates	preventing	 toxicity,	 could	 result	 in	 limited	 resources	being	
redirected	to	the	synthesis	of	AOX	rather	than	heterologous	protein.	The	result	of	
these	two	scenarios	is	that	there	could	be	a	tight	window	of	operation	for	methanol	





the	 Mut+	 phenotype:	 Extending	 the	 incubation	 time	 has	 likely	 led	 to	 P.	 pastoris	
Mut+	 to	 adapt	 to	 higher	 specific	 levels	 of	methanol,	 i.e.	 the	 amount	 of	methanol	
available	per	unit	of	biomass.	However,	this	adaptation,	unexpectedly,	did	not	lead	
to	 higher	 heterologous	 protein	 expression,	 but	 rather	 higher	 growth	 rates.	 In	
addition,	 methanol	 toxicity	 was	 shown	 to	 occur	 at	 low	 cell	 concentrations,	 high	
methanol	concentrations	and	at	relatively	early	induction	times.		
Extending	the	 incubation	time,	 increasing	the	concentration	of	 initial	biomass	and	
widening	 the	 range	of	methanol	 concentration	has	 resulted	 in	 significantly	higher	
levels	of	both	expression	and	cell	growth	for	the	MutS	phenotype.		
This	 illustrates	 an	 important	 difference	 between	Mut+	 and	MutS	 phenotypes.	 For	
MutS	 phenotypes	 the	 correlation	 between	 specific	 growth	 rate	 and	 heterologous	
protein	 expression	 has	 a	 propensity	 to	 be	 positive,	 whereas	 for	 the	 Mut+	
phenotypes	this	correlation	tends	to	be	inversed.		
This	difference	can	be	explained	through	Figure	5.3,	which	is	a	simplified	version	of	
an	 illustration	 of	 the	 methanol	 utilisation	 pathway	 by	 Krainer	 et	 al.	 (2012)	 and	
incorporates	 the	 explanation	 by	 Chiruvolu,	 Cregg	 and	 Meagher	 (1997)	 of	 the	
previous	mentioned	nutrient-competetion	effect	between	recombinant	protein	and	
AOX	proteins.	MutS	 is	known	to	express	considerably	 less	AOX	protein	 than	Mut+.	
This	 means	 that	 nutrient	 resources,	 such	 as	 a	 limited	 carbon	 source,	 would	 be	
available	 for	 the	 production	 of	 recombinant	 protein	 in	MutS	 at	 equal	 expression	
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stimuli.	 This	 could	 explain	 why,	 in	 all	 the	 screenings	 performed,	 volumetric	
expression	levels	of	tHBc	are	highest	in	the	MutS	phenotype.	
	
Figure	 5.3	 Diagram	 of	 the	 methanol	 utilisation	 pathway	 in	 P.	 pastoris	 demonstrating	
nutrient	 competetion	 affecting	 heterologous	 protein	 expression.	 Green	 arrows	 indicate	
positive	 stimuli;	 the	 red	 arrow	 shows	 a	 negative	 stimulus.	 ‘R’	 represents	 the	 overall	
nutrient	supply	available	to	a	cell.	(1)	Expression	of	AOX	protein(s)	through	aox	gene(s).	
(2)	 Expression	 of	 heterolgous	 protein,	 dependent	 on	 nutrient	 availibility	 and	 induction	
stimulus.	(3)	Degradation	of	heterologous	protein.		
This	section	has	demonstrated	how	microtitre	plates	were	used	to	screen	induction	
stage	 fermentation	 for	 two	 phenotypes	 of	 P.	 pastoris.	 Key	 differences	 between	
induction	 behaviour	 of	 the	 two	 strains	 were	 observed	 and	 it	 was	 demonstrated	
that,	 within	 the	 chosen	 design	 space,	 the	MutS	 phenotype	 produced	 the	 highest	
volumetric	yields	of	tHBc	(see	tables	10.3-10.6).	
With	 regards,	 to	 the	 suitability	 of	 microtitre	 plates	 used	 to	 study	 induction	
processes,	 three	 central	 limitations	were	 identified	 for	both	 strains	of	P.	pastoris:	
(1)	 the	 requirement	 for	 an	 adaptation	 period	 to	 methanol,	 (2)	 the	 substrate	
depletion	 of	 methanol	 and	 (3)	 methanol	 toxicity.	 To	 address	 these	 limitations,	





addition	 of	 significantly	 more	 factors	 added	 to	 screening	 (and	 eventually	
optimisation)	experimental	designs,	such	as	the	 interval	 length	between	the	bolus	
additions	and	the	total	 length	of	 induction	(or	the	total	amount	of	bolus	additions	
given).	Because	P.	pastoris	 cultures	are	 shown	 to	 require	an	adaptation	period	 to	
methanol,	 it	 would	 most	 likely	 be	 necessary	 to	 implement	 separate	 screening	
experiments	for	phases	where	the	cultures	are	not	adapted	to	methanol	and	when	
the	 cultures	 are	 adapted	 to	 methanol.	 Also,	 because	 the	 screening	 experiments	
shown	 in	 this	 chapter	 so	 far	 have	 not	 eliminated	 a	 single	 studied	 factor	 as	 being	
insignificant,	 the	 previous	 screened	 factors	 in	 addition	 to	 the	 proposed	 bolus-
associated	 factors	 would	 amount	 to	 a	 high	 number	 of	 runs13	that	 could	 be	
considered	uneconomical	from	a	time-management	point	of	view.			
5.5 Investigating	alternative	feeding	with	pectin	and	pectin	derivatives	
The	 previous	 section	 demonstrated	 the	 limitations	 that	 induction	 with	 pure	
methanol	 imposes	 on	 method	 development	 for	 microtitre	 plate-based	 upstream	
process	platforms	for	P.	pastoris.		
This	 section	 aims	 to	 address	 these	 issues	 with	 a	 question	 that	 seems	 to	 remain	










that	 these	microorganisms	 obtain	 nutrients	 from	 plant	 derivatives.	 In	 fact,	 many	
methylotrophic	yeasts	obtain	methanol	indirectly	from	a	plant	polymer:	pectin.	This	
happens	 through	 the	 conversion	 of	 pectin	 by	 pectin	 methyl	 esterase	 (PME)	 to	





Previous	 research	has	 also	 suggested	 that	 esters	 are	 converted	 to	methanol	 in	P.	
pastoris		through	an	unidentified	pathway	(Krainer	et	al.,	2012).		Taking	this	and	the	
phylogenetic	 similarity	 to	 other	 methylotrophic	 yeasts	 into	 account,	 it	 was	
hypothesised	that	P.	pastoris	may	be	able	to	metabolise	pectin	to	obtain	methanol.		
If	this	hypothesis	were	proven	to	be	true,	pectin,	or	its	derivatives,	could	be	used	as	














agent	 and	 that	 pectin	 would	 effectively	 act	 as	 molecular	 storage	 of	 methanol.	
Therefore,	 it	 had	 to	 be	 determined	 how	 much	 pectin	 would	 be	 appropriate	 to	
produce	a	significant	induction	response.	
Pectin	 is	 polymer	 of	 D-galacturonic	 acid	 and	 D-galacturonic	 acid	 methyl	 ester	
(Mohnen,	2008).	The	level	of	esterification,	denoted	in	%,	indicates	the	proportion	
of	 molecules	 in	 a	 pectin	 polymer	 that	 are	 D-galacturonic	 acid	 methyl	 ester.	 D-
galacturonic	acid	methyl	ester	(dGAME),	specifically,	has	been	postulated	to	be	the	
methanol	donating	group	within	pectin.		




However,	 pectin	 is	 poorly	 soluble	 in	 water	 and	 turns	 to	 gels	 at	 higher	
concentrations	 (data	 not	 shown).	 Increased	 viscosity	would	 provide	 unfavourable	
culturing	conditions,	as	this	would	lower	oxygen	transfer	conditions.	An	approach	to	






To	study	 if	pectin	could	 induce	P.	pastoris	 indirectly,	Pectin	Digest	Medium	(PDM;	
0.5%	vol.	MeOH	equivalent	dGAME)	was	prepared	as	described	in	2.3.1.1.		
Harvest	 times	 (t)	 and	 initial	biomass	 concentrations	 ([X0])	were	varied	 in	a	 similar	
screening-type	 fashion	 as	 described	 in	 previous	 section	 for	 both	 the	 Mut+	
phenotype	(Table	10-7)	and	the	MutS	phenotype	(Table	10-8).	
Table	10-9	and	Table	10-10	show	the	level	of	overall	response	variance	created	by	
each	 factor	 in	 screening	experiments	 for	Mut+	and	MutS	phenotypes	 respectively.	
The	 left	 side	 of	 Table	 10-11	 and	 Table	 10-12	 -	 Mut+	 and	 MutS	 phenotypes	
respectively-	show	the	goodness	of	fit	of	these	models,	using	r2.	The	robustness	of	
these	 models	 was	 subsequently	 assessed	 using	 r2	 adjusted.	 The	 same	 tables	
subsequently	 show	 formulae	 for	 each	 response	 model	 showing	 only	 significant	
model	 terms	 (p<0.05).	 Similarly,	 r2	 and	 r2	 adjusted	 of	 these	 simplified	models	 are	
shown	on	the	right-hand	side	of	these	tables.	
Mut+	 showed	 positive	 growth	 rates	 after	 each	 experimental	 run,	 with	 low	
expression	of	heterologous	protein.	However,	MutS	showed	slight	negative	growth	





Overall	 the	 use	 of	 PDM	 shows	 to	 induce	 P.	 pastoris	 proving	 the	 hypothesis	 that	
pectin	derivatives	can	be	used	to	induce	heterologous	protein	expression.		
However,	PDM	is	an	undefined	enzymatic	digest.	Previous	work	has	shown	that	the	





The	previous	 section	described	how	Pectin	Digest	Media	was	used	 successfully	 to	
induce	heterologous	protein	expression	in	two	phenotypes	of	P.	pastoris.		
This	 section	 describes	 using	 defined	 media	 conditions	 to	 test	 the	 hypothesis	 of	
monomeric	dGAME	being	able	to	 induce	heterologous	protein	expression	through	
PME	 activity.	 To	 explain	 the	 effect	 of	 other	 pectin	 digest	 components	 and	 to	
provide	a	benchmark	of	expression,	d-galacturonic	acid	 (dGA)	and	methanol	were	
also	considered.	
Molecularly	 equivalent	 amounts	 to	 1%	 MeOH	 (vol.)	 of	 dGA	 and	 dGAME	 were	
prepared	in	BSM.	Several	mixtures	were	prepared	in	which	2-level	combinations	of	
the	 three	 substrates	 were	 combined.	 To	 gain	 an	 indication	 of	 specific	 substrate	
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consumption	rates,	different	 levels	of	 initial	biomass	were	used	for	 induction.	The	
induction	was	carried	out	as	described	in	section	2.3.1.	
Figure	 5.6	 shows	 the	 levels	 of	 expression	 and	 substrate	 consumption	 for	 each	
possible	condition.	Expression	was	measured	using	dot	blotting	(2.5.10)	followed	by	
immunostaining	 and	 linear	 signal	 analysis	 (2.5.11).	 Residual	 dGA	 was	 measured	
using	uronic	acid	analysis	as	described	 in	 section	2.5.15,	and	 residual	dGAME	and	





















































































































































The	 data	 shows	 that	 induction	 was	 only	 observed	 in	 cultures	 with	 methanol	
addition	(Figure	5.6A).	In	all	cultures	in	which	methanol	was	introduced,	significant	
levels	 of	 methanol	 were	 consumed	 (Figure	 5.6B).	 No	 apparent	 induction	 was	
observed	 in	 cultures	 containing	 dGAME	 alone	 (Figure	 5.6A)	 nor	 was	 dGAME	
consumed	 (Figure	 5.6C),	 disproving	 the	 hypothesis	 that,	 at	 least	 under	 these	
conditions,	dGAME	can	be	used	to	induce	AOX.		
In	fact,	dGA	and	dGAME	seem	to	inhibit	the	uptake	of	methanol,	as	shown	in	Figure	
5.6D.	 This	 could	 be	 explained	 by	 the	 effect	 that	 under	 acidic	 conditions14	an	
equilibrium	 exists	 between	 dGAME	 on	 one	 end;	 and	 dGA	 and	 methanol	 on	 the	










One	 reason	 induction	was	not	observed	using	defined	pectin	derivatives	 could	be	
that	dGAME	is	too	small	a	molecule	for	PMEs	to	act	on	to	release	methanol.	Indeed,	






This	 chapter	 studied	 the	 use	 of	 microtitre	 plates	 to	 develop	 a	 miniaturised	
fermentation	platform	intended	for	rapid	upstream	process	characterisation.	
It	was	found	that	microtitre	plates	can	be	used	to	grow	P.	pastoris	for	the	purposes	
of	 increasing	 biomass	 in	 complex	 media.	 However,	 induction	 of	 heterologous	
protein	in	microtitre	plates	proved	to	be	more	challenging	due	to	the	requirement	
for	 an	 adaptation	 period	 to	 methanol,	 the	 substrate	 depletion	 of	 methanol	 and	
methanol	toxicity.	
Nonetheless,	 several	 critical	 process	 parameters	 were	 confirmed:	 Initial	 biomass	
concentration	at	induction,	harvest	time	and	methanol	concentration	in	media.		
Also,	 significant	differences	 in	growth	and	 induction	characteristics	between	MutS	
and	 Mut+	 phenotypes	 were	 identified.	 For	 the	 MutS	 phenotype	 the	 correlation	
between	 specific	 growth	 rate	 and	 heterologous	 protein	 expression	 tended	 to	 be	
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positive,	 whereas	 for	 the	 Mut+	 phenotype	 this	 correlation	 was	 inversed.	 It	 was	
postulated	 this	 was	 due	 to	 an	 intracellular	 nutrient	 competition	 effect	 between	
expression	of	AOX	protein	and	heterologous	protein.		
To	address	the	issues	associated	with	pure	methanol-based	induction	in	microtitre	
plates,	 the	use	of	pectin	digest	as	an	 indirect	 induction	agent	was	 studied.	 It	was	




likely	 be	 attributed	 to	 the	 release	 of	 free	 methanol	 during	 the	 saponification	
process	of	pectin	or	due	to	pectin	methyl	esterases	acting	exclusively	on	polymeric	
forms	of	d-galacturonic	methyl	ester.		
While	 microtitre	 plates	 have	 proved	 useful	 in	 previous	 published	 work	 to	 be	 an	
effective	 screening	 tool	 for	upstream	processing,	 in	 the	case	of	methylotrophic	P.	
pastoris	they	have	a	 limited	utility.	This	 is	because	the	methanol	 induction	system	
needs	 to	 be	 tightly	 regulated	 and	 controlled,	 which	 cannot	 be	 achieved	 through	








Several	 critical	 process	 parameters	 were	 identified	 in	 chapter	 3	 and	 5,	 including	
temperature;	harvest	time;	initial	biomass	concentration;	and	induction	strategies.		
Chapter	4	shows	how	microscale	sample	processing	techniques	were	developed	to	
enable	 high-throughput	 sample	 processing	 in	 upstream	 process	 development	 at	
miniaturised	 scales.	 Subsequently,	 chapter	 5	 aimed	 to	 investigate	 the	 use	 of	
microtiter	plates	for	the	purpose	of	upstream	process	characterisation.	However,	it	
was	 found	 that	 (1)	 the	 oxygen	 transfer	 rates	 required	 for	methanol	 induction	 in	











cell	 disruption	 tools	 to	 study	 VLP	 production	 in	 a	 bioprocessing	 context	 through	










in	 chapter	 3	will	 provide	 a	 good	 base	 case	 for	 the	 purpose	 of	 Tandem	 Core	 VLP	
assembly	in	this	chapter.	
This	chapter	will	address	the	variance	of	CCPs	identified	in	chapters	3	and	5	through	









Using	 the	 concentration	 of	 biomass	 to	monitor	 fermentation	 processes	 has	 been	
covered	 extensively	 in	 previous	 chapters.	 This	 chapter	 will	 use	 wet	 cell	 weight	
(2.5.2)	and	dry	cell	weight	(2.5.3)	to	measure	biomass	in	an	offline	fashion.		
6.3.1.2 Carbon	Dioxide	Evolution	Rate	
The	 Carbon	 Dioxide	 Evolution	 Rate	 (CER)	 is	 the	 net	 quantity	 of	 carbon	 dioxide	
observed	in	the	exhaust	gas	of	a	fermentation	process,	expressed	as	the	amount	of	
millimoles	of	carbon	dioxide	per	litre	of	working	volume	per	hour.	Hence:		










CER	 analysis	 is	 typically	 used	 to	 indicate	 the	 metabolic	 status	 of	 a	 fermentation	
process	through	online	measurements	(Omstead,	1990).		
In	 this	 series	of	experiments,	CER	will	 be	used	 (1)	 as	a	method	of	monitoring	 the	
activity	 and	 growth	 of	P.	 pastoris,	 (2)	 as	 a	 trigger	 for	 automatically	 initiating	 the	


















this	 was	 done	 by	 measuring	 (1)	 how	 much	 tHBc	 was	 recovered	 after	
homogenisation,	 (2)	how	much	of	 this	material	was	soluble;	and	 (3)	how	much	of	
this	material	was	in	the	correct	size	range	of	a	VLP.	These	‘states’	of	tHBc,	which	are	





Fermentation	 and	 harvesting,	 cell	 disruption,	 clarification,	 and	 purification.	 (Bottom)	
Outputs	of	respective	unit	operations:	(1)	Biomass,	(2)	lysate	containing	cell	debris,	host	
cell	 protein	 and	 total	 produced	 tHBc;	 (3)	 clarified	 lysate	 containing	 soluble	 host	 cell	
protein	 and	 soluble	 tHBc;	 (4)	 size-exclusion	 chromatography	 fractions	 containing	 tHBc	
and	host	cell	protein	in	within	the	20-220µm	size	range.		





amount	of	 tHBc	 assumed	 to	be	mostly	 assembled	VLP	was	measured	 after	 a	 size	






plates	 for	 upstream	 process	 characterisation.	 However,	 to	 gain	 higher	 level	 of	
process	control,	a	significant	trade-off	had	to	be	made	for	experimental	throughput.	
Bioreactor	 fermentation	 processes	 are	 considerably	 more	 expensive	 and	 time	













prior	 to	 culture	 induction	 without	 relying	 on	 offline	 data.	 Note	 that,	 the	 centre	
points	of	this	design	space	were	based	on	Invitrogen’s	protocol	for	P.	pastoris	MutS	
induction	(Invitrogen	Corporation,	2002).		






centre	 points	 of	 CCD	 used	 to	 investigate	 response	 variance	 over	 time	 at	 0,	 8,	 24	 and	 40	 hours	 of	 induction.	 Outputs:	 Metabolic	 data	 including			




Figure	 6.3	 describes	 the	 workflow	 used	 in	 this	 series	 of	 experiments.	 Step	 A	
described	the	inoculum	culture	required	to	generate	biomass	for	unit	operation	B,	
the	 fermentation	 unit	 operation.	 Variation	 of	 process	 parameters	 of	 this	 unit	
operation,	particularly	the	induction	phase,	will	be	the	focus	of	this	chapter.	Beyond	
step	B,	where	 the	workflow	diverges,	 the	 top	 row	 represents	unit	 the	operations	
involved	 in	 developing	 surface	 response	models;	 the	 bottom	 row	 represents	 the	
unit	 operations	 involved	 in	 developing	 time	 course	 profiles	 of	 each	 investigated	
response.	The	main	differences	between	the	top	and	bottom	processing	sequences	




Figure	 6.3	 Overview	 of	 methodology.	 (A)	 Shakeflask	 culture	 as	 described	 in	 2.3.2.	 (B)	




end	 filtration.	 (G)	 0.22µm	 dead-end	 filtration.	 Sample	 1	 represents	 total	 expression	 of	
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(Ytot.,	spec.),	 specific	 expression	of	 soluble	 core	protein	 (Ysol.,	spec.),	 specific	 expression	of	VLP-
sized	core	protein	(YVLP,	spec.),	volumetric	total	expression	of	core	protein	(Ytot.,	vol.),	volumetric	
expression	 of	 soluble	 core	 protein	 (Ysol.,	vol.)	 and	 volumetric	 expression	 of	 VLP-sized	 core	
protein	 (YVLP,	vol.).	 Goodness	 of	 fit	 is	 given	 on	 the	 left-hand	 side	 of	 the	 table	 (‘All	 terms’)	








	 R2	 R2	adj.	 Formulae	 R2	 R2	adj.	
[X]	(gWCW/L)	 0.871	 0.705	
! = 235 − 29.1*(,-./0 ∙ 2) −25.3*(2) − 23.3*(	25) +17.4	*(,-./0) + 11.4*(,9:)		 0.866	 0.786	
CER	
(mmoL/L/h)	 0.964	 0.917	
;<= = 46.8 + 20.8*(,-./0) −10.6*(,-./0 ∙ 2) − 8.08(2) −6.75*(	25) − 3.56*(,-./05) +3.00*(,9: ∙ 2)		 0.962	 0.940	
RQ	 0.796	 0.533	
=A = 0.554 + 0.0362*(,9:) +0.0300*(,-./05) + 0.0278*(2) +0.0242*(	25)	 − 0.0166*(,-./0)		 0.743	 0.626	
Ytot.,	spec.	
(µg/gWCW)	 0.596	 0.0771	
BCDC.,FGHI. 	= 4.17 − 1.36*(,9:5) −1.34*(,-./05)	 + 0.975*(2) +0.872*(,-./0))		 0.558	 0.411	
Ysol.,	spec.	
(µg/gWCW)	 0.590	 0.0632	
BFDJ.,FGHI. = 5.41	 − 2.02*(,-./05) −1.78*(,9:5) + 1.12*(,-./0) +1.05*(2)		 0.554	 0.405	
YVLP,	spec.	
(µg/gWCW)	 0.558	 -0.00945	
BKLM,FGHI. = 4.03 − 1.25*(,-./05) +1.08*(2) + 1.02*(,-./0) −0.922*(	25)		 0.476	 0.302	
Ytot.,	vol.	(µg/L)	 0.561	 -0.00307	
BCDC.,NDJ. = 980 − 304*(,9:5)	 +228*(,-./0) − 223*(,-./05) −167*(	25) + 137*(2)		 0.539	 0.329	
Ysol.,	vol.	(µg/L)	 0.5690	 0.0149	
BFDJ.,NDJ. = 1.35 ∙ 10O − 383*(,9:5) −344(	25) − 338(,-./05) +290*(,-./0)		 0.526	 0.370	
YVLP,	vol.	
(µg/gWCW)	 0.508	 0.0167	








To	 understand	 the	majority	 of	 the	metabolic	 responses,	 the	 uptake	 of	methanol	
must	 be	 understood.	 Figure	 6.4	 shows	 that	 there	 is	 an	 uptake	 limit	 of	 residual	
methanol	in	the	media	by	the	methylotrophic	culture	and	that	this	limit	occurs	at	an	
undefined	value	between	QMeOH=5.5mL/Li/h	and	QMeOH=8.0mL/Li/h.	The	 Invitrogen	
P.	 pastoris	 fermentation	 protocol	 recommends	 not	 to	 exceed	 a	 2%	 residual	
methanol	concentration	as	 this	will	 induce	toxicity	 (Invitrogen	Corporation,	2002).	
At	 the	 same	 time	 point	 that	 this	 residual	 concentration	 is	 reached,	 a	 decline	 in	
growth	rate	(Figure	6.5A),	a	reduction	in	CER	(Figure	6.5D)	and	an	increase	in	RQ	is	
observed	(Figure	6.5G).	





Figure	 6.4	 Time	 course	 profiles	 of	 residual	 methanol	 concentrations:	 (A)	 Residual	









The	 effect	 of	 glycerol	 flow	 rate	 in	 the	 fed	 batch	 phase	 seems	 to	 have	 a	 slight	
positive	 effect	 on	 the	 biomass	 yield	 after	 40	 hours	 of	 induction	 (Figure	 6.6C&D),	
however,	 as	 indicated	 by	 the	 convergence	 of	 growth	 curves	 in	 Figure	 6.5B,	 as	
induction	time	is	increased	the	effect	of	initial	biomass	concentration,	and	thus	the	
effect	of	QGY,	diminishes.	
Temperature	 seems	 to	 have	 a	 negative	 effect	 on	 overall	 biomass	 concentrations	
(Figure	6.6E&F).	This	could	be	explained	by	the	fact	that	alcohol	oxidase	activity	is	
increased	 at	 higher	 temperatures	 (Couderc	 and	 Baratti,	 1980).	 This	 results	 in	 the	














































































































































































Figure	 6.6	 Response	 Surface	 Model	 for	 biomass,	 [X].	 (A-B)	 Effect	 of	 QGY	 and	 T	 at	 (A)	





























































Methanol	 feed	 rate	 has	 a	 positive	 effect	 on	 CER	 in	 the	 investigated	 design	 space	
(Figure	6.7A&B).	However,	as	with	biomass	when	the	range	of	methanol	feed	rate	
was	 extended	 to	 promote	 toxic	 conditions,	 a	 drop	 in	 carbon	 evolution	 rate	 was	
observed	 in	 later	 stages	 of	 induction	 (Figure	 6.5D).	 Indeed,	 the	quadratic	 term	 in	
formula	in	Table	6-1	indicates	that	there	is	an	optimum	methanol	flow	rate	outside	
the	investigated	range	beyond	the	higher	end	of	the	flow	rate	levels.	
Glycerol	 flow	 rate	 seems	 to	 have	 a	 negative	 effect	 on	 CER,	 interacting	 with	
induction	temperature.		
The	 induction	 temperature	 also	 has	 a	 negative	 effect	 on	 the	 CER,	 the	 lower	 the	
temperature,	 the	higher	 the	CER.	However,	 the	model	 indicates	 that	 temperature	
may	 have	 an	 optimum	 outside	 the	 investigated	 range.	 However,	 this	 value	 is	





performance	 prediction	 of	 any	 P.	 pastoris	 culture,	 assuming	 negligible	 effects	












The	 respiratory	 quotient	 is	 significantly	 influenced	 by	 methanol	 flow	 rates.	 As	
shown	 in	 Figure	 6.8A-C	 there	 seems	 to	 be	 a	 minimum	 RQ	 occurring	 around	
3.55mL/Li/h.	Note	that	the	toxic	effect	of	methanol	 introduced	through	the	1.45α	
expansion	point	has	not	been	incorporated	into	this	model,	but	is	shown	in	Figure	






The	value	of	 the	RQ	can	be	explained	as	 follows.	When	methanol	 is	only	used	for	
maintenance	and	not	being	fixed	as	biomass:	
2"#$%# + 3%( → 4#(% +	2"%(	
Hence:	,- = 2 3 = 0.67	
This	principle	is	demonstrated	in	the	case	of	the	induction	at	QMeOH=0.5mL/Li/h	(see	




However,	when	methanol	 is	being	 fixed	as	biomass,	as	 is	 the	case	during	growth,	
this	 value	 can	 become	 lower	 as	 shown	 by	 a	 simplified	 version	 of	 Equation	 10-4,	
where	 the	 assumption	 is	 made	 that	 carbon	 fixation	 via	 protein	 expression	 is	
negligible16:	
"#$%# + 3 ∙ %( + 5 ∙ 6#7%# → 8 ∙ "#9%:6; + < ∙ "%( + = ∙ #(%	
Hence,	when	8 > 0,	,- = < 3 < 0.67	
																																																						






at	 (A)	 QMeOH=0.5mL/Li/h,	 (B)	 QMeOH=3.55mL/Li/h	 (response	 minimum)	 and	 (C)	











































































Figure	 6.9	 shows	 the	 response	 surface	 model	 for	 specific	 total	 core	 protein	
expression.	Optima	were	 established	 for	methanol	 flow	 rate	 (QMeOH=3.65mL/Li/h)	
and	glycerol	flow	rate	(QGY=18.15mL/Li/h)	and	a	positive	correlation	was	established	
between	 temperature	 and	 specific	 expression.	 The	 existence	 of	 an	 optimum	
methanol	flow	rate	for	this	response	can	explained	by	the	fact	that	methanol	acts	as	
a	 carbon	 source	 required	 for	 growth,	 yet	 is	 toxic	 at	 higher	 concentrations.	 The	
optimum	 glycerol	 feed	 rate	 in	 the	 fed	 batch	 phase	 is	 aliased	 to	 the	 optimum	
biomass	concentration	at	the	start	of	the	induction	phase.		
The	existence	of	 an	optimum	biomass	 concentration	at	 the	 start	of	 the	 induction	
phase	 has	 a	 similar	 explanation	 as	 the	 existence	 for	 an	 optimum	methanol	 flow	





the	previous	postulation,	made	 in	 section	6.4.2,	 that	higher	 temperatures	 lead	 to	
lower	 levels	 of	 biomass	 through	 alcohol	 oxidase	 hyperactivity.	 A	 decrease	 in	






























































T (°C) QMeOH (mL/Li/h)
Ytotal, spec. 
(µg/gWCW)



























































































































and	 increased	 amount	 of	 soluble	 tHBc	 expression.	 However,	 this	 correlation	 for	
soluble	tHBc	changed	beyond	QMeOH=5.5mL/Li/h.	At	QMeOH=8.0mL/Li/h,	virtually	no	
production	 of	 soluble	 protein	 was	 seen	 after	 24	 hours	 of	 induction,	 whilst	 total	
expression	was	the	highest	observed	at	this	time	point.	This	could	suggest	that,	at	
very	 high	 induction	 stimulus	 the	 resulting	 expression	 of	 tHBc	 is	 either	 incorrect,	
resulting	 in	 truncated	 heterologous	 protein,	 or	 is	 too	 high	 to	 permit	 assembly	 of	
soluble	multimeric	structures.	In	addition,	this	flow	rate	caused	observed	methanol	
toxicity	 at	 24	 hours	 after	 induction.	 This	 is	 indicated	 by	 a	 decreased	 growth	 rate	
(Figure	 6.5A),	 a	 decreased	 CER	 (Figure	 6.5D)	 and	 an	 increasing	 RQ	 (Figure	 6.5G)	
coinciding	with	a	residual	media	methanol	concentration	over	2%	vol.	(Figure	6.4A),	
which	 has	 been	 shown	 by	 previous	 work	 to	 be	 the	 limit	 toxicity	 threshold	
concentration	 of	 residual	 methanol	 (Invitrogen	 Corporation,	 2002).	 Methanol	
toxicity	could	have	triggered	various	stress	responses	including	the	up-regulation	of	
proteases,	which	would	 have	 resulted	 in	 truncation	 of	 tHBc,	 contributing	 to	 poor	
solubility	 or	 poor	 identification	 by	 dot	 blot,	 and	 poor	 assembly.	 In	 addition,	
methanol	 can	 weaken	 hydrophobic	 interactions	 between	 protein	 (Hwang	 et	 al.,	
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2011).	 This	 in	 turn	 can	affect	 the	assembly	of	 tHBc	 into	 soluble	material	 (such	as	
VLPs)	 as	 this	 action	 is	 based	 on	 hydrophobic	 interactions	 (Holmes	 et	 al.,	 2015;	
Peyret	et	al.,	2015).		
The	effect	of	glycerol	 flow	 rate	 in	 the	 fed	batch	phase,	 leading	 to	higher	biomass	
concentrations	 at	 the	 start	 of	 the	 induction	 phase,	 does	 not	 seems	 to	 have	 a	
significant	effect	on	the	solubility	of	expressed	tHBc	at	later	stages	of	induction.		
Temperature	 seemed	 to	 have	 a	 positive	 effect	 on	 the	 total	 specific	 expression	 of	
tHBc,	yet	a	negative	effect	on	soluble,	recoverable	heterologous	protein	expression.	
It	has	been	 reported	 that	 the	protein	 folding	 stress	 is	 increased	at	high	 induction	
temperatures	and	that	higher	titres	of	correctly	 folded	protein	are	often	achieved	
below	30°C	 (M	Dragosits	et	al.,	2009;	 Li	et	al.,	2011;	Anasontzis	et	al.,	2014).	The	
higher	 temperatures	 could	 have	 therefore	 led	 to	 increased	 misfolding	 and	
hydrophobicity	of	expressed	tHBc,	such	that,	either	during	the	induction	process	or	
during	 the	 cell	 disruption	 process,	 expressed	 Tandem	 Core	 material	 associated	














6.12,	 there	 are	 a	 number	 of	 differences	 between	 specific	 expression	 of	 VLP	 and	
soluble	and/or	total	specific	tHBc	expression.	Firstly,	for	VLP-fitting	tHBc	there	is	no	
apparent	 effect	 for	 the	 glycerol	 feed	 rate.	 Secondly,	 the	 induction	 temperature	








When	 looking	 at	 this	 figure,	 it	 appears	 that	 the	 higher	 the	 expression	 of	 soluble	












several	 findings	 in	 chapter	 3,	 supporting	 this	 data	 is	 the	 finding	 that	 VLP	 self-
assembly	requires	regulation,	as	relatively	high	and	uncontrolled	expression	of	free	
units	of	 tHBc	can	 result	 in	kinetic	 traps	and	 thus	 incomplete	 formation	of	 capsids	
(Zlotnick	 and	Mukhopadhyay,	 2011).	 Note	 that	 some	 degree	 of	 caution	must	 be	
taken	when	 interpreting	 the	 data	 in	 Figure	 6.13.	 This	 is	 because	 a	 VLP-to-soluble	
tHBc	ratio	above	1	is	unrealistic.	The	reason	the	existence	of	ratios	higher	than	1,	is	
most	 likely	 due	 to	 a	 non-specific	 binding	 effect	 of	 HCPs	 during	 immunoblotting	
detection.	 Hence,	 there	 would	 be	 less	 non-specific	 binding	 in	 relatively	 pure	
samples	 (i.e.	 SEC-derived	 sampled)	 resulting	 in	 higher	 levels	 of	 detection	 in	 an	
immunoassay.		
	






Overall,	 it	 seems	 that	 there	 is	 a	 very	 small	window	within	which	 soluble	 Tandem	
Core	 protein	 successfully	 assembles	 into	 VLPs	 per	 unit	 of	 biomass.	 One	 way	 to	









indicated	 by	 [X]	 and	 CER	 respectively,	 higher	methanol	 flow	 rates	 are	 preferable	
(QMeOH=5.5mL/Li/h).	However,	when	aiming	to	maximise	specific	expression	of	tHBc,	
regardless	of	its	state,	a	slightly	lower	flow	rate	is	required	(QMeOH~3.5mL/Li/h).	This	
setting	 is	 slightly	higher	when	aiming	 to	maximise	volumetric	expression	 since,	as	
mentioned	previously,	this	output	is	also	a	function	of	biomass.	
	Figure	 6.14B	 shows	 the	 different	 glycerol	 flow	 rate	 setting	 required	 to	 achieve	
different	optima.	Unsurprisingly,	 to	maximise	biomass	at	 the	end	of	 the	 induction	
phase	 the	 biomass	 at	 the	 start	 of	 the	 induction	 phase	 has	 to	 be	 maximised,	 as	





midpoints	 for	 all	 expression	 responses,	 except	 for	 VLP-fitting	 tHBc.	 In	 the	 latter	
case,	the	glycerol	flow	rate	was	not	found	to	have	a	significant	effect.		
Figure	 6.14C	 shows	 that	 to	 maximise	 biomass	 and	 metabolic	 activity,	 lower	
temperatures	 are	 preferable.	 For	 the	 lowest	 possible	 respiratory	 quotient,	 an	
optimum	 operating	 temperature	 of	 22°C	 was	 established.	 Interestingly,	 the	
maximum	 investigated	 temperature	was	 found	 to	 be	 the	 optimum	 for	 both	 total	
and	soluble	specific	expression	of	tHBc.	However,	for	maximum	specific	expression	
of	VLPs,	 a	 significantly	 lower	 temperature	was	 required.	 This	 again	 suggests,	 that	
for	 the	 production	 of	 VLPs,	 more	 control	 is	 required	 than	 simply	 upregulating	
expression	of	heterologous	protein.	
There	 are	 therefore	 trade-offs	 to	 be	 made	 when	 determining	 the	 fermentation	
protocol	 for	 the	 production	 of	 Tandem	 Core	 VLPs	 in	 P.	 pastoris.	 Lower	
temperatures	 seem	more	 favourable	 for	 increasing	 the	 concentration	of	biomass.	
This,	 however,	 lowers	 specific	 expression	 but,	 in	 turn,	 seems	 to	 promote	 the	
specific	 expression	 of	 soluble	 Tandem	 Core	 material.	 On	 the	 other	 hand,	 high	
specific	 expression	of	 Tandem	Core	protein,	 regardless	 of	 its	 state,	 is	 achieved	 at	
higher	 induction	 temperatures.	 A	 downside	 of	 this	 approach	 is	 a	 decrease	 in	
biomass	 and	 product	 solubility.	 For	 the	 purpose	 of	 this	 work,	 the	 aim	 was	 to	






flow	 rate	 settings	 and	 (C)	 induction	 temperature	 settings.	 The	 symbols	@ 	and	 –@	






the	 k1,k1	 construct	 in	 P.	 pastoris	 	 has	 been	 characterised.	 This	 characterisation	
yielded	several	key	findings.	
Metabolic	 responses,	 [X],	 CER	 and	 RQ,	 required	 significantly	 different	 optimum	
operating	conditions	than	specific	expression	responses	and	volumetric	responses.	
Assuming	 these	 models	 are	 not	 highly	 specific	 to	 the	 protein	 of	 interest	 being	
expressed,	 such	 data	 could	 translate	 to	many	 processes	 employing	P.	 pastoris	 to	
produce	heterologous	protein	in	general.	
Methanol	toxicity	was	studied	and	it	was	found	that	induction	feed	rates	can	be	set	
significantly	 higher	 than	 recommended	 by	 industry	 standard	 protocols	 for	 these	
constructs.	
Analysis	of	specific	expression	responses	showed	that	models	for	expression	of	total	
and	 crude	 tHBc	 were	 very	 much	 alike.	 However,	 the	 model	 for	 specific	 VLP-
assembled	 tHBc	 was	 very	 different.	 This	 indicated	 that	 maximising	 expression	 of	
tHBc	was	 not	 synonymous	 to	maximising	 the	 production	 of	 VLPs.	 It	 was,	 in	 fact,	
shown	that	a	relatively	narrow	window	for	specific	tHBc	expression	exists	in	which	a	
significant	part	of	Tandem	Core	units	assembles	into	Virus-Like	Particles.	There	are	




1. Higher	 expression	 rates	 could	 result	 in	 kinetic	 traps,	 resulting	 in	
unassembled	intermediate	material.	
2. Expressed	 material	 is	 expressed	 disproportionately	 high	 to	 chaperone	

























identify	 factor	 interactions	 affecting	 substrate	 consumption	 and	 induction	
stimuli.	
4. RNA	 measurements	 would	 provide	 a	 better	 measure	 of	 heterologous	
protein	expression	than	measuring	tHBc	concentrations	in	crude	lysate.	
However,	in	summary,	this	approach	has	increased	our	understanding	of	the	design	
















This	 chapter	 aims	 to	 investigate	 how	 the	 previous	 findings	 translate	 to	 applied	
industrial	scenarios.	Thus,	the	following	objectives	were	set:	
• Investigate	effects	of	varying	inserts:	This	chapter	will	investigate	the	effects	
on	 fermentation	 processes	 and	 product	 yields	 as	 a	 result	 of	 changing	
epitopes	on	the	Tandem	Core	VLP	exterior.	




• Investigate	 the	 effects	 of	 alternative	 feeding	 strategies	 on	 yield	 and	
scalability.		
7.3 Variation	of	inserts	with	universal	influenza	epitopes	
The	 k1,	 k1	 VLP	 constructs	 utilises	 lysine	 residues	 in	 the	 major	 insertion	 regions	
(MIR)	of	the	Tandem	Core	sub-unit.	However,	this	work	seeks	to	replace	the	lysine	
residues	 with	 small	 conserved	 regions	 of	 influenza	 that	 might	 be	 useful	 in	 a	
universal	vaccine.	Thus	far,	the	effect	of	changing	the	insert	on	VLP	production	and	
assembly	has	yet	to	be	characterised	and	therefore,	this	section	aims	to	scope	the	
effects	 of	 changing	 inserts	 on	 the	 Tandem	 Core	 scaffold	 on	 upstream	 process	
requirements.	This	was	done	by	inducing	various	transformants	of	P.	pastoris	MutS	
expressing	 different	 Tandem	Core	 constructs	 at	 identical	 fermentation	 conditions	
and	subsequently,	studying	metabolic	responses	and	product	titers.		
7.3.1.1 Pure	methanol	 induction	 yields	 lower	 observable	 titres	 for	more	 complex	
inserts	
Several	 constructs	 were	 created	 to	 monitor	 the	 effect	 on	 upstream	 processing.	
These	constructs	are	summarised	below.	
• k1,	 k1:	 As	 mentioned	 earlier,	 this	 represents	 the	 most	 simplified	 VLP	






Previous	 research	 has	 shown	 that	 this	 epitope	 provides	 the	 desired	
immunogenic	 response	 and	 can	 be	 placed	 onto	 a	 hepatitis	 B	 core	 VLP	
scaffold	(Krammer	and	Palese,	2013;	Chen	et	al.,	2015).		
• HA2.3,	 (M2e)3:	 This	 construct	 displays	 two	 different	 influenza-specific	
epitopes.	 The	 first	 epitope	 is	 HA2.3,	which	 comprises	 the	 long-alpha	 helix	
structural	domain,	plus	an	extended	amino	acid	sequence	(Barbey-Martin	et	
al.,	 2002).	 (M2e)3	 represents	 a	 triplet	 sequence	 of	 an	 evolutionarily	
conserved	 region	 ectodomain	 of	 the	 M2	 channel	 in	 influenza	 viruses.	




• LAH3,	 (M2e)3:	 This	 construct	 displays	 the	 previously	 discussed	 epitopes	
(M2e)3	and	LAH3.		
Using	 a	 pure	 methanol	 induction	 protocol	 (section	 2.3.3.1),	 at	 30°C,	 QMeOH=5.0	
mL/Li/h	 and	 QGY=13.15	 mL/Li/h,	 no	 significant	 differences	 in	 final	 biomass	 at	 40	








recycled	 as	 a	 carbon	 source,	 or	 differences	 in	 the	 copy	 numbers	 of	 heterologous	




and	 relatively	 smaller	 inserts	 (k1,	 k1	 and	 LAH,	 k1)	 had	 the	 highest	 specific	 yields.	
However,	 it	 should	 be	 noted	 that	 the	 chosen	 induction	 method	 was	 based	 on	
maximising	total	specific	tHBc	expression,	rather	than	maximising	total	specific	VLP	
production	as	the	assembly	kinetics	for	each	novel	VLP	was	unknown.		















induction	 conditions.	 Nonetheless,	 the	 aim	 of	 this	 research	 was	 to	 develop	 an	
influenza	 vaccine	 offering	 the	 broadest	 possible	 cross-protectiveness	 against	
influenza	variants.	Therefore,	to	maximise	the	potential	of	Tandem	Core	technology	




In	 an	 attempt	 to	 lower	 the	 specific	 expression	 of	 tHBc	 protein	 to	 facilitate	 the	
assembly	of	more	complex	Tandem	Core	units,	a	mixed	feeding	induction	protocol	
was	 implemented	 in	which	glycerol	was	 introduced	simultaneously	with	methanol	




such	 that	 cellular	 stress	 factors	 were	 not	 induced;	 and	 (2)	 to	 lower	 the	 specific	
expression	of	tHBc	through	partial	repression	of	AOX	genes	and	increased	levels	of	
biomass	generation	(Hartner	and	Glieder,	2006).		
The	HA2.3,(M2e)3	 (HC)	 construct	was	used	 for	 this	 study,	 as	 it	provided	 the	most	
complex	version	of	insert	combination	available	and	would,	therefore,	according	to	
the	 previously	 stated	 hypothesis,	 prove	 to	 be	 the	 most	 challenging	 version	 of	
Tandem	Core	protein	to	assemble	into	a	VLP.		
The	data	generated	from	this	mixed	feeding	approach	was	compared	to	harvested	
material	 derived	 from	 pure	 methanol	 induced	 fermentation	 for	 the	 low-copy	
HA2.3,(M2e)3	construct.		
As	 shown	 in	 Figure	 7.3A,	 a	 mixed	 feeding	 strategy	 resulted	 in	 higher	 metabolic	
activity	 as	 a	 result	 of	 higher	 biomass	 generation.	 As	 reported	 by	 several	 sources,	
this	can	be	explained	by	the	 fact	 that	 the	maximum	specific	growth	rate	 is	higher	
when	glycerol	is	used	as	a	carbon	source	than	when	methanol	is	used	as	a	carbon	
source	 (Orman,	Çelık	and	Ozdamar,	2009;	Looser	et	al.,	2014).	The	utilisation	of	a	
different	 carbon	 source	 is	 confirmed	 through	 analysis	 of	 the	 RQ	 shown	 in	 Figure	









different	 induction	 modes.	 (A)	 Carbon	 Dioxide	 Evolution	 Rates.	 Event	 A	 shows	 the	
approximate	 time	of	 	 the	glycerol	 fed-batch	phase	 for	pure	methanol	 feeding	 induction	
processes	 and	 the	 start	 of	 innduction	 for	 the	mixed	 feeding	 induction	process.	 Event	B	
shows	the	time	for	the	start	of	induction	for	the	pure	feeding	processes.	(B)	Respiratory	
Quotients.	 The	 orange	 curves	 denote	 the	 responses	 of	 the	 mixed	 feeding	 induction	
process,	whereas	 the	 blue	 curves	 denote	 the	 responses	 for	 the	 pure	 feeding	 induction	
processes	at	high	copy	numbers	(dark	blue)	and	low	copy	numbers	(light	blue).		





the,	 simpler,	 k1,k1	 VLP	 construct,	 yielding	 significantly	 different	 results.	 This	
suggests	that	VLP	expression	and	assembly	is	highly	dependent	on	the	construct.	
On	the	other	hand,	when	comparing	the	titres	from	a	mixed	feed	induction	to	pure	
methanol	 induction	of	 the	 same	VLP	 construct	 (HA2.3,	 (M2e)3),	 specific	 titres	 are	





Figure	 7.4	 Size	 Exclusion	 Chromatography	 (2.4.11)	 fractions	 of	 bead-lysed	 (2.4.9)	
HA2.3(M2e)3	 construct	 ( ± 65kDa)	 using	 pure	 methanol	 induction.	 Two-minute	
chromatography	fractions	were	collected	after	10	minutes	for	an	additional	20	minutes.	







Figure	 7.5	 Size	 Exclusion	 Chromatography	 (2.4.11)	 fractions	 of	 bead-lysed	 (2.4.9)	
HA2.3(M2e)3	 construct	 (±65kDa)	 using	 glycerol	 mixed	 feed	 induction.	 Two-minute	
chromatography	fractions	were	collected	after	10	minutes	for	an	additional	20	minutes.		
(A-D)	 Coomassie	 stains	 of	 reduced	 gels.	 (E-H)	 Western	 Blots	 (1-minute	 exposure).	
Fermentation	samples	were	collected	after	1.5	hours	(A	&	E),	9	hours	(B	&	F),	31	hours	(C	





So	 far,	 this	 chapter	 has	 investigated	 two	 categories	 of	 induction	 modes	 at	
miniaturised	 scales	 of	 fermentation:	 pure	 methanol-based	 induction	 and	
glycerol/methanol	mixed	feed	induction.	This	section	will	compare	the	scalability	of	
each	 of	 these	 induction	 modes.	 The	 processes	 were	 scaled	 120-fold:	 from	
miniaturised	bioreactor	scale	(VT=250mL)	to	pilot	plant	scale	(VT=30L).	
Process	scale-up	was	performed	using	constant	power	per	volume	input	at	constant	









Maintaining	 constant	 power	 per	 volume	 input	 is	 achieved	 through	 the	 following	
correlation:	







A	 high-yield	 process	 for	 VLP	 production	 of	 k1,	 k1-VLPs	 was	 established	 in	 the	
previous	 chapter	 and	 was	 chosen	 as	 the	 fermentation	 process	 to	 scale-up	 to	
investigate	pure	methanol	 induction	 scalability.	 The	 induction	parameters	 for	 this	
scaled-down	process	were:	T=25°C,	QGY=13.15mL/Li/h	and	QMeOH=5.0mL/Li/h.		









at	 large-scale,	 oxygen	 was	 blended	 while	 maintaining	 a	 constant	 gas	 flow	 rate.	
Because	the	gas	flow	rate	was	increased	at	small-scale,	a	lower	gas	concentration	of	
carbon	dioxide	was	observed.	However,	aside	from	different	off-gas	carbon	dioxide	




for	 this	 is	 that	 the	 smaller	 scale	 bioreactors	 have	 reduced	mass	 transfer	 capacity	
due	to	surface	tension	effects.	










Finally,	 volumetric	 productivity	 profiles	 were	 established	 (Figure	 7.6D)	 and	 were	











The	 previous	 section	 discussed	 the	 challenges	 observed	 when	 scaling	 up	 a	 pure	
methanol-based	induction	process.	It	was	hypothesised	that	these	differences	arose	
during	 the	 glycerol	 fed-batch	 phase,	 where	 gas	 blending	 is	 most	 critical.	 On	 the	
other	hand,	a	mixed	feeding	protocol	omits	this	fed-batch	phase	and,	therefore,	did	
not	require	significant	levels	of	pure	oxygen	gas	blending.		
It	 was	 hypothesised	 that	 scaling	 up	 the	 mixed	 feed	 induction	 process	 (section	
7.3.1.2)	would	yield	higher	process	similarity	at	large-scale	than	scaling	up	the	pure	
methanol	based	induction	process	(section	7.4.1).		





Qualitative	 product	 analysis	 shown	 in	 Figure	 7.8	 shows	 near-identical	 expression	
profiles	 of	 total	 and	 soluble	 specific	 expressed	 tHBc	 in	 harvested	 material	 at	 48	







Figure	7.7	 Fermentation	data	of	process	 scale-up	of	 P.	pastoris	 	 expressing	 tHBc-HA2.3,	
(M2e)3	 using	 mixed	 feeding	 induction	 (section	 2.3.5.2).	 Large-scale	 data,	 at	 30L	 total	
working	 volume,	 is	 shown	 in	 blue.	 Small-scale	 data,	 at	 250mL	 total	working	 volume,	 is	






Figure	 7.8	 Qualitative	 protein	 data	 of	 large-scale	 and	 small-scale	 fermentations,	 both	
using	 the	 same	 mixed	 feeding	 induction	 protocol.	 For	 the	 large-scale	 fermentation	
(VT=30L),	samples	were	taken	at	0,	9,	31	and	48	hours	of	induction.	Samples	for	the	small-
scale	 fermentation	 (VT=250mL)	 were	 taken	 at	 48	 hours	 of	 induction.	 Extractions	 were	
performed	with	homogenisation.	(A)	Membrane	stain	of	reduced	SDS-PAGE	gel	showing	
host	 cell	 protein	 expression	 profiles	 in	 crude	 and	 clarified	 lysates.	 (B)	 Western	 blot	






epitopes	 inserted	 on	 the	 MIR	 of	 the	 VLP	 scaffold	 on	 product	 titres	 and	 other	
bioprocess-related	 responses,	 such	 as	metabolic	 activity	 and	 respiratory	 quotient	
profiles;	 the	 suitability	 of	 two	 different	modes	 of	 induction	 for	 the	 expression	 of	
different	VLP	constructs;	and	the	process-scalability	of	these	two	different	modes	of	




would	 have	 a	 practical	 application.	 Therefore,	 this	 section	 aimed	 to	 combine	 the	
findings	by	investigating	the	effects	of	titres	of	different	VLP	constructs	containing	
different	combinations	candidate	influenza	epitopes,	produced	at	large-scale	using	
the	most	 scalable	 induction	method,	which,	 as	 discussed	 earlier	was	 found	 to	 be	
mixed	feeding.	The	candidate	VLP	constructs	for	a	universal	influenza	vaccine	were:	
(1)	k1,	LAH3;	(2)	k1,	(M2e)3	and	(3)	HA2.3,	(M2e)3.		
Figure	7.9	 shows	 that	 the	differences	between	metabolic	 responses	 are	 relatively	













concentration	 profiles	 for	 k1,LAH3,	 k1,(M2e)3	 and	 HA2.3,(M2e)3	 constructs	 during	 30L	








2.5.9	 and	 2.5.11.	 All	 samples	 were	 standardised	 to	 a	 concentration	 of	 50µg/mL	 total	
protein.	Fermentations	for	the	k1,LAH3	(±48kDa);	k1,(M2e)3	(±58kDa)	and	HA2.3,(M2e)3	




in	 crude	 lysate	 (A),	 clarified	 lysates	 (B)	 and	 VLP-sized	 material	 fractions	 (C).	 (Bottom)	
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process	 as	 described	 in	 section	 7.4.1.	 Note	 that	 dot	 blot	 analysis	was	 performed	 using	
linear	 fitting	 (r2=0.96,	 n=18)	 rather	 than	 four	 parameter	 logistic	 fitting.	 This	 was	 done	
because	 4PL	 analysis	 could	 not	 capture	 the	 higher-end	 concentration	 of	 the	 harvested	








total	 tHBc	 expression.	 It	 was	 postulated	 that,	 aside	 from	 lowering	 induction	
temperature,	this	could	be	achieved	by	employing	a	glycerol	mixed	feed	induction	
process.	 Indeed,	for	an	 influenza	vaccine,	providing	broad	cross-protection	against	
influenza	 variants,	 larger	 and	 more	 complex	 inserts	 are	 required.	 It	 was	
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demonstrated	 that	higher	VLP	 titres	 containing	 these	 inserts	were	achieved	using	
mixed	 feed	 induction	 when	 compared	 to	 the	 previously	 studied	 pure	 methanol-
based	induction	processes.		
Overall,	 the	 results	 initially	 demonstrated	 in	 the	 ambr®	 250	 system	 have	 been	
confirmed	at	pilot	scale	using	the	30L	fermenter	and	have	netted	similar	results.	
The	 scale-up	 of	 an	 optimised	 pure	methanol-based	 induction	 process	 proved,	 to	





VLPs	presenting	 various	 influenza	 epitopes,	was	 investigated	 at	 pilot	 scale.	 It	was	
again	 shown	 that	 the	 implementation	 of	more	 complex	 inserts	 resulted	 in	 lower	
VLP	titres.	To	fully	understand	why	will	require	further	study,	but	insert	complexity	
may	have	a	role	to	play.		
Comparing	 the	 yields	 of	 these	 mixed	 feeding	 induction	 fermentations	 with	 the	










phenotype	 and	 the	 introduction	 of	 smaller	 inserts	 of	 the	 Tandem	 Core	 scaffold,	
soluble	 and	 heat-stable	 VLPs	 were	 successfully	 produced	 in	 the	 appropriate	 size	
range.	 This	 chapter	 also	 identified	 a	 relatively	 large	 number	 of	 critical	 process	
parameters,	 therefore	 recognising	 the	 need	 for	 robust,	 high-throughput	
miniaturised	 fermentation	 platforms,	 more	 effective	 extraction	 processes;	 ideally	
combined	with	experimentally	economic	experimental	design	methodology.		
The	 time	 and	 cost	 benefits	 of	 such	miniaturised	 fermentation	 platforms	 could	 be	
gained	 only	 by	 employing	 complementary	 techniques	 facilitating	 high-throughput	
processing	 at	 small	 sample	 volumes.	 Chapter	 4	 therefore	 focused	 on	 the	
development	 of	 a	 high-performance,	 high-throughput,	 non-contact,	 automated,	
small-scale,	 scalable	 disruption	 tool	 for	microbial	 bioprocess	 development.	 It	was	
found	that	Adaptive	Focused	Acoustics	(AFA)	on	enzymatically	pre-treated	samples	
provided	 the	 most	 suitable	 platform	 fulfilling	 these	 criteria.	 Development	 and	
optimisation	 of	 this	 method	 led	 to	 matching	 and	 even	 outperforming	
homogenisation	 performance,	 depending	 on	 the	 performance	 criterion	
investigated.	 The	 resulting	overlap	of	performance	 ranges	between	High	Pressure	
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Homogenisation	 and	 AFA-mediated	 cell	 disruption	 allowed	 for	 small-scale	 AFA	
performance	 mimicry	 of	 High	 Pressure	 Homogenisation.	 The	 utility	 of	 this	 work	
means	 that,	 for	microbial	 cultures	with	 sizeable	 cell	walls,	 such	 as	P.	 pastoris,	 an	
efficient	scale-down	tool	is	now	available	adding	to	the	processing	tools	set.		
It	was	found	in	chapter	5	that	methanol-based	induction	of	P.	pastoris	in	microtitre	
plates	 proved	 to	 be	 challenging	 predominantly	 due	 to	 reduced	 mass	 transfer	
capacity	 and	 due	 to	 the	 tight	 regulation	 required	 of	 methanol	 induction.	 As	 an	
alternative,	 the	use	of	pectin	digest	as	an	 indirect	 induction	agent	was	 studied.	 It	





critical	 process	 parameters	 were	 confirmed:	 initial	 biomass	 concentration	 at	
induction,	harvest	time	and	methanol	concentration	in	media.		
The	 effects	 of	 variance	 of	 these	 critical	 process	 parameters	 were	 studied	 to	 a	
greater	 extent	 using	 miniaturised	 bioreactors	 in	 chapter	 6.	 Metabolic	 responses,	
such	 as	 final	 biomass	 concentration,	 required	 significantly	 different	 optimum	






the	production	of	VLPs.	 It	was,	 in	 fact,	shown	that	a	relatively	narrow	window	for	
specific	 tHBc	 expression	exists	 in	 which	 a	 significant	 part	 of	 Tandem	 Core	 units	
assembles	into	VLPs.		
Chapter	 7	 showed	 that	 different	 fermentation	 processes	 are	 appropriate	 for	
different	constructs.	It	was	demonstrated	that	higher	titres	for	complex	VLPs	were	
achieved	using	mixed	feeding	induction	rather	than	pure	methanol-based	induction.	
In	 addition,	 the	 scale-up	 of	 an	 optimised	 pure	methanol-based	 induction	 process	
proved	 problematic.	 The	 issues	 that	 arose	 mainly	 resulted	 from	 the	 requisite	 of	
oxygen	 gas	 blending	 during	 the	 glycerol	 fed-batch	 phase.	 Because	mixed	 feeding	
induction	omitted	this	phase	in	its	process,	the	resulting	process	scale-up	was	more	
successful.	 Using	 this	 mixed	 feeding	 strategy,	 the	 expression	 of	 three	 influenza	
vaccine	 candidates	 was	 investigated	 at	 pilot	 scale.	 It	 was	 again	 shown	 that	 the	
implementation	of	more	complex	inserts	resulted	in	lower	VLP	titres.		
8.2 Future	work	
Although	 chapter	 3	 showed	 how	 critical	 process	 parameters	 were	 identified	
associated	 with	 fermentation	 primary	 recovery,	 relatively	 little	 investigation	 was	
performed	on	the	development	of	high-throughput	analytical	techniques	that	could	
distinguish	 between	 assembled	 and	 unassembled	 Tandem	 Core	material.	 A	main	
assumption	 in	 this	 thesis	 has	 been	 that	 Tandem	 Core-positive	 material	 within	 a	
particular	size	range	represented	assembled	VLP.	However,	it	must	be	stressed	that	




Future	work	 should	 therefore	 focus	 on	 the	 development	 of	 alternative	 analytical	
techniques.	Nonetheless,	for	preparative	purposes,	Size	Exclusion	Chromatography	
is	 a	 highly	 scalable	 purification	 technique	 and	 therefore	 has	merit.	 It	 is	 therefore	
also	 recommended	 that	 the	 employed	 SEC	 method	 is	 improved	 to	 maximise	
recovery	of	VLPs.		
The	 results	 in	 chapter	 4	 demonstrated	 that	 AFA-mediated	 cell	 disruption	 can	 be	
employed	in	high-throughput	miniaturised	fashion.	This	technology	could	therefore	
be	 used	 as	 a	 tool	 for	 a	 wide	 variety	 of	 applications	 including	 lysis	 buffer	
development,	 strain	 selection,	 fermentation	 process	 development	 and	 whole	








in	 comparison	 to	 the	 industry	 standard	 of	 cell	 disruption,	 High	 Pressure	
Homogenisation,	 at	 small-scale.	 Cell	 disruption	 of	 P.	 pastoris	 using	 AFA	 could	 be	
implemented	 at	 industrial	 scale	 using	 continuous	 flow	 systems	 as	 pilot	 scale	 AFA	
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units	now	exists	 that	could	offer	better	 recovery	with	 less	micronised	debris.	This	
could	have	significant	implications	for	the	development	of	continuous	bioprocesses.		
Chapter	 5	 focused	 on	 the	 development	 of	 microscale	 fermentation	 platforms.	
Although	 the	experiments	 show	that	growth	and	 induction	can	be	achieved	using	
microtitre	plates,	 tighter	process	controls	are	 required,	particularly	 relating	 to	 the	
introduction	of	methanol	 into	media.	 	Future	work	should	therefore	 focus	on	two	
areas:	 (1)	 the	 implantation	 of	 more	 sophisticated	 microscale	 fermentation	
platforms,	such	as	the	ambr®	15	micro	bioreactor	(Sartorius	AG,	Goettingen,	DE)	or	
the	Micro-Matrix	 system	 (Applikon	 Biotechnology	 B.V.,	 Delft,	 NL);	 and	 (2)	 further	
investigation	 of	 indirect	 AOX	 induction	 through	 the	 introduction	 of	 pectin	
oligomers.		





(BiP)	 and	Protein	Disulphide	 Isomerase	 (PDI).	Higher	 levels	of	 co-expression	 could	
prove	 to	be	 favourable	 for	VLP	 assembly.	 In	 addition,	 cellular	 stress	 responses	 to	
either	high	levels	of	tHBc	internalisation	or	high	methanol	concentrations	could	be	




Although	 the	 number	 of	 factors	 in	 the	 experimental	 design	was	 limited	 to	 three,	









However,	 there	could	be	benefits	 in	studying	the	effect	of	 increased	acidity	as	pH	
values	below	3	could	inhibit	protease	activity	triggered	by	stress	responses,	thereby	
minimising	 the	 formation	 of	 truncated	 heterologous	 protein	 (Invitrogen	
Corporation,	2002).	DOT	was	also	not	considered	a	priority	factor,	as	an	increase	in	
DOT	 would	 mainly	 result	 in	 an	 increase	 in	 excess	 oxygen	 concentrations.	 Also,	
assuming	 a	 scenario	 in	 which	 high	 DOT	 levels	 are	 most	 favourable,	 maintaining	
relatively	 high	 DOT	 levels	 would	 become	 problematic	 when	 scaling	 up	 a	
fermentation	 process.	 Nonetheless,	 the	 effect	 of	 variance	 of	 DOT	 levels	 on	
heterologous	protein	expression	by	P.	pastoris	 	has	 reported	to	be	significant	and	
would	be	worthwhile	to	investigate	(Invitrogen	Corporation,	2002;	Lee	et	al.,	2003).	
Chapter	 7	 showed	 the	 benefits	 of	 implementing	 mixed	 feeding	 induction.	 A	





glycerol	 fed-batch	phase.	This	would	 reduce	 the	number	of	 factors	 to	be	 studied,	
making	it	more	feasible	to	study	the	additional	factors	of	interest	discussed	above.	
It	 should	 also	 be	 stressed	 that	 the	 scale-up	 of	 processes	 discussed	 in	 chapter	 7	
assumed	 geometric	 similarity	 of	 miniature	 and	 pilot	 scale	 bioreactors	 for	 the	
purpose	 of	 simplicity.	 In	 reality,	 there	 are	 dissimilarities	 between	 these	 vessel	
geometries.	Therefore,	to	improve	process	scalability,	accounting	for	the	geometric	
differences	 between	 the	 vessels	 could	 account	 for	 better	 scale-up.	 Additionally,	
alternative	 scaling	 strategies	 could	 also	 be	 investigated,	 for	 instance,	maintaining	
constant	oxygen	transfer	capacity	has	proven	to	be	an	effective	basis	 for	scale-up	
when	vessel	geometry	is	dissimilar	(Islam	et	al.,	2008).		
This	work	has	 shown	 that	upstream	process	development	 is	highly	dependent	on	
the	VLP	construct	involved.	Future	work	could	therefore	explore	the	fundamentals	
of	VLP	assembly	and	its	change	with	insert	variation.	However,	the	requirement	of	
reassessing	 the	 suitability	 of	 a	 bioprocess	 after	 candidate	 epitope	 selection	
significantly	 impedes	 vaccine	 development.	 To	 move	 towards	 a	 more	 flexible	
vaccine	 development	 platform,	 a	 universal	 vaccine	 production	 process,	 such	
variance	 needs	 to	 be	 eliminated	 or	 reduced.	 This	 could	 be	 achieved	 by	
implementing	 a	 different	 VLP-production	 strategy	 altogether,	 in	 which	 a	
standardised	VLP	scaffold	is	produced	in	a	single	fermentation	process	followed	by	
epitope	conjugation	in	a	separate	unit	operation	post-purification.	The	investigated	
k1,	 k1	 construct	 would	 in	 fact	 be	 suitable	 for	 lysine	 residue-based	 conjugation.	







VLP	assembly	 can	be	controlled	outside	 the	cell	 in	a	 separate	unit	operation.	VLP	
assembly	of	hepatitis	B	core	protein	outside	cells	has	indeed	been	demonstrated	in	
previous	 works	 (Ludgate	 et	 al.,	 2016).	 Such	 an	 approach	 would	 be	 beneficial	
because	 it	would	 (1)	 reduce	 intracellular	proteolytic	degradation	of	 tHBc	 resulting	
from	a	variety	of	possible	 cellular	 stress	 responses,	 (2)	allow	 for	highly	 controlled	
assembly	of	VLPs	and	(3)	eliminate	the	need	of	a	cell	disruption	method.	The	latter	
unit	operation	has	been	proven	 in	 this	work	 to	have	 the	potential	 to	 significantly	
impede	 VLP	 recovery	 due	 to	 the	 generation	 of	 micronised	 debris.	 This	 secretory	
assembly	 could	 possibly	 be	 achieved	 by	 developing	 a	 construct	 that	 contains	 a	































































































































































































































































































































































































































































































































































































































































































































































Growth from master cell bank inoculum





































Figure	 10.5	 Mixed	 feeding	 induction	 fermentation	 data	 of	 P.pastoris	 Mut+	 expressing	














YeastBusterTM	 is	 a	 protein	 extraction	 reagent	 produced	 by	 Novagen®	 with	 a	
proprietary	 mix	 of	 mild	 detergents,	 protein	 stabilisation	 buffer	 reducing	 agent	
called	tris(hydroxypropyl)phosphine	(THP).	 It	has	reportedly	been	used	to	perform	
extractions	of	proteins	from	Pichia	pastoris	 through	‘gentle	conditions’	 	 (Novagen,	
2004).		
As	 this	 agent	 has	 previously	 been	 used	 to	 disrupt	 Pichia	 pastoris,	 it	 was	











standard	deviations	are	derived	 from	triplicate	measurements	on	duplicate	 samples	 for	
both	 crude	 and	 clarified	 lysates.	 Total	 protein	 quantification	was	determined	using	 the	
Nanodrop	method	(section	2.5.5).		
Figure	10.7	shows	total	protein	concentrations	of	both	crude	and	clarified	lysates	of	
cells	 incubated	 with	 YeastbusterTM	 at	 various	 biomass	 concentrations.	 The	 data	
shows	that	YeastbusterTM	is	capable	of	disrupting	cells	and	that	the	total	amount	of	
total-	 and	 soluble	 protein	 released	 by	 YeastbusterTM	 increases	 as	 the	 biomass	
concentration	increases.	However,	the	proportion	of	soluble	protein	to	total	protein	
measured	decreases	as	the	concentration	of	biomass	increases.	
The	data	 shows	 that	YeastbusterTM	 is	 suitable	 for	disrupting	P.	pastoris.	However,	
the	 aim	 of	 using	 this	 agent	 is	 to	 recover	 soluble	 core-positive	material.	 This	 was	
assessed	 using	 qualitative	 product	 analysis,	 which	 shown	 in	 Figure	 10.8	 and	 was	
performed	 on	 crude	 and	 clarified	 lysates	 using	 dot	 blot	 analysis	 as	 described	 in	
sections	2.5.10	and	2.5.11.	
10



















Figure	 10.8	 Qualitative	 analysis	 of	 crude	 and	 clarified	 lysates	 following	 lyticase	 (LY)	




Figure	 10.8	 shows	 no	 detectable	 recovery	 of	 soluble	 core-positive	material	when	
YeastbusterTM	 is	used.	This	demonstrates	that,	despite	being	capable	of	disrupting	





waves.	 These	waves	 can	be	produced	by	 sonication	devices	 such	 as	 the	 SoniPrep	
150	(MSE,	2017).	This	method	of	disruption	has	been	used	for	the	disruption	for	a	
variety	of	microbial	expression	systems	(Chakrabarti	et	al.,	2001;	Hemsworth	et	al.,	
2014),	 including	P.	 pastoris.	 Section	 2.4.4	 shows	 how	 the	 SoniPrep	 150	was	 used	









Figure	 10.9	 Comparison	 of	 lyticase-mediated	 cell	 disruption	 versus	 SoniPrep-mediated	





shown	 that	 the	 implementation	 of	 sonication	 resulted	 in	 a	 loss	 of	 soluble	 core-
positive	material.	 It	has	been	speculated	that	this	could	be	due	to	heating	effects.	
Furthermore,	 this	 method	 of	 cell	 disruption	 relies	 heavily	 on	 manual	 operation,	
presents	 an	 increased	 risk	 of	 sample	 cross-contamination	 and	 is	 not	 suitable	 for	




























A	 change	 in	working	 volume	 (Vw)	 leads	 to	 a	 change	 in	 the	 oxygen	mass	 transfer	
coefficient,	kLa,	as	shown	in	the	following	correlation	(Doran,	1996):		
"#$ = & '( 	 	 Equation	10-1	




)*+ = "#$ ,∗ − ,# 		 	 Equation	10-2	
Where:	
• OTR	represents	the	Oxygen	Transfer	Rate	(mmol/L/h)	









The	OUR	describes	 the	 rate	of	oxygen	 consumption	by	a	 culture,	which	 in	 turn	 is	
dependent	on	the	specific	growth	rate	as	shown	in	the	following	equation:		




• m 	represents	 a	 maintenance	 coefficient	 and	 can	 be	 determined	
experimentally	
The	 yield	 of	 biomass	 over	 oxygen	 can	 be	 calculated	 using	 Equation	 10-4.	 This	
equation	is	a	representation	of	the	metabolism	of	a	culture.	















Table	 10-2	 Growth	 kinetics	 screening	 in	 microtitre	 plates:	 Design	 space	 (left)	 and	
corresponding	response	values	(right).		
Pattern	 Vw(mL)	 [X]0	(OD600)	 t	(h)	 [X]t	(OD600)	 µ	(h-1)	
−−−	 0.5	 20	 2	 27.2	 1.54•10-1	
−−+	 0.5	 20	 30	 58.4	 3.57•10-2	
−+−	 0.5	 100	 2	 140	 1.70•10-1	
−++	 0.5	 100	 30	 108	 2.44•10-3	
+−−	 2.5	 20	 2	 21.2	 2.91•10-1	
+−+	 2.5	 20	 30	 62.8	 3.81•10-1	
++−	 2.5	 100	 2	 105	 2.53•10-2	
+++	 2.5	 100	 30	 98.4	 -5.38•10-4	
000	 1.5	 60	 16	 94.8	 2.86•10-2	
000	 1.5	 60	 16	 95.6	 2.91•10-2	
000	 1.5	 60	 16	 94.8	 2.86•10-2	
10.4.3 Calculation	for	correlation	between	incubation	time	and	working	volume		
µ = 4.91 ∙ 10dM − 3.78 ∙ 10dMf t − 3.37 ∙ 10dMf Vj + 3.35 ∙ 10dMf Vj ∙ t = 0	
∴ 1.46 − 1.13f t − 1.01f Vj + f Vj ∙ f t = 0	
∴ f t − 1.01 f Vj − 1.13 = −0.319	
∴ f t = −0.319f Vj − 1.13 + 1.01	
f t = t − 1614 	∪ 	f Vj = Vj − 1.5	
∴ o(6qr) = dt.tu'(d:.vw + wr. xt		 	 Equation	10-5	
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10.4.4 Design	space	and	model	summaries	for	 induction	screenings	 in	microtitre	
plates	
Table	10-3	Growth	and	expression	kinetics	screening	in	microtitre	plates	during	methanol	












−−−	 0.5	 18	 2	 5.54	 -5.89•10-1	 8.12	 1.47	
+−−	 5	 18	 2	 6.50	 -5.09•10-1	 24.7	 0.380	
−+−	 0.5	 90	 2	 65.6	 -1.58•10-1	 25.5	 0.389	
++−	 5	 90	 2	 63.2	 -1.77•10-1	 27.1	 0.429	
0	 2.75	 54	 16	 29.2	 -3.84•10-2	 76.2	 2.61	
0	 2.75	 54	 16	 31.6	 -3.35•10-2	 76.6	 2.42	
0	 2.75	 54	 16	 27.2	 -4.29•10-2	 80.0	 2.94	
−−+	 0.5	 18	 30	 10.0	 -1.96•10-2	 89.7	 8.96	
+−+	 5	 18	 30	 12.8	 -1.14•10-2	 85.2	 6.66	
−++	 0.5	 90	 30	 41.6	 -2.57•10-2	 38.3	 0.920	
+++	 5	 90	 30	 53.2	 -1.75•10-2	 61.7	 1.16	
	
Table	10-4	Growth	and	expression	kinetics	screening	in	microtitre	plates	during	methanol	












−−−	 0.3	 18	 2	 6.26	 -5.28•10-1	 0	 0	
+−−	 1.0	 18	 2	 6.48	 -5.11•10-1	 0	 0	
−+−	 0.3	 90	 2	 79.2	 -6.39•10-2	 0	 0	
++−	 1.0	 90	 2	 87.2	 -1.58•10-2	 0	 0	
0	 0.65	 54	 16	 26.8	 -4.38•10-2	 0	 0	
0	 0.65	 54	 16	 27.2	 -4.29•10-2	 0	 0	
0	 0.65	 54	 16	 31.6	 -3.35•10-2	 0	 0	
−−+	 0.3	 18	 30	 9.6	 -2.10•10-2	 0	 0	
+−+	 1.0	 18	 30	 12.8	 -1.14•10-2	 0	 0	
−++	 0.3	 90	 30	 46.4	 -2.21•10-2	 13.7	 0.295	








Table	 10-5	 Second	 screening	 of	 growth	 and	 expression	 kinetics	 screening	 in	microtitre	












−−−	 2.5	 9	 16	 23.2	 5.92•10-2	 0.506	 2.18•10-2	
+−−	 7.5	 9	 16	 4.92	 -3.77•10-2	 1.99	 4.04•10-1	
−+−	 2.5	 45	 16	 71.2	 2.87•10-2	 0.0292	 4.11•10-4	
++−	 7.5	 45	 16	 63.6	 2.16•10-2	 0.172	 2.71•10-3	
000	 5	 27	 31	 50	 2.05•10-2	 0.445	 8.90•10-3	
000	 5	 27	 31	 53.6	 2.29•10-2	 0.450	 8.40•10-3	
000	 5	 27	 31	 49.2	 2.00•10-2	 0.0841	 1.71•10-3	
−−+	 2.5	 9	 46	 28.8	 2.53•10-2	 0.0499	 1.73•10-3	
+−+	 7.5	 9	 46	 24.4	 2.17•10-2	 0.399	 1.63•10-3	
−++	 2.5	 45	 46	 72	 1.02•10-2	 0.387	 5.38•10-3	
+++	 7.5	 45	 46	 74.4	 1.09•10-2	 0.215	 2.89•10-3	
	
Table	10-6	Second	screening	of	growth	and	expression	kinetics	in	microtitre	plates	during	














−−−	 0.5	 90	 16	 96	 4.03•10-3	 11.4	 1.19•10-1	
+−−	 2.5	 90	 16	 109.2	 1.21•10-2	 7.13	 6.53•10-2	
−+−	 0.5	 135	 16	 116.8	 -9.05•10-3	 4.55	 3.90•10-2	
++−	 2.5	 135	 16	 134	 -4.65•10-4	 6.85	 5.11•10-2	
000	 1.5	 112.5	 31	 114.8	 6.75•10-4	 8.10	 7.05•10-2	
000	 1.5	 112.5	 31	 114.8	 6.75•10-4	 10.7	 9.35•10-2	
000	 1.5	 112.5	 31	 109.2	 -9.92•10-4	 9.05	 8.29•10-2	
−−+	 0.5	 90	 46	 93.2	 7.60•10-4	 10.8	 1.16•10-1	
+−+	 2.5	 90	 46	 95.2	 1.22•10-3	 8.49	 8.91•10-2	
−++	 0.5	 135	 46	 118.8	 -2.78•10-3	 5.95	 5.01•10-2	







Table	 10-7	 Growth	 and	 expression	 kinetics	 screening	 in	 microtitre	 plates	 during	 PDM	










−−	 10.8	 16	 18	 3.19•10-2	 0.975	 0.0542	
+−	 54	 16	 58	 4.47•10-3	 0	 0	
00	 32.4	 30	 36	 3.51•10-3	 0	 0	
00	 32.4	 30	 35.6	 3.14•10-3	 0	 0	
−+	 10.8	 46	 16.4	 9.08•10-3	 2.34	 0.142	
++	 54	 46	 56.8	 1.10•10-3	 0	 0	
	
Table	 10-8	 Growth	 and	 expression	 kinetics	 screening	 in	 microtitre	 plates	 during	 PDM	










−−	 108	 16	 100.8	 -4.31•10-3	 3.13	 0.0311	
+−	 162	 16	 146.4	 -6.33•10-3	 4.85	 0.0331	
00	 135	 30	 120	 -3.93	•10-3	 9.60	 0.0800	
00	 135	 30	 118	 -4.49•10-3	 10.8	 0.0911	
−+	 108	 46	 98	 -2.11•10-3	 10.6	 0.108	
++	 162	 46	 147.6	 -2.02•10-3		 6.16	 0.0417	
	
Table	10-9:	Relative	factor	contributions	in	a	two-factor,	two-level,	full-fractional	factorial	










Table	 10-10	 Relative	 factor	 contributions	 in	 a	 two-factor,	 two-level,	 full-fractional	
factorial	screening	designs	investigating	induction	of	P.	pastoris	MutS	in	microtitre	plates	










Table	 10-11	 dGAME	 Models	 and	 goodness	 of	 fit	 for	 second	 screening	 designs	







	 R2	 R2	adj.	 Formulae	 R2	 R2	adj.	
µ	(h-1)	 0.863	 0.657	 µ = 8.87 ∙ 10dy − 8.70 ∙ 10dyf X{ 	 0.467	 0.333	




HBc~ = 3.27 ∙ 10dM − 4.92 ∙10dMf X{ 		
	
0.576	 0.470	
f X{ = X{ − 32.421.6 	
	
Table	 10-12	 dGAME	 Models	 and	 goodness	 of	 fit	 for	 second	 screening	 designs	







	 R2	 R2	adj.	 Formulae	 R2	 R2	adj.	
µ	(h-1)	 0.972	 0.929	 µ = −3.83 ∙ 10dy − 1.64 ∙ 10dyf t 	 0.816	 0.770	
[tHBc]	(µg/mL)	 0.551	 -0.124	 tHBc = 7.56 − 2.10f t 	 0.337	 0.171	
[tHBc]	
(µg/mL/OD600)	
0.715	 0.285	 HBc~ = 6.46 ∙ 10dM − 2.06 ∙ 10dMf t 		 0.312	 0.141	














































































































































































































T (°C) QMeOH (mL/Li/h)



















Ysol.,	spec.	 YVLP,	spec.	 Ytot.,	vol.	 Ysol.,	vol.	 YVLP.,	vol.	
1	 −−−	 1	 13.15	 20	 180	 16.7	 0.568	 1.93·10-1	 1.87·10-2	 3.76·10-1	 34.7	 3.36	 67.6	
2	 −−+	 1	 13.15	 30	 181	 18.5	 0.570	 1.43	 4.05·10-1	 2.58	 259	 73.2	 466	
3	 −+−	 1	 23.15	 20	 203	 14.6	 0.647	 6.70·10-2	 3.05·10-2	 1.67·10-1	 13.6	 6.19	 33.8	
4	 −++	 1	 23.15	 30	 209	 18.6	 0.675	 5.39·10-1	 5.39·10-1	 1.32	 113	 113	 275	
5	 +−−	 5	 13.15	 20	 257	 78.5	 0.522	 9.09·10-1	 9.82·10-2	 2.09	 234	 25.3	 537	
6	 +−+	 5	 13.15	 30	 139	 28.0	 0.589	 2.60	 2.42	 3.13	 361	 336	 435	
7	 ++−	 5	 23.15	 20	 270	 69.4	 0.611	 1.33	 1.28	 8.08·10-1	 360	 347	 218	
8	 +++	 5	 23.15	 30	 162	 40.7	 0.704	 7.85·10-1	 1.18	 1.18	 127	 192	 191	
9	 000	 3	 18.15	 25	 238	 45.7	 0.551	 3.56	 3.79	 2.93	 845	 900	 696	
10	 000	 3	 18.15	 25	 240	 46.5	 0.574	 2.75	 3.95	 3.17	 660	 949	 762	
11	 000	 3	 18.15	 25	 228	 45.3	 0.546	 3.14	 4.96	 4.12	 714	 1.13·103	 937	
12	 0α0	 3	 24.4	 25	 250	 48.9	 0.558	 2.57	 4.08	 4.34	 642	 1.02·103	 1.08·103	
13	 α00	 5.5	 18.15	 25	 279	 76.7	 0.534	 5.85	 7.87	 7.52	 1.63·103	 2.19·103	 2.10·103	
14	 0-α0	 3	 11.9	 25	 217	 45.8	 0.546	 4.00	 5.58	 5.45	 870	 1.21·103	 1.18·103	
15	 00α	 3	 18.15	 31.25	 178	 31.7	 0.632	 8.37	 9.65	 7.49	 1.49·103	 1.72·103	 1.33·103	
16	 00-α	 3	 18.15	 18.75	 228	 44.9	 0.538	 1.97	 2.77	 1.67	 448	 63.1	 381	






construct	 (42.5kDa)	 using	 pure	 methanol	 induction.	 Two-minute	 chromatography	
fractions	were	collected	after	10	minutes	for	an	additional	20	minutes.	(A-D)	Coomassie	







Figure	 10.16	 Log-scaled	 fermentation	 data	 of	 process	 scale-up	 of	 Pichia	 pastoris	
expressing	 tHBc-HA2.3,	 (M2e)3	 using	 mixed	 feeding	 induction.	 Large-scale	 data,	 at	 30L	
total	working	volume,	is	shown	in	blue.	Small-scale	data,	at	250mL	total	working	volume,	
is	 shown	 in	orange.	Carbon	dioxide	concentrations	 ([CO2])	was	measured	 in	off-gas	and	
biomass	concentrations	([X])	were	determined	through	wet	cell	weight	analysis.				
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